Document:

Form of Shareholder Rights Agreement

 Exhibit 4.2 
 MYRIAD PHARMACEUTICALS, INC. 
 AND 
 AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, AS RIGHTS AGENT 
 SHAREHOLDER
RIGHTS AGREEMENT 
 DATED AS OF JUNE     , 2009 

 TABLE OF CONTENTS 
  

					
	Section 1.	  	 Certain Definitions
	  	1
	Section 2.	  	 Appointment of Rights Agent
	  	7
	Section 3.	  	 Issue of Right Certificates.
	  	7
	Section 4.	  	 Form of Right Certificates.
	  	9
	Section 5.	  	 Countersignature and Registration.
	  	10
	Section 6.	  	 Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated, Destroyed, Lost or Stolen Right
Certificates.
	  	10
	Section 7.	  	 Exercise of Rights; Exercise Price; Expiration Date of Rights.
	  	11
	Section 8.	  	 Cancellation and Destruction of Right Certificates
	  	13
	Section 9.	  	 Reservation and Availability of Preferred Stock.
	  	13
	Section 10.	  	 Preferred Stock Record Date
	  	14
	Section 11.	  	 Adjustment of Exercise Price, Number and Kind of Shares or Number of Rights
	  	15
	Section 12.	  	 Certificate of Adjusted Exercise Price or Number of Shares
	  	22
	Section 13.	  	 Consolidation, Merger or Sale or Transfer of Assets or Earning Power.
	  	22
	Section 14.	  	 Fractional Rights and Fractional Shares.
	  	25
	Section 15.	  	 Rights of Action
	  	25
	Section 16.	  	 Agreement of Right Holders
	  	26
	Section 17.	  	 Right Certificate Holder Not Deemed a Shareholder
	  	26
	Section 18.	  	 Concerning the Rights Agent.
	  	27
	Section 19.	  	 Merger or Consolidation or Change of Name of Rights Agent.
	  	27
	Section 20.	  	 Duties of Rights Agent
	  	28
	Section 21.	  	 Change of Rights Agent
	  	29
	Section 22.	  	 Issuance of New Right Certificates
	  	30
	Section 23.	  	 Redemption.
	  	31
	Section 24.	  	 Exchange.
	  	31
	Section 25.	  	 Notice of Certain Events.
	  	33
	Section 26.	  	 Notices
	  	34
	Section 27.	  	 Supplements and Amendments
	  	34
	Section 28.	  	 Successors
	  	35
	Section 29.	  	 Determinations and Actions by the Board of Directors
	  	35
	Section 30.	  	 Benefits of this Agreement
	  	35
	Section 31.	  	 Severability
	  	35
	Section 32.	  	 Governing Law
	  	36
	Section 33.	  	 Counterparts
	  	36
	Section 34.	  	 Descriptive Headings
	  	36
	Section 35.	  	 Force Majeure
	  	36
			
	Exhibit A	  	 Certificate of Designation classifying and designating the Series A Junior Participating Preferred Stock
	  	
			
	Exhibit B	  	 Form of Right Certificate
	  	

  

 i 

 SHAREHOLDER RIGHTS AGREEMENT 
 This Shareholder Rights Agreement (“this Agreement”), dated as of June     , 2009, between Myriad
Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agent”). 
 WITNESSETH: 
 WHEREAS, the Board of Directors
of the Company has authorized and declared a dividend distribution of one right (a “Right”) for each share of Common Stock, par value $0.01 per share, of the Company outstanding as of June     , 2009 (the
“Record Date”), and has authorized the issuance of one Right (as such number may be adjusted pursuant to Section 11(p) hereof) for each share of Common Stock of the Company issued (whether originally issued or delivered from
the Company’s treasury) between the Record Date and the Distribution Date, each Right initially representing the right to purchase one one-thousandth of a share of Series A Junior Participating Preferred Stock of the Company having the rights,
powers and preferences set forth on Exhibit A attached hereto, upon the terms and subject to the conditions hereinafter set forth; 
 NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows: 
 Section 1. Certain Definitions. For purposes of this Agreement, the following terms have the meanings indicated: 
 (a) “Acquiring Person” shall mean any Person who or which, after the date of the distribution of shares of Common Stock on a pro rata basis to the stockholders of Myriad Genetics, Inc., as described
in the Registration Statement on Form 10 of the Company filed with and declared effective by the Securities and Exchange Commission, together with all Affiliates and Associates of such Person, and together with any Person with whom such Person is
Acting in Concert (or any Affiliate or Associate thereof), shall be the Beneficial Owner of 15% or more of the shares of Common Stock of the Company then outstanding, but shall not include (i) the Company, (ii) any Subsidiary of the
Company, and in the case of each of the foregoing subsections (i) and (ii), the officers and members of the Board of Directors thereof acting in their fiduciary capacities, (iii) any employee benefit plan of the Company or any Subsidiary
of the Company or (iv) any Person organized, appointed or established by the Company or any Subsidiary of the Company for or pursuant to the terms of any such employee benefit plan (the Persons described in clauses (i) through
(iv) above are referred to herein as “Exempt Persons”). 
 Notwithstanding the foregoing, no Person shall become an
“Acquiring Person” as the result of an acquisition by the Company of its own shares of Common Stock which, by reducing the number of shares outstanding, increases the proportionate number of shares Beneficially Owned by such Person
to 15% or more of the shares of Common Stock of the Company then outstanding; provided, that if a Person shall become the Beneficial Owner of 15% or more of the shares of Common Stock of the Company then outstanding solely by reason of share
purchases by the Company and shall, after such share purchases by the Company, become the Beneficial Owner of any additional shares (other than pursuant to a stock split, stock dividend or similar transaction) of Common Stock of the Company and
immediately thereafter be the Beneficial Owner of 15% or more of the shares of Common Stock of the Company then outstanding, then such Person shall be deemed to be an “Acquiring Person.” 

 In addition, notwithstanding the foregoing, and notwithstanding anything to the contrary provided in the
Agreement, including, without limitation, in Sections 1(gg), 3(a) or 27, a Person shall not be an “Acquiring Person” if the Board of Directors of the Company determines at any time that a Person who would otherwise be an
“Acquiring Person,” has become such without intending to become an “Acquiring Person,” and such Person promptly (and in any event within five Business Days or such shorter period as requested by the Company) divests
or enters into an irrevocable commitment to divest as promptly as practicable, and thereafter divests as required by such commitment, a sufficient number of shares of Common Stock of the Company (or, for the avoidance of doubt, with respect to any
Derivative Common Shares, terminates the subject derivative transaction or transactions or disposes of the subject derivative security or securities) so that such Person would no longer be an “Acquiring Person,” as defined pursuant
to the foregoing provisions of this Section 1(a). 
 (b) A Person shall be deemed to be “Acting in
Concert” with another Person if such Person knowingly acts (whether or not pursuant to an express agreement, arrangement or understanding) in concert with, or towards a common goal relating to, changing or influencing the control of the
Company or in connection with or as a participant in any transaction having that purpose or effect, in parallel with such other Person where (i) each Person is conscious of the other Person’s conduct and this awareness is an element in
their decision-making processes and (ii) at least one additional factor supports a determination by the Board of Directors that such Persons intended to act in concert or in parallel, which such additional factors may include, without
limitation, exchanging information, attending meetings, conducting discussions, or making or soliciting invitations to act in concert or in parallel. A Person which is Acting in Concert with another Person shall also be deemed to be Acting in
Concert with any third party who is also Acting in Concert with such other Person. 
 (c) “Adjustment Shares”
shall have the meaning set forth in Section 11(a)(ii) hereof. 
 (d) “Affiliate” and
“Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations (the “Rules”) under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), as in effect on the date of this Agreement; provided that no Person who is a director or officer of the Company shall be deemed an Affiliate or an Associate of any other director or officer of the Company solely as a result of his or
her position as director or officer of the Company. 
 (e) A Person shall be deemed the “Beneficial Owner”
of, and shall be deemed to “Beneficially Own” and have “Beneficial Ownership” of, any securities: 
 (i) which such Person or any of such Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), directly or indirectly, Beneficially Owns (as determined
pursuant to Rule 13d-3 of the Rules under the Exchange Act, as in effect on the date of this Agreement); 
 (ii) which such
Person or any of such Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), directly or indirectly, has: 
 (A) the legal, equitable or contractual right to acquire (whether directly or indirectly, whether such right is exercisable immediately
or only after the passage of time, compliance with regulatory requirements, fulfillment of a 

  

 2 

 
condition or otherwise or whether within the control of such Person) pursuant to any agreement, arrangement or understanding (whether or not in writing)
(other than customary agreements with and between underwriters and selling group members with respect to a bona fide public offering of securities), including, without limitation, for the avoidance of doubt, through any agreement to enter into an
agreement that would permit a Person to purchase or otherwise acquire such securities, or upon the exercise of conversion rights, exchange rights, rights (other than the Rights), warrants or options, or otherwise and including any securities
represented by “when-issued” trading thereof; provided, that a Person shall not be deemed the “Beneficial Owner” of, or to “Beneficially Own” or have “Beneficial Ownership” of,
(1) securities tendered pursuant to a tender or exchange offer made by or on behalf of such Person or any of such Person’s Affiliates or Associates until such tendered securities are accepted for purchase or exchange; (2) securities
issuable upon exercise of these Rights at any time prior to the occurrence of a Triggering Event; or (3) securities issuable upon exercise of Rights from and after the occurrence of a Triggering Event, which Rights were acquired by such Person
or any of such Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), prior to the Distribution Date or pursuant to Sections 3(a), 11(i) or 22 hereof;

 (B) the right to vote pursuant to any agreement, arrangement or understanding (whether or not in writing); provided that a
Person shall not be deemed the “Beneficial Owner” of, or to “Beneficially Own” or have “Beneficial Ownership” of, any security under this clause (B) if the agreement, arrangement or
understanding to vote such security (1) arises solely from a revocable proxy or consent given in response to a public proxy or consent solicitation made pursuant to a written proxy or consent solicitation statement filed with the Securities and
Exchange Commission, in accordance with the Rules under the Exchange Act and (2) is not also then reportable by such person on Schedule 13D pursuant to Rule 13(d)-1 under the Exchange Act (or any comparable or successor report); or 

(C) the right to dispose of, pursuant to any agreement, arrangement or understanding, whether or not in writing (other than customary
arrangements with and between underwriters and selling group members with respect to a bona fide public offering of securities); 
 (iii) which are Beneficially Owned, directly or indirectly, by any other Person (or any Affiliate or Associate thereof), or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), with which such
Person or any of such Person’s Affiliates or Associates (or any other Person with whom such Person is Acting in Concert, or any Affiliate or Associate thereof) has any agreement, arrangement or understanding (whether or not in writing) (other
than customary agreements with and between underwriters and selling group members with respect to a bona fide public offering of securities) for the purpose of acquiring, holding, voting (except pursuant to a revocable proxy as described in clause
(B) of Section 1(e)(ii) hereof) or disposing of any voting securities of the Company; 
 (iv) provided, that
(1) no Person engaged in business as an underwriter of securities shall be deemed the Beneficial Owner of any securities acquired through such Person’s participation as an underwriter in good faith in a firm commitment underwriting until
the expiration of forty (40) days after the date of such acquisition, and (2) no Person who is a director or 

  

 3 

 
an officer of the Company shall be deemed, as a result of his or her position as director or officer of the Company, the Beneficial Owner of any securities
of the Company that are Beneficially Owned by any other director or officer of the Company; or 
 (v) of which such Person
would otherwise be deemed to be the beneficial owner pursuant to Rule 13d-3 under the Exchange Act. 
 A Person who or which, together with
all Affiliates and Associates of such Person, and together with any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), shall be the Beneficial Owner (within the meaning of this Section 1(e)) of 5%
or more of the Common Stock of the Company then outstanding, shall also be deemed to be the Beneficial Owner of, to have beneficial ownership of or to Beneficially Own any securities that are the subject of one or more derivative transactions
entered into by such Person or any of such Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), or derivative security acquired by such Person or any of such
Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), which gives such Person or any of such Person’s Affiliates or Associates, or any other Person with
whom such Person is Acting in Concert (or any Affiliate or Associate thereof), the economic equivalent of ownership of an amount of such securities due to the fact that the value of the derivative is determined by reference to the price or value of
such securities, or which provides such Person or any of such Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), an opportunity, directly or indirectly, to
profit, or to share in any profit, derived from any change in the value of such securities, in any case without regard to whether (a) such derivative conveys any voting rights in such securities to such Person or any of such Person’s
Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), (b) the derivative is required to be, or capable of being, settled through delivery of such securities, or
(c) such Person or any of such Person’s Affiliates or Associates, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), may have entered into other transactions that hedge the economic
effect of such derivative. 
 In determining the number of shares of Common Stock of the Company Beneficially Owned by virtue of the operation
of this Section 1(e), the subject Person, or any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), shall be deemed to Beneficially Own (without duplication), the notional or other number of shares
of Common Stock of the Company specified in the documentation evidencing the derivative position as being subject to be acquired upon the exercise or settlement of the applicable right or as the basis upon which the value or settlement amount of
such right, or the opportunity of the holder of such right to profit or share in any profit, is to be calculated in whole or in part, and in any case (or if no such number of shares of Common Stock of the Company is specified in such documentation
or otherwise), as determined by the Board of Directors of the Company in good faith to be the number of shares of Common Stock of the Company to which the derivative position relates. Such shares of Common Stock of the Company that are deemed so
Beneficially Owned pursuant to the operation of this Section 1(e) shall be referred to herein as “Derivative Common Shares.” 
 For all purposes of this Agreement, the phrase “then outstanding,” when used with reference to the percentage of the then outstanding securities Beneficially Owned by a Person, shall mean the number of securities then
issued and outstanding, together with the number of such securities not then actually issued and outstanding which such Person would be deemed to Beneficially Own hereunder. 
  

 4 

 The term “beneficially own” shall have the same meaning as the term “Beneficially
Own.” 
 (f) “Business Day” shall mean any day other than a Saturday, Sunday, or a day on which banking
institutions in the State of New York are authorized or obligated by law or executive order to close. 
 (g)
“Certificate of Incorporation” when used in reference to the Company, shall mean the Restated Certificate of Incorporation, as amended and as may be further amended from time to time, of the Company. 
 (h) “Close of Business” on any given date shall mean 5:00 p.m., New York, New York, local time, on such date; provided,
that, if such date is not a Business Day, it shall mean 5:00 p.m., New York, New York local time, on the next succeeding Business Day. 
 (i) “Common Stock” when used in reference to the Company, shall mean the Common Stock, par value $0.01 per share, of the Company or any other shares of capital stock of the Company into which such
stock shall be reclassified or changed. “Common Stock,” when used with reference to any Person, other than the Company, organized in corporate form, shall mean (i) the capital stock or other equity interest of such Person
with the greatest voting power, (ii) the equity securities or other equity interest having power to control or direct the management of such Person or (iii) if such Person is a Subsidiary of another Person, the Person or Persons which
ultimately control such first-mentioned Person and which have issued any such outstanding capital stock, equity securities or equity interest. “Common Stock” when used with reference to any Person not organized in corporate form
shall mean units of beneficial interest which (x) shall represent the right to participate generally in the profits and losses of such Person (including, without limitation, any flow-through tax benefits resulting from an ownership interest in
such Person) and (y) shall be entitled to exercise the greatest voting power of such Person or, in the case of a limited partnership, shall have the power to remove or otherwise replace the general partner or partners. 
 (j) “Current Value” shall have the meaning set forth in Section 11(a)(iii) hereof. 
 (k) “Depositary Agent” shall have the meaning set forth in Section 7(c) hereof. 
 (l) “Distribution Date” shall have the meaning defined in Section 3(a) hereof. 
 (m) “Exempt Person” shall have the meaning set forth in the definition of “Acquiring Person.”

 (n) “Exercise Price” shall have the meaning defined in Section 4(a) hereof. 
 (o) “Expiration Date” and “Final Expiration Date” shall have the meanings set forth in Section 7(a)
hereof. 
 (p) “Fair Market Value” of any securities or other property shall be as determined in accordance
with Section 11(d) hereof. 
  

 5 

 (q) “Group” shall have the meaning set forth in clause (b) of the
definition of “Person.” 
 (r) “Person” shall mean any (a) individual, firm,
corporation, partnership, limited liability company, association, joint stock company, trust, business trust, government or political subdivision, unincorporated organization, or other entity, including any successor (by merger or otherwise) thereof
or thereto, or (b) “group” as that term is used for purposes of Section 13(d)(3) of the Exchange Act. 
 (s) “Preferred Stock” shall mean shares of Series A Junior Participating Preferred Stock, par value $0.01 per share, of the Company having the rights and preferences set forth in the form of Certificate of Designation,
Rights and Preferences of the Preferred Stock classifying and designating the Series A Junior Participating Preferred Stock, in the form attached hereto as Exhibit A. 
 (t) “Preferred Stock Equivalents” shall have the meaning set forth in Section 11(b) hereof. 
 (u) “Principal Party” shall have the meaning defined in Section 13(b) hereof. 
 (v) “Redemption Price” shall have the meaning defined in Section 23 hereof. 
 (w) “Registered Common Stock” shall have the meaning set forth in Section 13(b) hereof. 
 (x) “Right Certificates” shall have the meaning set forth in Section 3(a) hereof. 
 (y) “Section 11(a)(ii) Event” shall have the meaning set forth in Section 11(a)(ii) hereof. 
 (z) “Section 11(a)(ii) Trigger Date” shall have the meaning set forth in Section 11(a)(iii) hereof. 
 (aa) “Section 13 Event” shall mean any event described in clauses (x), (y) or (z) of Section 13(a) hereof.

 (bb) “Section 24(a)(i) Exchange Ratio” shall have the meaning set forth in Section 24(a)(i) hereof.

 (cc) “Section 24(a)(ii) Exchange Ratio” shall have the meaning set forth in Section 24(a)(ii) hereof.

 (dd) “Spread” shall have the meaning set forth in Section 11(a)(iii) hereof. 
 (ee) “Stock Acquisition Date” shall mean the date of the first public announcement (which, for purposes of this
definition, shall include, without limitation, the issuance of a press release or the filing of a publicly-available report or other document with the Securities and Exchange Commission or any other governmental agency) by the Company, acting
pursuant to a resolution adopted by the Board of Directors of the Company, or an Acquiring Person, subject in each case to the last paragraph of Section 1(a), that an Acquiring Person has become such. 
  

 6 

 (ff) “Subsidiary” shall mean, with reference to any Person, any
corporation or other entity of which securities or other ownership interests having ordinary voting power sufficient, in the absence of contingencies, to elect a majority of the board of directors or other persons performing similar functions of
such corporation or other entity are at the time directly or indirectly Beneficially Owned or otherwise controlled by such Person, either alone or together, with one or more Affiliates of such Person. 
 (gg) “Substitution Period” shall have the meaning set forth in Section 11(a)(iii) hereof. 
 (hh) “Triggering Event” shall mean any Section 11(a)(ii) Event or any Section 13 Event. 
 Section 2. Appointment of Rights Agent. The Company hereby appoints the Rights Agent to act as agent for the Company, in accordance with the
terms and conditions hereof, and the Rights Agent hereby accepts such appointment. The Company may, from time to time, appoint such co-rights agents as it may deem necessary or desirable. In the event the Company appoints one or more co-rights
agents, the respective duties of the Rights Agent and any co-rights agents shall be as the Company shall determine, subject to the terms and conditions of this Agreement. The Company shall give ten (10) days’ prior written notice to the
Rights Agent of the appointment of one or more co-rights agents and the respective duties of the Rights Agent and any such co-rights agents. The Rights Agent shall have no duty to supervise, and shall, in no event, be liable for, the acts or
omissions of any such co-rights agents. 
 Section 3. Issuance of Right Certificates. 
 (a) From the date hereof until the earlier of (i) the Close of Business on the
tenth (10th) Business Day after the Stock Acquisition Date or (ii) the Close of Business on the tenth (10th) Business Day (or such later date, if any, as the Board of Directors of the Company may determine in its sole discretion) after the date a tender or
exchange offer by any Person, other than an Exempt Person, is first published or sent or given within the meaning of Rule 14d-2(a) of the Rules under the Exchange Act, or any successor rule, if, upon consummation thereof, such Person could become
the Beneficial Owner of 15% or more of the shares of Common Stock of the Company then outstanding (including any such date which is after the date of this Agreement and prior to the issuance of the Rights) (the earliest of such dates being herein
referred to as the “Distribution Date”), (x) the Rights shall be evidenced (subject to the provisions of Section 3(b) hereof) by the certificates for the Common Stock of the Company registered in the names of the holders
of the Common Stock of the Company (which certificates for Common Stock of the Company shall be deemed also to be certificates for Rights) and not by separate certificates, and (y) the Rights shall be transferable only in connection with the
transfer of the underlying shares of Common Stock of the Company (including a transfer to the Company). As soon as practicable after the Distribution Date, the Rights Agent shall, at the Company’s expense, send, by first-class, insured, postage
prepaid mail, to each record holder of the Common Stock of the Company as of the Close of Business on the Distribution Date, at the address of such holder shown on the records of the Company, one or more certificates, in substantially the form of
Exhibit B attached hereto (the “Right Certificates”), evidencing one Right for each share of Common Stock of the Company so held, subject to adjustment as provided herein. In the event that an adjustment in the number of
Rights per share of Common Stock of the Company has been made pursuant to Section 11(p) hereof, the Company may make the necessary and appropriate rounding adjustments (in accordance with Section 14(a) hereof) at the time of distribution
of the Right Certificates, so that Right Certificates representing only whole numbers of Rights are distributed and cash is paid in lieu of any fractional Rights. As of and after the Close of Business on the Distribution Date, the Rights shall be
evidenced solely by such Right Certificates and the Rights shall be transferable separately from the shares of Common Stock of the Company. 
  

 7 

 (b) With respect to certificates for the Common Stock of the Company issued prior to the
Close of Business on the Record Date, the Rights shall be evidenced by such certificates for the Common Stock of the Company on or until the Distribution Date (or the earlier redemption, expiration or termination of the Rights), and the registered
holders of the Common Stock of the Company also shall be the registered holders of the associated Rights. Until the Distribution Date (or the earlier redemption, expiration or termination of the Rights), the transfer of any of the certificates for
the Common Stock of the Company outstanding prior to the date of this Agreement shall also constitute the transfer of the Rights associated with the Common Stock of the Company represented by such certificate. 
 (c) Certificates for Common Stock of the Company issued after the Record Date, but prior to the earlier of the Distribution Date or the
Expiration Date, shall be deemed also to be certificates for Rights, and shall bear a legend, substantially in the form set forth below: 
 This certificate also evidences and entitles the holder hereof to certain Rights as set forth in a Shareholder Rights Agreement between Myriad Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC (or any successor
thereto), as Rights Agent, dated as of June     , 2009, as amended, restated, renewed, supplemented or extended from time to time (the “Rights Agreement”), the terms of which are hereby incorporated herein
by reference and a copy of which is on file at the principal offices of Myriad Pharmaceuticals, Inc. and the stock transfer administration office of the Rights Agent. Under certain circumstances, as set forth in the Rights Agreement, such Rights
shall be evidenced by separate certificates and shall no longer be evidenced by this certificate. Myriad Pharmaceuticals, Inc. may redeem the Rights at a redemption price of $0.01 per Right, subject to adjustment, under the terms of the Rights
Agreement. Myriad Pharmaceuticals, Inc. shall mail to the holder of this certificate a copy of the Rights Agreement, as in effect on the date of mailing, without charge, promptly after receipt of a written request therefor. Under certain
circumstances, Rights issued to or held by Acquiring Persons or any Affiliates or Associates thereof (as defined in the Rights Agreement), and any subsequent holder of such Rights, may become null and void. The Rights shall not be exercisable, and
shall be void so long as held, by a holder in any jurisdiction where the requisite qualification, if any, to the issuance to such holder, or the exercise by such holder, of the Rights in such jurisdiction shall not have been obtained or be
obtainable. 
 With respect to such certificates containing the foregoing legend, the Rights associated with the Common Stock of the Company represented by
such certificates shall be evidenced by such certificates alone until the earlier of the Distribution Date or the Expiration Date), and the transfer of any of such certificates shall also constitute the transfer of the Rights associated with the
Common Stock of the Company represented by such certificates. In the event that the Company purchases or acquires any shares of Common Stock of the Company after the Record Date but prior to the Distribution Date, any Rights associated with such
Common Stock of the Company shall be deemed canceled and retired so that the Company shall not be entitled to exercise any Rights associated with the shares of Common Stock of the Company which are no longer outstanding. The failure to print the
foregoing legend on any such certificate representing Common Stock of the Company or any defect therein shall not affect in any manner whatsoever the application or interpretation of the provisions of Section 7(e) hereof. 
  

 8 

 Section 4. Form of Right Certificates. 
 (a) The Right Certificates (and the forms of election to purchase shares and of assignment and certificate to be printed on the reverse
thereof) shall each be substantially in the form of Exhibit B attached hereto and may have such marks of identification or designation and such legends, summaries or endorsements printed thereon as the Company may deem appropriate and as are
not inconsistent with the provisions of this Agreement, or as may be required to comply with any applicable law, rule or regulation or with any rule or regulation of any stock exchange on which the Rights may from time to time be listed, or to
conform to customary usage. The Right Certificates shall be in a machine printable format and in a form reasonably satisfactory to the Rights Agent. Subject to the provisions of Section 11 and Section 22 hereof, the Right Certificates,
whenever distributed, shall be dated as of the Record Date, shall show the date of countersignature and, on their face, shall entitle the holders thereof to purchase such number of one one-thousandths of a share of Preferred Stock as shall be set
forth therein at the price set forth therein (the “Exercise Price”), but the amount and type of securities and the Exercise Price shall be subject to adjustment as provided herein. 
 (b) Any Right Certificate issued pursuant to Section 3(a) or Section 22 hereof that represents Rights Beneficially Owned by
(i) an Acquiring Person or any Associate or Affiliate of an Acquiring Person, and any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), (ii) a transferee of an Acquiring Person (or of any
Associate or Affiliate of an Acquiring Person), and any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), who becomes a transferee after the Acquiring Person becomes such, or (iii) a transferee of
an Acquiring Person (or of any such Associate or Affiliate), and any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), who becomes a transferee prior to or concurrently with the Acquiring Person
becoming such and receives such Rights pursuant to either (A) a transfer (whether or not for consideration) from the Acquiring Person to holders of equity interests in such Acquiring Person or to any Person with whom the Acquiring Person has
any continuing agreement, arrangement or understanding (whether or not in writing) regarding the transferred Rights, the shares of Common Stock of the Company associated with such Rights or the Company or (B) a transfer which the Board of
Directors of the Company has determined is part of a plan, arrangement or understanding which has as a primary purpose or effect the avoidance of Section 7(e) hereof, and any Right Certificate issued pursuant to Section 6, Section 11
or Section 22 upon transfer, exchange, replacement or adjustment of any other Right Certificate referred to in this sentence, shall have deleted therefrom the second sentence of the existing legend on such Right Certificate (to the extent
feasible and if the Company has provided specific written instructions to the Rights Agent) and, in substitution therefor, shall contain the following legend: 
 The Rights represented by this Right Certificate are or were Beneficially Owned by a Person who was or became an Acquiring Person or an Affiliate or an Associate of an Acquiring Person (as such terms are defined in
the Rights Agreement). This Right Certificate and the Rights represented hereby may become null and void under certain circumstances as specified in Section 7(e) of the Rights Agreement. 
 The Company shall give notice to the Rights Agent promptly after it becomes aware of the existence and identity of any Acquiring Person or any Associate
or Affiliate thereof and any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof). The Company shall instruct the Rights Agent in writing of the Rights which should be so legended. The failure to print the
foregoing legend on any such Right Certificate or any defect therein shall not affect in any manner whatsoever the application or interpretation of the provisions of Section 7(e) hereof. 
  

 9 

 Section 5. Countersignature and Registration. 
 (a) The Right Certificates shall be executed on behalf of the Company by its Chairman of the Board of Directors, its President or any Vice
President and by its Treasurer, any Assistant Treasurer, its Secretary or any Assistant Secretary, either manually or by facsimile signature, and shall have affixed thereto the Company’s seal or a facsimile thereof which shall be attested to by
the Secretary or any Assistant Secretary of the Company, either manually or by facsimile signature. The Right Certificates shall be countersigned, either manually or by facsimile signature, by an authorized signatory of the Rights Agent and shall
not be valid for any purpose unless so countersigned, and such countersignature upon any Right Certificate shall be conclusive evidence, and the only evidence, that such Right Certificate has been duly countersigned as required hereunder. In case
any officer of the Company who shall have signed any of the Right Certificates shall cease to be such officer of the Company before countersignature by the Rights Agent and issuance and delivery by the Company, such Right Certificates, nevertheless,
may be countersigned by an authorized signatory of the Rights Agent, and issued and delivered by the Company with the same force and effect as though the person who signed such Right Certificates had not ceased to be such officer of the Company; and
any Right Certificates may be signed on behalf of the Company by any person who, at the actual date of the execution of such Right Certificate, shall be a proper officer of the Company to sign such Right Certificate, although at the date of the
execution of this Rights Agreement any such person was not such an officer. 
 (b) Following the Distribution Date, upon
receipt by the Rights Agent of notice to that effect and all other relevant information referred to in Section3(a) hereof, the Rights Agent shall keep or cause to be kept, at one of its offices designated for such purpose, books for registration and
transfer of the Right Certificates issued hereunder. Such books shall show the names and addresses of the respective holders of the Right Certificates, the number of Rights evidenced on its face by each of the Right Certificates and the date of each
of the Right Certificates. 
 Section 6. Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated, Destroyed,
Lost or Stolen Right Certificates. 
 (a) Subject to the provisions of Section 4(b), Section 7(e) and
Section 14 hereof, at any time after the Close of Business on the Distribution Date, and at or prior to the Close of Business on the Expiration Date, any Right Certificate or Certificates may be transferred, split up, combined or exchanged for
another Right Certificate or Certificates (other than Right Certificates representing Rights that may have been exchanged pursuant to Section 24 hereof), entitling the registered holder to purchase a like number of one one-thousandth of a share
of Preferred Stock (or following a Triggering Event, Common Stock of the Company, cash, property, debt securities, Preferred Stock or any combination thereof, including any such securities, cash property or other assets following a Section 13
Event) as the Right Certificate or Certificates surrendered then entitled such holder to purchase and at the same Exercise Price. Any registered holder desiring to transfer, split up, combine or exchange any Right Certificate shall make such request
in writing delivered to the Rights Agent, and shall surrender the Right Certificate or Certificates to be transferred, split up, combined or exchanged, at the office of the Rights Agent designated for such purpose. The Rights shall only be
transferable on the registry books of the Rights Agent. Neither the Rights Agent nor the Company shall be obligated to take any action whatsoever with respect to the transfer of any such surrendered Right Certificate until the registered holder
shall have completed and signed the certificate contained in the form of assignment on the reverse side of such 

  

 10 

 
Right Certificate and shall have provided such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner) as the Company shall
reasonably request and shall have paid a sum sufficient to cover any tax charge that may be imposed in connection with any transfer, split up, combination or exchange of Right Certificates. Thereupon, the Rights Agent shall, subject to
Section 4(b), Section 7(e) and Section 14 hereof, countersign and deliver the Right Certificate to the Person entitled thereto, as so requested. 
 (b) Upon receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the loss, theft, destruction or
mutilation of a Right Certificate, and, in case of loss, theft or destruction, of indemnity or security satisfactory to them, and reimbursement to the Company and the Rights Agent of all reasonable expenses incidental thereto, and upon surrender to
the Rights Agent and cancellation of the Right Certificate, if mutilated, the Company shall execute and deliver a new Right Certificate of like tenor to the Rights Agent for countersignature and delivery to the registered owner in lieu of the Right
Certificate so lost, stolen, destroyed or mutilated. 
 Section 7. Exercise of Rights; Exercise Price; Expiration Date of Rights.

 (a) Subject to Section 7(e) hereof, the registered holder of any Right Certificate may exercise the Rights evidenced
thereby (except as otherwise provided herein) in whole or in part, at any time after the Distribution Date, upon surrender of the Right Certificate, with the form of election to purchase and the certificate on the reverse side thereof properly
completed and duly executed, to the Rights Agent at the office of the Rights Agent designated for such purpose, together with payment of the aggregate Exercise Price for the total number of one one-thousandths of a share of Preferred Stock (or other
securities, cash or other assets, as the case may be) as to which such surrendered Rights are then exercised, at or prior to the earlier of (i) the Close of Business on the tenth anniversary of the Record Date (the “Final Expiration
Date”), (ii) the time at which the Rights are redeemed, as provided in Section 23 hereof (the “Redemption Date”), or (iii) the time at which such Rights are exchanged, as provided in Section 24 hereof
(the “Exchange Date”) (the earliest of (i), (ii) or (iii) being herein referred to as the “Expiration Date”). Except as set forth in Section 7(e) hereof and notwithstanding any other provision of this
Agreement, any Person who, prior to the Distribution Date becomes a record holder of shares of Common Stock of the Company, may exercise all of the rights of a registered holder of a Right Certificate with respect to the Rights associated with such
shares of Common Stock of the Company in accordance with the provisions of this Agreement, as of the date such Person becomes a record holder of shares of Common Stock of the Company. 
 (b) The Exercise Price for each one one-thousandth of a share of Preferred Stock pursuant to the exercise of a Right shall initially be
Seventy-Two United States Dollars (US$72.00), shall be subject to adjustment from time to time as provided in Section 11 and Section 13 hereof and shall be payable in lawful money of the United States of America in accordance with
Section 7(c) below. 
 (c) As promptly as practicable following the Distribution Date, the Company shall deposit with a
corporation, trust, bank or similar institution in good standing organized under the laws of the United States or any State of the United States, which is authorized under such laws to exercise corporate trust or stock transfer powers and is subject
to supervision or examination by a federal or state authority (such institution is hereinafter referred to as the “Depositary Agent”), certificates representing the shares of Preferred Stock that may be acquired upon exercise of the
Rights and the Company shall cause such Depositary Agent to enter into an agreement pursuant to which the Depositary Agent shall issue receipts representing interests in the shares of 

  

 11 

 
Preferred Stock so deposited. Upon receipt of a Right Certificate representing exercisable Rights, with the form of election to purchase and the certificate
on the reverse side thereof properly completed and duly executed, accompanied by payment of the Exercise Price for the shares (or other securities, cash, property or other assets, as the case may be) to be purchased and an amount equal to any
applicable tax or charge required to be paid pursuant to Section 9(e) hereof, the Rights Agent shall, subject to Section 20(k) hereof, thereupon promptly (i) requisition from the Depositary Agent (or make available, if the Rights
Agent is the Depositary Agent) depositary receipts or certificates for the number of one one-thousandths of a share of Preferred Stock to be purchased and the Company hereby irrevocably authorizes the Depositary Agent to comply with all such
requests, (ii) when necessary to comply with this Agreement, requisition from the Company the amount of cash, if any, to be paid in lieu of issuance of fractional shares in accordance with Section 14 hereof, (iii) when necessary to
comply with this Agreement after receipt of such certificates or depositary receipts, cause the same to be delivered to or upon the order of the registered holder of such Right Certificate, registered in such name or names as may be designated by
such holder and, (iv) when necessary to comply with this Agreement, after receipt of each certificates or deposit receipts, promptly deliver such cash to or upon the order of the registered holder of such Right Certificate. In the event that
the Company is obligated to issue other securities of the Company (including Common Stock), pay cash or distribute other property pursuant to Section 11(a) hereof, the Company shall make all arrangements necessary so that such other securities,
cash or other property are available for distribution by the Rights Agent, if and when appropriate. The payment of the Exercise Price may be made by certified or bank check payable to the order of the Company, or by money order or wire transfer of
immediately available funds to the account of the Company (provided that notice of such wire transfer shall be given by the holder of the related Right to the Rights Agent). 
 (d) In case the registered holder of any Right Certificate shall exercise less than all the Rights evidenced thereby, a new Right
Certificate evidencing Rights equivalent to the Rights remaining unexercised shall be issued by the Rights Agent and delivered to the registered holder of such Right Certificate or to his duly authorized assigns, subject to the provisions of
Section 14 hereof. 
 (e) Notwithstanding anything in this Agreement to the contrary, from and after the first occurrence
of a Section 11(a)(ii) Event or Section 13 Event, any Rights Beneficially Owned by (i) an Acquiring Person or any Associate or Affiliate thereof, and any other Person with whom such Person is Acting in Concert (or any Affiliate or
Associate thereof), (ii) a transferee of an Acquiring Person (or of any Associate or Affiliate of an Acquiring Person) and any other Person with whom such Person is Acting in Concert (or any Affiliate or Associate thereof), who becomes a
transferee after the Acquiring Person becomes such or (iii) a transferee of an Acquiring Person (or of any Associate or Affiliate of an Acquiring Person) and any other Person with whom such Person is Acting in Concert (or any Affiliate or
Associate thereof), who becomes a transferee prior to or concurrently with the Acquiring Person becoming such and receives such Rights pursuant to either (A) a transfer (whether or not for consideration) from the Acquiring Person to holders of
equity interests in such Acquiring Person or to any Person with whom the Acquiring Person has any continuing agreement, arrangement or understanding regarding the transferred Rights, or (B) a transfer which the Board of Directors of the Company
has determined is part of a plan, arrangement or understanding which has, as a primary purpose or effect, the avoidance of this Section 7(e), shall be null and void without any further action and no holder of such Rights shall have any rights
whatsoever with respect to such Rights, whether under any provision of this Agreement or otherwise. The Company shall use all reasonable efforts to ensure that the provisions of this Section 7(e) and Section 4(b) hereof are complied with
but shall have no liability to any holder of Right Certificates or other Person as a result of its failure to make any determinations with respect to an Acquiring Person or any Affiliates or Associates of an Acquiring Person or any transferee of any
of them hereunder. 
  

 12 

 (f) Notwithstanding anything in this Agreement to the contrary, neither the Rights Agent
nor the Company shall be obligated to undertake any action with respect to a registered holder of Rights or other securities upon the occurrence of any purported exercise as set forth in this Section 7 unless such registered holder shall have
(i) properly completed and duly executed the certificate contained in the form of election to purchase set forth on the reverse side of the Right Certificate surrendered for such exercise, and (ii) provided such additional evidence of the
identity of the Beneficial Owner (or former Beneficial Owner) or Affiliates or Associates thereof as the Company or the rights Agent shall reasonably request. 
 (g) The Board of Directors of the Company shall establish a committee, the membership of which shall consist of non-management directors
who are otherwise eligible to serve on such committee in accordance with the Company’s bylaws (the “Shareholder Rights Plan Committee”) and which shall periodically consider whether the maintenance of this Agreement continues
to be in the best interests of the Company and its shareholders. The Shareholder Rights Plan Committee shall conduct each such review when, as and in such manner as the Shareholder Rights Plan Committee deems appropriate, after giving due regard to
all relevant circumstances; provided that the Shareholder Rights Plan Committee shall take such action at least once every three years. Following each such review, the Shareholder Rights Plan Committee shall report its conclusions to the full Board
of Directors of the Company, including any recommendation in light thereof as to whether this Agreement should be maintained or terminated. The Shareholder Rights Plan Committee is authorized to retain such legal counsel, financial advisors and
other advisors as such committee deems appropriate in order to assist the Shareholder Rights Plan Committee in carrying out its foregoing responsibilities under this Agreement. 
 Section 8. Cancellation and Destruction of Right Certificates. All Right Certificates surrendered for the purpose of exercise, transfer,
split up, combination or exchange shall, if surrendered to the Company or any of its agents, be delivered to the Rights Agent for cancellation or in canceled form, or, if surrendered to the Rights Agent, shall be canceled by it, and no Right
Certificates shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to the Rights Agent for cancellation and retirement, and the Rights Agent shall so cancel and retire,
any other Right Certificate purchased or acquired by the Company otherwise than upon the exercise thereof. The Rights Agent shall deliver all canceled Right Certificates to the Company or, at the written request of the Company, destroy all such
canceled Right Certificates and certify in writing to the Company that it has done so. 
 Section 9. Reservation and Availability of
Preferred Stock. 
 (a) The Company covenants and agrees that it will cause to be reserved and kept available out of its
authorized and unissued shares of Preferred Stock (or, following the occurrence of a Triggering Event, out of its authorized and unissued shares of Common Stock of the Company or any shares of Common Stock of the Company held in its treasury), the
number of shares of Preferred Stock (or, following the occurrence of a Triggering Event, Common Stock) that will be sufficient to permit the exercise in full of all outstanding and exercisable Rights. 
 (b) The Company shall use its best efforts to cause, from and after such time as the Rights become exercisable, all shares of Preferred
Stock (and, following the occurrence of a Triggering Event, all shares of Common Stock of the Company issued or 
  

 13 

 reserved for issuance to be listed, upon official notice of issuance, upon the principal national
securities exchange, if any, upon which the Common Stock of the Company is listed or, if the principal market for the Common Stock of the Company is not on any United States national securities exchange, to be eligible for quotation on the quotation
system on which the common Stock of the company is quoted. 
 (c) The Company shall use its best efforts to (i) file, as
soon as practicable following the earliest date after the occurrence of a Section 11(a)(ii) Event on which the consideration to be delivered by the Company upon exercise of the Rights has been determined in accordance with
Section 11(a)(iii) hereof, or as soon as required by law following the Distribution Date, as the case may be, a registration statement under the Securities Act of 1933, as amended (the “Securities Act”), with respect to the
securities purchasable upon exercise of the Rights on an appropriate form, (ii) cause such registration statement to become effective as soon as practicable after such filing and (iii) cause such registration statement to remain effective
(with a prospectus that at all times meets the requirements of the Securities Act) until the earlier of (A) the date as of which the Rights are no longer exercisable for such securities or (B) the Expiration Date. The Company shall also
take such action as may be appropriate under, and which will ensure compliance with, the securities or “blue sky” laws of the various states in connection with the exercisability of the Rights. The Company may temporarily suspend, for a
period of time not to exceed ninety (90) days after the date determined in accordance with the provisions of the first sentence of this Section 9(c), the exercisability of the Rights in order to prepare and file such registration statement
and permit it to become effective. Upon such suspension, the Company shall issue a public announcement stating that the exercisability of the Rights has been temporarily suspended, as well as a public announcement at such time as the suspension is
no longer in effect, in each case with prompt written notice to the Rights Agent. Notwithstanding any such provision of this Agreement to the contrary, the Rights shall not be exercisable in any jurisdiction unless the requisite qualification in
such jurisdiction shall have been obtained. 
 (d) The Company covenants and agrees that it will take all such action as may
be necessary to ensure that all shares of Preferred Stock (and, following the occurrence of a Triggering Event, all of the shares of Common Stock of the Company) delivered upon the exercise of the Rights shall, at the time of delivery of the
certificates or depositary receipts for such shares (subject to payment of the Exercise Price), be duly and validly authorized and issued, fully-paid and non-assessable. 
 (e) The Company further covenants and agrees that it will pay, when due and payable, any and all federal and state transfer taxes and
charges which may be payable in respect of the issuance or delivery of the Right Certificates or of any certificates for shares of Preferred Stock and/or other property upon the exercise of Rights. The Company shall not, however, be required to pay
any transfer tax which may be payable in respect of any transfer or delivery of Right Certificates or the issuance or delivery of other securities or property to a person other than, or in respect of the issuance or delivery of securities or other
property in a name other than that of, the registered holder of the Right Certificates evidencing Rights surrendered for exercise or to issue or deliver any certificates for securities or other property in a name other than that of the registered
holder upon the exercise of any Rights until such tax shall have been paid (any such tax being payable by the holder of such Right Certificate at the time of surrender) or until it has been established to the Company’s satisfaction that no such
tax is due. 
 Section 10. Preferred Stock Record Date. Each Person in whose name any certificate for Preferred Stock (including
any fraction of a share of Preferred Stock) is issued upon the exercise of Rights shall for all purposes be deemed to have become the holder of 

  

 14 

 
record of the shares of Preferred Stock represented thereby on, and such certificate shall be dated, the date upon which the Right Certificate evidencing
such Rights was duly surrendered and payment of the Exercise Price (and any applicable transfer taxes) was made; provided that if the date of such surrender and payment is a date upon which the transfer books of the Company are closed, such person
shall be deemed to have become the record holder of such shares on, and such certificate shall be dated, the next succeeding Business Day on which the Preferred Stock transfer books of the Company are open; and further provided that, if delivery of
shares of Preferred Stock is delayed pursuant to Section 9(c), such Person shall be deemed to have become the record holder of such shares of Preferred Stock only when such shares first become deliverable. Prior to the exercise of the Right
evidenced thereby, the holder of a Right Certificate shall not be entitled to any rights of a shareholder of the Company with respect to shares for which the Rights shall be exercisable, including, without limitation, the right to vote, to receive
dividends or other distributions or to exercise any preemptive rights, and shall not be entitled to receive any notice of any proceedings of the Company, except as provided herein. 
 Section 11. Adjustment of Exercise Price, Number and Kind of Shares or Number of Rights. The Exercise Price, the number and kind of shares
covered by each Right and the number of Rights outstanding are subject to adjustment from time to time as provided in this Section 11. 
 (a)(i) In the event that the Company shall, at any time after the date of this Agreement, (A) declare a dividend on the Preferred Stock payable in shares of Preferred Stock, (B) subdivide the outstanding
Preferred Stock, (C) combine the outstanding Preferred Stock into a smaller number of shares or (D) issue any shares of its capital stock in a reclassification or recapitalization of the Preferred Stock (including any such reclassification
or recapitalization in connection with a consolidation or merger in which the Company is the continuing or surviving corporation), except as otherwise provided in this Section 11(a) and Section 7(e) hereof, the Exercise Price in effect at
the time of the record date for such dividend or of the effective time of such subdivision, combination, reclassification or recapitalization, and the number and kind of shares of capital stock issuable on such date or at such time, shall be
proportionately adjusted so that the holder of any Right exercised after such time shall be entitled to receive the aggregate number and kind of shares of capital stock which, if such Right had been exercised immediately prior to such date and at a
time when the Preferred Stock transfer books of the Company were open, such holder would have owned upon such exercise and been entitled to receive by virtue of such dividend, subdivision, combination, reclassification or recapitalization. If an
event occurs which would require an adjustment under both Section 11(a)(i) and Section 11(a)(ii) hereof, the adjustment provided for in this Section 11(a)(i) shall be in addition to, and shall be made prior to, any adjustment required
pursuant to Section 11(a)(ii) hereof. 
 (ii) Subject to the provisions of Section 24 hereof, in the event any
Person, alone or together with its Affiliates and Associates, shall become an Acquiring Person, then promptly following any such occurrence (a “Section 11(a)(ii) Event”), proper provision shall be made so that each holder of a
Right, except as provided in Section 7(e) hereof, shall thereafter have a right to receive, upon exercise thereof at the then current Exercise Price in accordance with the terms of this Agreement, in lieu of a number of one one-thousandths of a
share of Preferred Stock, such number of shares of Common Stock of the Company as shall equal the result obtained by (x) multiplying the then current Exercise Price by the then number of one one-thousandths of a share of Preferred Stock for
which a Right was exercisable immediately prior to the first occurrence of a Section 11(a)(ii) Event, whether or not such Right was then exercisable, and dividing that product by (y) 50% of the Fair Market Value per share of Common Stock
of the Company (determined pursuant to Section 11(d)) on the date of the occurrence of a Section 11(a)(ii) Event (such number of shares being referred to as the “Adjustment Shares”)). 
  

 15 

 (iii) In lieu of issuing any shares of Common Stock of the Company in accordance with
Section 11(a)(ii) hereof, the Company, acting by or pursuant to a resolution of the Board of Directors of the Company, may, and in the event that the number of shares of Common Stock of the Company which are authorized by the Company’s
Certificate of Incorporation but not outstanding or reserved for issuance for purposes other than upon exercise of the Rights is not sufficient to permit the exercise in full of the Rights in accordance with the foregoing subparagraph (ii) of
this Section 11(a), the Company, acting by or pursuant to a resolution of the Board of Directors of the Company, shall: (A) determine the excess of (X) the Fair Market Value of the Adjustment Shares issuable upon the exercise of a
Right (the “Current Value”) over (Y) the Exercise Price attributable to each Right (such excess being referred to as the “Spread”) and (B) with respect to all or a portion of each Right (subject to
Section 7(e) hereof), make adequate provision to substitute for the Adjustment Shares, upon payment of the applicable Exercise Price, (1) Common Stock of the Company or equity securities of the Company other than Common Stock of the
Company (including, without limitation, shares or units of shares of preferred stock that the Board of Directors of the Company determines to have the same value as shares of Common Stock of the Company, such shares of preferred stock being referred
to herein as “Common Stock Equivalents”), (2) cash, (3) a reduction in the Exercise Price, (4) Preferred Stock Equivalents which the Board of Directors of the Company has deemed to have the same value as shares of
Common Stock of the Company, (5) debt securities of the Company, (6) other assets or securities of the Company or (7) any combination of the foregoing having an aggregate value equal to the Current Value, where such aggregate value
has been determined by the Board of Directors of the Company after receiving the advice of a nationally recognized investment banking firm selected by the Board of Directors of the Company; provided that, if the Company shall not have made adequate
provision to deliver value pursuant to clause (B) above within thirty (30) days following the later of (x) the first occurrence of a Section 11(a)(ii) Event and (y) the date on which the Company’s right of redemption
pursuant to Section 23(a) expires (the later of (x) and (y) being referred to herein as the “Section 11(a)(ii) Trigger Date”), then the Company shall be obligated to deliver, upon the surrender for exercise of a Right
and without requiring payment of the Exercise Price, shares of Common Stock of the Company (to the extent available) and then, if necessary, cash, which shares and/or cash have an aggregate value equal to the Spread. If the Board of Directors of the
Company shall determine in good faith that it is likely that sufficient additional shares of Common Stock of the Company could be authorized for issuance upon exercise in full of the Rights, the 30-day period set forth above may be extended to the
extent necessary, but not more than ninety (90) days after the Section 11(a)(ii) Trigger Date, in order that the Company may seek shareholder approval for the authorization of such additional shares (such period, as it may be extended,
being referred to herein as the “Substitution Period”). To the extent that the Company determines that action should be taken pursuant to the first and/or second sentences of this Section 11(a)(iii), the Company (x) shall
provide, subject to Section 7(e) hereof, that such action shall apply uniformly to all outstanding Rights and (y) may suspend the exercisability of the Rights until the expiration of the Substitution Period in order to seek any
authorization of additional shares and/or to decide the appropriate form of distribution to be made pursuant to such first sentence and to determine the value thereof. In the event of any such suspension, the Company shall issue a public
announcement stating that the exercisability of the Rights has been 

  

 16 

 
temporarily suspended and a further public announcement at such time as the suspension is no longer in effect. For purposes of this Section 11(a)(iii),
the value of the Common Stock of the Company and the Preferred Stock shall be the Fair Market Value (as determined pursuant to Section 11(d) hereof) per share of the Common Stock of the company and the Preferred Stock on the
Section 11(a)(ii) Trigger Date, the value of the Common Stock Equivalents shall be deemed to be the same as the Common Stock of the Company on such date, and the value of any Preferred Stock Equivalents shall be deemed to have the same value as
the Preferred Stock on such date. 
 (b) If the Company shall fix a record date for the issuance of rights, options or
warrants to all holders of Preferred Stock entitling them (for a period expiring within forty-five (45) calendar days after such record date) to subscribe for or purchase Preferred Stock (or securities having the same or more favorable rights,
privileges and preferences as the shares of Preferred Stock (“Preferred Stock Equivalents”)) or securities convertible into Preferred Stock or Preferred Stock Equivalents at a price per share of Preferred Stock or per share of
Preferred Stock Equivalents (or having a conversion price per share, if a security convertible into Preferred Stock or Preferred Stock Equivalents) less than the Fair Market Value (as determined pursuant to Section 11(d) hereof) per share of
Preferred Stock on such record date, the Exercise Price to be in effect after such record date shall be determined by multiplying the Exercise Price in effect immediately prior to such record date by a fraction, the numerator of which shall be the
number of shares of Preferred Stock outstanding on such record date, plus the number of shares of Preferred Stock which the aggregate offering price of the total number of shares of Preferred Stock and/or Preferred Stock Equivalents to be offered
(and the aggregate initial conversion price of the convertible securities so to be offered) would purchase at such Fair Market Value and the denominator of which shall be the number of shares of Preferred Stock outstanding on such record date, plus
the number of additional shares of Preferred Stock and Preferred Stock Equivalents to be offered for subscription or purchase (or into which the convertible securities so to be offered are initially convertible). In case such subscription price may
be paid in a consideration part or all of which shall be in a form other than cash, the value of such consideration shall be the Fair Market Value thereof determined in accordance with Section 11(d) hereof. Shares of Preferred Stock owned by or
held for the account of the Company shall not be deemed outstanding for the purpose of any such computation. Such adjustments shall be made successively whenever such a record date is fixed; and, in the event that such rights or warrants are not so
issued, the Exercise Price shall be adjusted to be the Exercise Price which would then be in effect if such record date had not been fixed. 
 (c) If the Company shall fix a record date for the making of a distribution to all holders of Preferred Stock (including any such distribution made in connection with a consolidation or merger in which the Company is
the continuing or surviving corporation), of evidences of indebtedness, cash (other than a regular periodic cash dividend out of the earnings or retained earnings of the Company), assets (other than a dividend payable in Preferred Stock, but
including any dividend payable in stock other than Preferred Stock) or convertible securities, subscription rights or warrants (excluding those referred to in Section 11(b)), the Exercise Price to be in effect after such record date shall be
determined by multiplying the Exercise Price in effect immediately prior to such record date by a fraction, the numerator of which shall be the Fair Market Value (as determined pursuant to Section 11(d) hereof) per one one-thousandth of a share
of Preferred Stock on such record date, less the Fair Market Value (as determined pursuant to Section 11(d) hereof) of the portion of the cash, assets or evidences of indebtedness so to be distributed or of such convertible securities,
subscription rights or warrants applicable to one one-thousandth of a share of 

  

 17 

 
Preferred Stock and the denominator of which shall be the Fair Market Value (as determined pursuant to Section 11(d) hereof) per one one-thousandth of a
share of Preferred Stock. Such adjustments shall be made successively whenever such a record date is fixed; and in the event that such distribution is not so made, the Exercise Price shall again be adjusted to be the Exercise Price which would be in
effect if such record date had not been fixed. 
 (d) For the purpose of this Agreement, the “Fair Market
Value” of any share of Preferred Stock, Common Stock or any other stock or any Right or other security or any other property shall be determined as provided in this Section 11(d). 
 (i) In the case of a publicly-traded stock or other security, the Fair Market Value on any date for the purpose of any computation
hereunder, other than computations made pursuant to Section 11(a)(iii) hereof, shall be deemed to be the average of the daily closing prices per share of such stock or per unit of such other security for the thirty (30) consecutive Trading
Days immediately prior to but not including such date and, for purposes of computations pursuant to Section 11(a)(ii) hereof ten (10) Trading Days; provided that in the event that the Fair Market Value per share of any share of stock is
determined during a period following the announcement by the issuer of such stock of (x) a dividend or distribution on such stock payable in shares of such stock or securities convertible into shares of such stock or (y) any subdivision,
combination or reclassification of such stock, and prior to the expiration of the thirty (30) Trading Day period or the ten (10) Trading Day period, as applicable, after the ex-dividend date for such dividend or distribution, or the record
date for such subdivision, combination or reclassification, then, and in each such case, the Fair Market Value shall be properly adjusted to take into account ex-dividend trading. The closing price for each day shall be the last sale price, regular
way, or, in case no such sale takes place on such day, the average of the closing bid and asked prices, regular way, in either case as reported in the principal consolidated transaction reporting system with respect to securities listed or admitted
to trading on the Nasdaq Stock Market or, if the securities are not listed or admitted to trading on the Nasdaq Stock Market, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal
national securities exchange on which such security is listed or admitted to trading; or, if not listed or admitted to trading on any national securities exchange, the last quoted price (or, if not so quoted, the average of the last quoted high bid
and low asked prices) in the over-the-counter market, as reported by the OTC Bulletin Board or the “Pink Sheets” or such other system then in use; or, if on any such date no bids for such security are quoted by any such organization, the
average of the closing bid and asked prices as furnished by a professional market maker making a market in such security selected by the Board of Directors of the Company. If on any such date no market maker is making a market in such security, the
Fair Market Value of such security on such date shall be determined reasonably and in good faith by the Board of Directors of the Company; provided that, if at the time of such determination there is an Acquiring Person, the Fair Market Value of
such security on such date shall be determined by a nationally recognized investment banking firm selected by the Board of Directors of the Company, which determination shall be described in a statement filed with the Rights Agent and shall be
binding on the Rights Agent and the holders of the Rights. The term “Trading Day” shall mean a day on which the principal national securities exchange on which such security is listed or admitted to trading is open for the
transaction of business or, if such security is not listed or admitted to trading on any national securities exchange, a Business Day. 
 (ii) If a security is not publicly held or not so listed or traded, “Fair Market Value” shall mean the fair value per share of stock or per other unit of such security, determined reasonably and in
good faith by the Board of Directors of the Company; provided that, if at the time of such determination there is an Acquiring Person, the Fair Market Value of such 

  

 18 

 
security on such date shall be determined by a nationally recognized investment banking firm selected by the Board of Directors of the Company, which
determination shall be described in a statement filed with the Rights Agent and shall be binding on the Rights Agent and the holders of the Rights; and provided further that for the purposes of making any adjustment provided for by
Section 11(a)(ii) hereof, the Fair Market Value of a share of Preferred Stock shall not be less than the product of the then Fair Market Value of a share of Common Stock multiplied by the higher of the then Dividend Multiple or Vote Multiple
(as both of such terms are defined in Exhibit A hereto) applicable to the Preferred Stock and shall not exceed 105% of the product of the then Fair Market Value of a share of Common Stock multiplied by the higher of the then Dividend Multiple
or Vote Multiple applicable to the Preferred Stock. 
 (iii) In the case of property other than securities, the Fair Market
Value thereof shall be determined reasonably and in good faith by the Board of Directors of the Company; provided that, if at the time of such determination there is an Acquiring Person, the Fair Market Value of such property on such date shall be
determined by a nationally recognized investment banking firm selected by the Board of Directors of the Company, which determination shall be described in a statement filed with the Rights Agent and shall be binding upon the Rights Agent and the
holders of the Rights. 
 (e) Anything herein to the contrary notwithstanding, no adjustment in the Exercise Price shall be
required unless such adjustment would require an increase or decrease of at least 1% in the Exercise Price; provided that any adjustments which by reason of this Section 11(e) are not required to be made shall be carried forward and taken into
account in any subsequent adjustment. All calculations under this Section 11 shall be made to the nearest cent or to the nearest one-millionth of a share of Common Stock of the Company or ten-millionth of a share of Preferred Stock, as the case
may be, or to such other figure as the Board of Directors of the Company may deem appropriate. Notwithstanding the first sentence of this Section 11(e), any adjustment required by this Section 11 shall be made no later than the earlier of
(i) three (3) years from the date of the transaction which mandates such adjustment or (ii) the Expiration Date. 
 (f) If as a result of any adjustment made pursuant to Section 11(a)(ii) or Section 13(a) hereof, the holder of any Right thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than
Preferred Stock, thereafter the number of such other shares so receivable upon exercise of any Right shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the
Preferred Stock contained in Section 11(a), (b), (c), (d), (e), (g) through (k) and (m), inclusive, and the provisions of Sections 7, 9, 10, 13 and 14 hereof with respect to the Preferred Stock shall apply on like terms to any such
other shares. 
 (g) All Rights originally issued by the Company subsequent to any adjustment made to the Exercise Price
hereunder shall evidence the right to purchase, at the adjusted Exercise Price, the number of one one-thousandths of a share of Preferred Stock (or other securities or amount of cash or combination thereof) purchasable from time to time hereunder
upon exercise of the Rights, all subject to further adjustment as provided herein. 
 (h) Unless the Company shall have
exercised its election as provided in Section 11(i), upon each adjustment of the Exercise Price as a result of the calculations made in Sections 11(b) and (c), each Right outstanding immediately prior to the making of such adjustment shall
thereafter evidence the right to purchase, at the adjusted Exercise Price, that number of one one-thousandths of a share of Preferred Stock (calculated to the nearest one ten-millionth) as the Board of Directors of the 

  

 19 

 
Company determines is appropriate to preserve the economic value of the Rights, including, by way of example, that number obtained by (i) multiplying
(x) the number of one one-thousandths of a share of Preferred Stock for which a Right may be exercisable immediately prior to this adjustment by (y) the Exercise Price in effect immediately prior to such adjustment of the Exercise Price
and (ii) dividing the product so obtained by the Exercise Price in effect immediately after such adjustment of the Exercise Price. 
 (i) The Company may elect on or after the date of any adjustment of the Exercise Price to adjust the number of Rights, in substitution for any adjustment in the number of shares of Preferred Stock purchasable upon the
exercise of a Right. Each of the Rights outstanding after the adjustment in the number of Rights shall be exercisable for the number of one one-thousandths of a share of Preferred Stock for which a Right was exercisable immediately prior to such
adjustment. Each Right held of record prior to such adjustment of the number of Rights shall become that number of Rights (calculated to the nearest one-millionth) obtained by dividing the Exercise Price in effect immediately prior to adjustment of
the Exercise Price by the Exercise Price in effect immediately after adjustment of the Exercise Price. The Company shall make a public announcement of its election to adjust the number of Rights, indicating the record date for the adjustment, and,
if known at the time, the amount of the adjustment to be made. This record date may be the date on which the Exercise Price is adjusted or any day thereafter, but, if the Right Certificates have been issued, shall be at least ten (10) days
later than the date of the public announcement. If Right Certificates have been issued, upon each adjustment of the number of Rights pursuant to this Section 11(i), the Company shall, as promptly as practicable, cause to be distributed to
holders of record of Right Certificates on such record date Right Certificates evidencing, subject to Section 14 hereof, the additional Rights to which such holders shall be entitled as a result of such adjustment, or, at the option of the
Company, shall cause to be distributed to such holders of record in substitution and replacement for the Right Certificates held by such holders prior to the date of adjustment, and upon surrender thereof, if required by the Company, new Right
Certificates evidencing all the Rights to which such holders shall be entitled after such adjustment. Right Certificates so to be distributed shall be issued, executed and delivered by the Company and countersigned by the Rights Agent in the manner
provided for herein (and may bear, at the option of the Company, the adjusted Exercise Price) and shall be registered in the names of the holders of record of Right Certificates on the record date specified in the public announcement. 
 (j) Irrespective of any adjustment or change in the Exercise Price or the number of one one-thousandths of a share of Preferred Stock
issuable upon the exercise of the Rights, the Right Certificates theretofore and thereafter issued may continue to express the Exercise Price per share and the number of shares which were expressed in the initial Right Certificates issued hereunder,
without prejudice to any adjustment or change. 
 (k) Before taking any action that would cause an adjustment reducing the
Exercise Price below the then stated value, if any, of the number of one one-thousandths of a share of Preferred Stock issuable upon exercise of the Rights, the Company shall take any corporate action which may, in the opinion of its counsel, be
necessary in order that the Company may validly and legally issue such number of fully-paid and non-assessable one one-thousandths of a share of Preferred Stock at such adjusted Exercise Price. 
 (l) In any case in which this Section 11 shall require that an adjustment in the Exercise Price be made effective as of a record date
for a specified event, the Company may elect to defer until the occurrence of such event the issuing to the holder of any Right exercised after such record date the number of one one-thousandths of a share of Preferred Stock or other capital 

  

 20 

 
stock or securities of the Company, if any, issuable upon such exercise over and above the number of one one-thousandths of a share of Preferred Stock and
other capital stock or securities of the Company, if any, issuable upon such exercise on the basis of the Exercise Price in effect prior to such adjustment; provided that the Company shall deliver to such holder a due bill or other appropriate
instrument evidencing such holder’s right to receive such additional shares (fractional or otherwise) or other securities upon the occurrence of the event requiring such adjustment. 
 (m) Anything in this Section 11 to the contrary notwithstanding, the Company shall be entitled to make such reductions in the
Exercise Price, in addition to those adjustments expressly required by this Section 11, as and to the extent that in its good faith judgment the Board of Directors of the Company shall determine to be advisable in order that any
(i) consolidation or subdivision of the Preferred Stock, (ii) issuance wholly for cash of any shares of Preferred Stock at less than the Fair Market Value, (iii) issuance wholly for cash of shares of Preferred Stock or securities
which by their terms are convertible into or exchangeable for shares of Preferred Stock, (iv) stock dividends or (v) issuances of rights, options or warrants referred to hereinabove in this Section 11, hereafter made by the Company to
holders of its Preferred Stock, shall not be taxable to such stockholders. 
 (n) The Company covenants and agrees that it
will not, at any time after the Distribution Date and so long as the Rights have not been redeemed pursuant to Section 23 hereof or exchanged pursuant to Section 24 hereof, (i) consolidate with (other than a Subsidiary of the Company
in a transaction that complies with the proviso at the end of this sentence), (ii) merge with or into, or (iii) sell or transfer (or permit any Subsidiary to sell or transfer), in one transaction or a series of related transactions, assets
or earning power aggregating 50% or more of the assets or earning power of the Company and its Subsidiaries taken as a whole, to any other Person or Persons (other than the Company and/or any of its Subsidiaries in one or more transactions each of
which complies with the proviso at the end of this sentence) if (x) at the time of or immediately after such consolidation, merger or sale there are any rights, warrants or other instruments outstanding or agreements or arrangements in effect
which would substantially diminish or otherwise eliminate the benefits intended to be afforded by the Rights, or (y) prior to, simultaneously with or immediately after such consolidation, merger or sale the shareholders of a Person who
constitutes, or would constitute, the “Principal Party” for the purposes of Section 13(a) hereof shall have received a distribution of Rights previously owned by such Person or any of its Affiliates and Associates; provided that,
subject to the immediately preceding sentence, this Section 11(n) shall not affect the ability of any Subsidiary of the Company to consolidate with, or merge with or into, or sell or transfer assets or earning power to, any other Subsidiary of
the Company. The Company further covenants and agrees that after the Distribution Date it will not, except as permitted by Section 23 or Section 27 hereof, take (or permit any Subsidiary to take) any action if at the time such action is
taken it is reasonably foreseeable that such action will substantially diminish or otherwise eliminate the benefits intended to be afforded by the Rights. 
 (o) The Company covenants and agrees that, after the earlier of the Stock Acquisition Date or the Distribution Date, it will not, except as permitted by Section 23 or Section 27, take (or permit any
Subsidiary to take) any action if at the time such action is taken it is reasonable foreseeable that such action will diminish substantially or otherwise eliminate the benefits intended to be afforded by the Rights. 
  

 21 

 (p) Notwithstanding anything in this Agreement to the contrary, in the event the Company
shall at any time after the date of this Agreement and prior to the Distribution Date (i) declare any dividend on the outstanding Common Stock of the Company payable in shares of Common Stock of the Company or (ii) effect a subdivision,
combination or consolidation of the outstanding shares of Common Stock of the Company (by reclassification or otherwise than by payment of dividends in shares of Common Stock of the Company) into a greater or lesser number of shares of Common Stock
of the Company, then in any such case (A) the number of one one-thousandths of a share of Preferred Stock purchasable after such event upon proper exercise of each Right shall be determined by multiplying the number of one one-thousandths of a
share of Preferred Stock so purchasable immediately prior to such event by a fraction, the numerator of which is the number of shares of Common Stock of the Company outstanding immediately prior to such event and the denominator of which is the
number of shares of Common Stock of the Company outstanding immediately after such event, and (B) each share of Common Stock of the Company outstanding immediately after such event shall have issued with respect to it that number of Rights
which each share of Common Stock of the Company outstanding immediately prior to such event had issued with respect to it. The adjustments provided for in this Section 11(p) shall be made successively whenever such a dividend is declared or
paid or such a subdivision, combination or consolidation is effected. 
 (q) The exercise of Rights under
Section 11(a)(ii) shall only result in the loss of rights under Section 11(a)(ii) to the extent so exercised and neither such exercise nor any exchange of Rights pursuant to Section 24 hereof shall otherwise affect the rights of
holders of Right Certificates under this Rights Agreement, including rights to purchase securities of the Principal Party following a Section 13 Event which has occurred or may thereafter occur, as set forth in Section 13 hereof. Upon
exercise of a right represented by a Right Certificate under Section 11(a)(ii), the Rights Agent shall return such Right Certificate duly marked to indicate that such exercise has occurred. 
 Section 12. Certificate of Adjusted Exercise Price or Number of Shares. Whenever an adjustment is made as provided in Section 11 or
Section 13 hereof, the Company shall (a) promptly prepare a certificate setting forth such adjustment and a brief statement of the facts accounting for such adjustment, (b) promptly file with the Rights Agent and with each transfer
agent for the Preferred Stock and the Common Stock of the Company a copy of such certificate and (c) mail a brief summary thereof to each holder of a Right Certificate (or, if prior to the Distribution Date, to each holder of a certificate
representing shares of Common Stock of the Company) in accordance with Section 26 hereof. The Rights Agent shall be fully protected in relying on any such certificate and on any adjustment contained therein and shall not be deemed to have
knowledge of any such adjustment unless and until it shall have received such certificate. 
 Section 13. Consolidation, Merger or
Sale or Transfer of Assets or Earning Power. 
 (a) In the event that, following the Stock Acquisition Date, directly or
indirectly, (x) the Company consolidates with, or merges with and into, any other Person (other than a Subsidiary of the Company in a transaction which is not prohibited by Section 11(n) hereof), and the Company shall not be the continuing
or surviving corporation of such consolidation or merger, (y) any Person (other than a Subsidiary of the Company in a transaction which is not prohibited by the proviso at the end of the first sentence of Section 11(n) hereof) shall
consolidate with the Company, or merge with and into the Company and the Company shall be the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of Common Stock of the Company shall be
changed into or exchanged for stock or other securities of any other Person or cash or any other property, or (z) the Company shall sell or otherwise transfer (or one or more of its Subsidiaries shall sell or otherwise transfer), in one
transaction or a series of related transactions, assets, cash-flow or earning power aggregating 50% 

  

 22 

 
or more of the assets, cash-flow or earning power of the Company and its Subsidiaries (taken as a whole) to any other Person or Persons (other than the
Company or any Subsidiary of the Company in one or more transactions, each of which is not prohibited by the proviso at the end of the first sentence of Section 11(n) hereof), then, and in each such case, proper provision shall be made so that:
(i) each holder of a Right, except as provided in Section 7(e) hereof, shall have the right to receive, upon the exercise thereof at the then current Exercise Price in accordance with the terms of this Agreement, such number of validly
authorized and issued, fully-paid and non-assessable shares of freely tradable shares of Common Stock of the Principal Party, free and clear of rights of call or first refusal, liens, encumbrances, transfer restrictions or other adverse claims, as
shall be equal to the result obtained by (1) multiplying the then current Exercise Price by the number of one one-thousandths of a share of Preferred Stock for which a Right is exercisable immediately prior to the first occurrence of a
Section 13 Event (without taking into account any adjustment previously made pursuant to Section 11(a)(ii) or Section 11(a)(iii) hereof, and dividing that product by (2) 50% of the Fair Market Value (determined pursuant to
Section 11(d) hereof) per share of the Common Stock of such Principal Party on the date of consummation of Section 13 Event; (ii) such Principal Party shall thereafter be liable for, and shall assume, by virtue of such Section 13
Event, all the obligations and duties of the Company pursuant to this Agreement; (iii) the term “Company” shall thereafter be deemed to refer to such Principal Party, it being specifically intended that the provisions of
Section 11 hereof shall apply only to such Principal Party; (iv) such Principal Party shall take such steps (including, without limitation, the reservation of a sufficient number of shares of its Common Stock to permit exercise of all
outstanding Rights in accordance with this Section 13(a) and the making of payments in cash and/or other securities in accordance with Section 11(a)(iii) hereof) in connection with such consummation as may be necessary to assure that the
provisions hereof shall thereafter be applicable, as nearly as reasonably may be, in relation to its shares of Common Stock thereafter deliverable upon the exercise of the Rights; and (v) and the provisions of Section 11(a)(ii) hereof
shall be of no force or effect following the occurrence of the first Section 13 event. 
 (b) “Principal
Party” shall mean 
 (i) in the case of any transaction described in clause (x) or (y) of the first
sentence of Section 13(a) hereof, the Person that is the issuer of any securities into which shares of Common Stock of the Company are converted in such merger or consolidation, or, if there is more than one such issuer, the issuer of Common
Stock that has the highest aggregate Fair Market Value (determined pursuant to Section 11(d)), and if no securities are so issued, the Person that is the other party to the merger or consolidation, or, if there is more than one such Person, the
Person the Common Stock of which has the highest aggregate Fair Market Value (determined pursuant to Section 11(d) hereof); and 
 (ii) in the case of any transaction described in clause (z) of the first sentence of Section 13(a) hereof, the Person that is the party receiving the greatest portion of the assets, cash-flow or earning power transferred pursuant
to such transaction or transactions, or, if each Person that is a party to such transaction or transactions receives the same portion of the assets, cash-flow or earning power transferred pursuant to such transaction or transactions or if the Person
receiving the largest portion of the assets, cash-flow or earning power cannot be determined, whichever Person the Common Stock of which has the highest aggregate Fair Market Value (determined pursuant to Section 11(d) hereof); 
  

 23 

 provided, that in any such case described in clauses (i) or (ii) of this Section 13(b),
(1) if the Common Stock of such Person is not at such time and has not been continuously over the preceding 12-month period registered under Section 12 of the Exchange Act (“Registered Common Stock”) or such Person is not
a corporation, and such Person is a direct or indirect Subsidiary of another Person who has Registered Common Stock outstanding, “Principal Party” shall refer to such other Person; (2) if the Common Stock of such Person is not
Registered Common Stock or such Person is not a corporation, and such Person is a direct or indirect Subsidiary of another Person but is not a direct or indirect Subsidiary of another Person which has Registered Common Stock outstanding,
“Principal Party” shall refer to the ultimate parent entity of such first-mentioned Person; (3) if the Common Stock of such Person is not Registered Common Stock or such Person is not a corporation, and such Person is directly or
indirectly controlled by more than one Person, and one or more of such other Persons has Registered Common Stock outstanding, “Principal Party” shall refer to whichever of such other Persons is the issuer of the Registered Common Stock
having the highest aggregate Fair Market Value (determined pursuant to Section 11(d)); and (4) if the Common Stock of such Person is not Registered Common Stock or such Person is not a corporation, and such Person is directly or indirectly
controlled by more than one Person, and none of such other Persons has Registered Common Stock outstanding, “Principal Party” shall refer to whichever ultimate parent entity is the corporation having the greatest shareholders’ equity
or, if no such ultimate parent entity is a corporation, “Principal Party” shall refer to whichever ultimate parent entity is the entity having the greatest net asset value. 
 (c) The Company shall not consummate any such consolidation, merger, sale or transfer unless prior thereto (x) the Principal Party
shall have a sufficient number of authorized shares of its Common Stock, which have not been issued or reserved for issuance, to permit the exercise in full of the Rights in accordance with this Section 13, and (y) the Company and each
Principal Party and each other Person who may become a Principal Party as a result of such consolidation, merger, sale or transfer shall have executed and delivered to the Rights Agent a supplemental agreement providing for the terms set forth in
Section 13(a) and (b) and further providing that, as soon as practicable after the date of any consolidation, merger, or sale or transfer of assets mentioned in Section 13(a), the Principal Party at its own expense shall: 

(i) prepare and file a registration statement under the Securities Act with respect to the Rights and the securities purchasable upon
exercise of the Rights on an appropriate form, and will use its best efforts to cause such registration statement to (A) become effective as soon as practicable after such filing and (B) remain effective (with a prospectus that at all
times meets the requirements of the Securities Act) until the Expiration Date; 
 (ii) qualify or register the Rights and the
securities purchasable upon exercise of the Rights under the blue sky laws of such jurisdictions as may be necessary or appropriate; 
 (iii) list (or continue the listing of) the Rights and the securities purchasable upon exercise of the Rights on a national securities exchange or to meet the eligibility requirements for quotation on a stock quotation system; and

 (iv) deliver to holders of the Rights historical financial statements for the Principal Party and each of its Affiliates
which comply in all respects with the requirements for registration on Form 10 under the Exchange Act. 
  

 24 

 (d) In case the Principal Party which is to be a party to a transaction referred to in
this Section 13 has a provision in any of its authorized securities or in its certificate of incorporation (or equivalent constituent document) or by-laws or other instrument governing its affairs, which provision would have the effect of
(i) causing such Principal Party to issue (other than to holders of Rights pursuant to this Section 13), in connection with, or as a consequence of, the consummation of a transaction referred to in this Section 13, shares of Common
Stock of such Principal Party at less than the then current Fair Market Value (determined pursuant to Section 11(d)) or securities exercisable for, or convertible into, Common Stock of such Principal Party at less than such Fair Market Value,
or (ii) providing for any special payment, tax or similar provisions in connection with the issuance of the Common Stock of such Principal Party pursuant to the provisions of this Section 13, then, in such event, the Company shall not
consummate any such transaction unless prior thereto the Company and such Principal Party shall have executed and delivered to the Rights Agent a supplemental agreement providing that the provision in question of such Principal Party shall have been
canceled, waived or amended, or that the authorized securities shall be redeemed, so that the applicable provision will have no effect in connection with, or as a consequence of, the consummation of the proposed transaction. 
 The provisions of this Section 13 shall similarly apply to successive mergers or consolidations or sales or other transfers. 
 Section 14. Fractional Rights and Fractional Shares. 
 (a) The Company shall not be required to issue fractions of Rights, except prior to the Distribution Date as provided in
Section 11(p) hereof, or to distribute Right Certificates which evidence fractional Rights. If the Company elects not to issue such fractional Rights, the Company shall pay, in lieu of such fractional Rights, to the registered holders of the
Right Certificates with regard to which such fractional Rights would otherwise be issuable, an amount in cash equal to the same fraction of the Fair Market Value of a whole Right, as determined pursuant to Section 11(d) hereof. 
 (b) The Company shall not be required to issue fractions of shares of Preferred Stock (other than fractions which are integral multiples
of one one-thousandth of a share of Preferred Stock) upon exercise of the Rights or to distribute certificates which evidence fractional shares of Preferred Stock (other than fractions which are integral multiples of one one-thousandth of a share of
Preferred Stock). In lieu of fractional shares of Preferred Stock that are not integral multiples of one one-thousandth of a share of Preferred Stock, the Company may pay to the registered holders of Right Certificates at the time such Rights are
exercised as herein provided an amount in cash equal to the same fraction of the Fair Market Value of one one-thousandth of a share of Preferred Stock. For purposes of this Section 14(b), the Fair Market Value of one one-thousandth of a share
of Preferred Stock shall be determined pursuant to Section 11(d) hereof for the Trading Day immediately prior to the date of such exercise. 
 (c) The holder of a Right by the acceptance of the Rights expressly waives his right to receive any fractional Rights or any fractional shares upon exercise of a Right, except as permitted by this Section 14.

 Section 15. Rights of Action. All rights of action in respect of this Agreement, other than rights of action vested in the
Rights Agent pursuant to Sections 18 and 20 hereof, are vested in the respective registered holders of the Right Certificates (or, prior to the Distribution Date, the registered holders of the Common Stock of the Company); and any registered holder
of any Right Certificate (or, prior to the Distribution Date, of the Common Stock of the Company), without the consent of the Rights Agent or of the holder 

  

 25 

 
of any other Right Certificate (or, prior to the Distribution Date, of the Common Stock of the Company), may, in such registered holder’s own behalf and
for such registered holder’s own benefit, enforce, and may institute and maintain any suit, action or proceeding against the Company to enforce, or otherwise act in respect of, his right to exercise the Right evidenced by such Right Certificate
in the manner provided in such Right Certificate and in this Agreement. Without limiting the foregoing or any remedies available to the holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy
at law for any breach of this Agreement and shall be entitled to specific performance of the obligations hereunder and injunctive relief against actual or threatened violations of the obligations hereunder of any Person subject to this Agreement.
Holders of Rights shall be entitled to recover the reasonable costs and expenses, including attorneys’ fees, incurred by them in any action to enforce the provisions of this Agreement. 
 Section 16. Agreement of Right Holders. Every holder of a Right, by accepting the same, consents and agrees with the Company and the Rights
Agent and with every other holder of a Right that: 
 (a) prior to the Distribution Date, each Right will be transferable only
simultaneously and together with the transfer of shares of Common Stock of the Company; 
 (b) after the Distribution Date,
the Right Certificates are transferable only on the registry books of the Rights Agent if surrendered at the office of the Rights Agent designated for such purpose, duly endorsed or accompanied by a proper instrument of transfer; 
 (c) subject to Sections 6(a) and 7(f), the Company and the Rights Agent may deem and treat the person in whose name a Right Certificate
(or, prior to the Distribution Date, the associated certificate representing Common Stock of the Company) is registered as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any notations of ownership or writing on the
Right Certificates or the associated certificate representing Common Stock of the Company made by anyone other than the Company or the Rights Agent) for all purposes whatsoever and, subject to the last sentence of Section 7(e), neither the
Company nor the Rights Agent shall be affected by any notice to the contrary; and 
 (d) notwithstanding anything in this
Agreement to the contrary, neither the Company nor the Rights Agent shall have any liability to any holder of a Right or other Person as the result of its inability to perform any of its obligations under this Agreement by reason of any preliminary
or permanent injunction or other order, judgment, decree or ruling issued (whether interlocutory or final) by a court of competent jurisdiction or by a governmental, regulatory, self-regulatory or administrative agency or commission, or any statute,
rule, regulation or executive order promulgated or enacted by any governmental authority prohibiting or otherwise restraining performance of such obligations; provided that the Company must use its best efforts to have any such injunction, order,
judgment, decree or ruling lifted or otherwise overturned as soon as possible. 
 Section 17. Right Certificate Holder Not Deemed a
Shareholder. No holder, as such, of any Right Certificate shall be entitled to vote, receive dividends or be deemed for any purpose the holder of the shares of Preferred Stock or any other securities of the Company which may at any time be
issuable on the exercise of the Rights represented thereby, nor shall anything contained herein or in any Right Certificate be construed to confer upon the holder of any Right Certificate, as such, any of the rights of a shareholder of the Company
or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting shareholders
(except as provided in Section 25 hereof), or to receive dividends or subscription rights, or otherwise, until the Right or Rights evidenced by such Right Certificate shall have been exercised in accordance with the provisions hereof.

  

 26 

 Section 18. Concerning the Rights Agent. 
 (a) The Company agrees to pay to the Rights Agent such compensation as shall be agreed to in writing between the Company and the Rights
Agent for all services rendered by it hereunder and, from time to time, on demand of the Rights Agent, its reasonable expenses and counsel fees and disbursements and other disbursements incurred in the administration and execution of this Agreement
and the exercise and performance of its duties hereunder. The Company also agrees to indemnify the Rights Agent for, and to hold it harmless against, any loss, liability, or expense, incurred without gross negligence, bad faith or willful misconduct
on the part of the Rights Agent, for anything done or omitted by the Rights Agent in connection with the acceptance and administration of this Agreement, including the costs and expenses of defending against any claim of liability arising therefrom,
directly or indirectly. The provisions of this Section 18(a) and Section 20 shall survive the expiration of the Rights and the termination of this Agreement. 
 (b) The Rights Agent shall be fully protected and shall incur no liability for or in respect of any action taken, suffered or omitted by
it in connection with its administration of this Agreement in reliance upon any Right Certificate or certificate representing Common Stock of the Company, Preferred Stock, or other securities of the Company, instrument of assignment or transfer,
power of attorney, endorsement, affidavit, letter, notice, direction, consent, certificate, statement, or other paper or document believed by it in good faith and without gross negligence to be genuine and to be signed and executed by the proper
Person or Persons. 
 (c) The Rights Agent shall not be liable for consequential damages under any provision of this Agreement
or for any consequential damages arising out of any act or failure to act hereunder. 
 Section 19. Merger or Consolidation or Change
of Name of Rights Agent. 
 (a) Any corporation into which the Rights Agent or any successor Rights Agent may be merged or
with which it may be consolidated, or any corporation resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any corporation succeeding to the shareholder services business of the
Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto, but only if such corporation would
be eligible for appointment as a successor Rights Agent under the provisions of Section 21 hereof. In case at the time such successor Rights Agent shall succeed to the agency created by this Agreement, any of the Right Certificates shall have
been countersigned but not delivered, any such successor Rights Agent may adopt the countersignature of the predecessor Rights Agent and deliver such Right Certificates so countersigned; and in case at that time any of the Right Certificates shall
not have been countersigned, any successor Rights Agent may countersign such Right Certificates either in the name of the predecessor or in the name of the successor Rights Agent; and in all such cases such Right Certificates shall have the full
force provided in the Right Certificates and in this Agreement. 
 (b) In case at any time the name of the Rights Agent shall
be changed and at such time any of the Right Certificates shall have been countersigned but not delivered, the Rights Agent may adopt the countersignature under its prior name and deliver Right Certificates so countersigned; and in case at that time
any of the Right Certificates shall not have been countersigned, 

  

 27 

 
the Rights Agent may countersign such Right Certificates either in its prior name or in its changed name; and in all such cases such Right Certificates shall
have the full force provided in the Right Certificates and in this Agreement. 
 Section 20. Duties of Rights Agent. The Rights
Agent undertakes the duties and obligations expressly imposed by this Agreement upon the following terms and conditions, by all of which the Company and the holders of Right Certificates, by their acceptance thereof, shall be bound: 
 (a) The Rights Agent may consult with legal counsel selected by it (who may be legal counsel for the Company), and the opinion of such
counsel shall be full and complete authorization and protection to the Rights Agent as to any action taken or omitted by it in good faith and in accordance with such opinion. 
 (b) Whenever in the performance of its duties under this Agreement the Rights Agent shall deem it necessary or desirable that any fact or
matter (including, without limitation, the identity of any Acquiring Person and the determination of “Fair Market Value”) be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter
(unless other evidence in respect thereof shall be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by a person believed by the Rights Agent to be the Chairman of the Board of Directors,
the President, a Vice President, the Treasurer, any Assistant Treasurer, the Secretary or an Assistant Secretary of the Company and delivered to the Rights Agent. Any such certificate shall be full authorization to the Rights Agent for any action
taken or suffered in good faith by it under the provisions of this Agreement in reliance upon such certificate. 
 (c) The
Rights Agent shall be liable hereunder only for its own gross negligence, bad faith or willful misconduct. 
 (d) The Rights
Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Right Certificates (except its countersignature thereof) or be required to verify the same, but all such statements and
recitals are and shall be deemed to have been made by the Company only. 
 (e) The Rights Agent shall not be under any
responsibility in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution hereof by the Rights Agent) or in respect of the validity or execution of any Right Certificate (except its countersignature
thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Right Certificate; nor shall it be responsible for any change in the exercisability of the Rights (including the
Rights becoming void pursuant to Section 7(e) hereof) or any adjustment required under the provisions of Sections 11, 13 or 23(c) hereof or responsible for the manner, method or amount of any such adjustment or the ascertaining of the existence
of facts that would require any such adjustment (except with respect to the exercise of Rights evidenced by Right Certificates after receipt of a certificate describing any such adjustment furnished in accordance with Section 12 hereof), nor
shall it be responsible for any determination by the Board of Directors of the Company of the Fair Market Value of the Rights or Preferred Stock pursuant to the provisions of Section 14 hereof; nor shall it by any act hereunder be deemed to
make any representation or warranty as to the authorization or reservation of any shares of Common Stock of the Company or Preferred Stock to be issued pursuant to this Agreement or any Right Certificate or as to whether or not any shares of Common
Stock of the Company or Preferred Stock will, when so issued, be validly authorized and issued, fully-paid and non-assessable. 
  

 28 

 (f) The Company agrees that it will perform, execute, acknowledge and deliver or cause to
be performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances as may reasonably be required by the Rights Agent for the carrying out or performing by the Rights Agent of the provisions of this
Agreement. 
 (g) The Rights Agent is hereby authorized and directed to accept instructions with respect to the performance of
its duties hereunder and certificates delivered pursuant to any provision hereof from any person believed by the Rights Agent to be the Chairman of the Board of Directors, the President, a Vice President, the Secretary, an Assistant Secretary, the
Treasurer or an Assistant Treasurer of the Company, and is authorized to apply to such officers for advice or instructions in connection with its duties, and it shall not be liable for any action taken or suffered to be taken by it in good faith in
accordance with instructions of any such officer. Any application by the Rights Agent for written instructions from the Company may, at the option of the Rights Agent, set forth in writing any action proposed to be taken or omitted by the Rights
Agent under this Agreement and the date on or after which such action shall be taken or such omission shall be effective. The Rights Agent shall not be liable for any action taken by, or omission of, the Rights Agent in accordance with a proposal
included in such application on or after the date specified in such application (which date shall not be less than five Business Days after the date any officer of the Company actually receives such application, unless any such officer shall have
consented in writing to an earlier date) unless, prior to taking any such action (or the effective date in the case of an omission), the Rights Agent shall have received written instructions in response to such application specifying the action to
be taken or omitted. 
 (h) The Rights Agent and any Affiliate, shareholder, member, partner, director, officer or employee of
the Rights Agent may buy, sell or deal in any of the Rights or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money to the Company or otherwise act
as fully and freely as though it were not the Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Company or for any other legal entity. 
 (i) The Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself
or by or through its attorneys or agents. 
 (j) No provision of this Agreement shall require the Rights Agent to expend or
risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate
indemnification against such risk or liability is not reasonably assured to it. 
 (k) If, with respect to any Right
Certificate surrendered to the Rights Agent for exercise or transfer, the certificate attached to the form of assignment or form of election to purchase, as the case may be, has either not been completed or indicates an affirmative response to
clause (1) or clause (2) thereof, the Rights Agent shall not take any further action with respect to such requested exercise or transfer without first consulting with the Company. 
 Section 21. Change of Rights Agent. The Rights Agent or any successor Rights Agent may resign and be discharged from its duties under this
Agreement upon not less than thirty (30) days’ notice in writing mailed to the Company by first class mail; 

  

 29 

 
provided that in the event the transfer agency relationship in effect between the Company and the Rights Agent terminates, the Rights Agent shall be deemed
to resign automatically on the effective date of such termination. The Company may remove the Rights Agent or any successor Rights Agent (with or without cause), effective immediately or on a specified date, by written notice given to the Rights
Agent or successor Rights Agent, as the case may be, and to each transfer agent of the Common Stock of the Company and Preferred Stock, and by giving notice to the holders of the Right Certificates by any means reasonably determined by the Company
to inform such holders of such removal (including without limitation, by including such information in one or more of the Company’s reports to shareholders or reports or filings with the Securities and Exchange Commission). If the Rights Agent
shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint a successor to the Rights Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after giving notice of
such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent or by the holder of a Right Certificate (who shall, with such notice, submit his Right Certificate for inspection
by the Company), then the incumbent Rights Agent or the registered holder of any Right Certificate may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights Agent, whether appointed by the
Company or by such a court, shall be (a) a corporation organized and doing business under the laws of the United States or of the State of Delaware or the State of New York (or of any other state of the United States so long as such corporation
is authorized to do business as a banking institution in the State of Delaware or the State of New York), in good standing, which is authorized under such laws to exercise stock transfer or corporate trust powers and is subject to supervision or
examination by federal or state authority and which has at the time of its appointment as Rights Agent a combined capital and surplus of at least $10,000,000 or (b) an Affiliate of a Person described in clause (a) of this sentence. After
appointment, the successor Rights Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent without further act or deed; but the predecessor Rights Agent shall deliver and
transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose. Not later than the effective date of any such appointment, the
Company shall file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the Common Stock of the Company and the Preferred Stock, and give notice to the holders of the Right Certificates by any means reasonably
determined by the Company to inform such holders of such appointment (including without limitation, by including such information in one or more of the Company’s reports to shareholders or reports or filings with the Securities and Exchange
Commission). Failure to give any notice provided for in this Section 21, however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights
Agent, as the case may be. 
 Section 22. Issuance of New Right Certificates. Notwithstanding any of the provisions of this
Agreement or of the Rights to the contrary, the Company may, at its option, issue new Right Certificates evidencing Rights in such form as may be approved by the Board of Directors of the Company to reflect any adjustment or change in the Exercise
Price per share and the number or kind or class of shares of stock or other securities or property purchasable under the Right Certificates made in accordance with the provisions of this Agreement. In addition, in connection with the issuance or
sale of shares of Common Stock of the Company following the Distribution Date and prior to the redemption or expiration of the Rights, the Company (a) shall, with respect to shares of Common Stock of the Company so issued or sold pursuant to
the exercise of stock options or under any employee plan or arrangement, or upon the exercise, conversion or exchange of securities hereafter issued by the Company, and (b) may, in any other case, if deemed necessary or appropriate by the Board
of Directors of the Company, issue Right Certificates representing the appropriate number of Rights in connection with such issuance or sale; provided that (i) no such Right Certificate shall be issued if, and to the extent that, the Company
shall be advised by counsel that such issuance would create a significant risk of material adverse tax consequences to the Company or the person to whom such Right Certificate would be issued, and (ii) no such Right Certificate shall be issued
if, and to the extent that, appropriate adjustments shall otherwise have been made in lieu of the issuance thereof. 
  

 30 

 Section 23. Redemption. 
 (a) The Board of Directors of the Company may, at its option, at any time prior to the earlier of the Stock Acquisition Date or the Final
Expiration Date, (x) redeem all but not less than all of the then outstanding Rights at a redemption price of $0.01 per Right (rounded upward to the nearest whole $0.01 in the case of any holder whose holding is not a multiple of ten Rights, as
such amount may be appropriately adjusted to reflect any stock split, stock dividend, combination of the outstanding shares of Common Stock of the Company or similar event or transaction occurring after the date of this Agreement (such redemption
price, as adjusted from time to time, being hereinafter referred to as the “Redemption Price”) or (y) amend this Agreement to change the Final Expiration Date to another date, including an earlier date. 
 (b) Immediately upon the action of the Board of Directors of the Company ordering the redemption of the Rights in accordance with this
Section 23, and without any further action and without any notice, the right to exercise the Rights shall terminate and the only right thereafter of the holders of Rights shall be to receive the Redemption Price for each Right so held. Promptly
after the action of the Board of Directors of the Company ordering the redemption of the Rights in accordance with this Section 23, the Company shall give notice of such redemption to the Rights Agent and the holders of the then outstanding
Rights by mailing such notice to the Rights Agent and to all such holders at their last addresses as they appear upon the registry books of the Rights Agent or, prior to the Distribution Date, on the registry books of the transfer agent for the
Common Stock of the Company. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice. Any notice which is mailed in the manner herein provided shall be deemed given, whether or
not the holder receives the notice. Each such notice of redemption shall state the method by which the payment of the Redemption Price will be made. 
 (c) The Company may, at its option, pay the Redemption Price in cash, shares of Common Stock of the Company (based on the Fair Market Value of the Common Stock of the Company as of the time of redemption) or any other
form of consideration deemed appropriate by the Board of Directors of the Company. 
 Section 24. Exchange. 
 (a) (i) The Board of Directors of the Company may, at its option, at any time on or after the occurrence of a Section 11(a)(ii)
Event, exchange all or part of the then outstanding and exercisable Rights (which shall not include Rights that have become void pursuant to the provisions of Section 7(e) hereof) for shares of Common Stock of the Company at an exchange ratio
of one share of Common Stock of the Company per Right, appropriately adjusted to reflect any stock split, stock dividend, combination of the outstanding shares of Common Stock of the Company or similar event or transaction occurring after the date
hereof (such exchange ratio being hereinafter referred to as the “Section 24(a)(i) Exchange Ratio”). Notwithstanding the foregoing, the Board of Directors of the Company shall not be empowered to effect such exchange at any time
after any Person (other than an Exempt Person), together with all Affiliates and Associates of such Person, becomes the Beneficial Owner of 50% or more of the Common Stock of the Company. 
  

 31 

 (ii) Notwithstanding the foregoing, the Board of Directors of the Company may, at its
option, at any time on or after the occurrence of a Section 11(a)(ii) Event, exchange all or part of the then outstanding and exercisable Rights (which shall not include Rights that have become null and void pursuant to the provisions of
Section 7(e) hereof) for shares of Common Stock of the Company at an exchange ratio specified in the following sentence, as appropriately adjusted to reflect any stock split, stock dividend, combination of the outstanding shares of Common Stock
of the Company or similar event or transaction occurring after the date of this Agreement. Subject to the adjustment described in the foregoing sentence, each Right may be exchanged for that number of shares of Common Stock of the Company obtained
by dividing the Spread (as defined in Section 11(a)(iii)) by the then Fair Market Value per one one-thousandth of a share of Preferred Stock on the earlier of (x) the date on which any person becomes an Acquiring Person or (y) the
date on which a tender or exchange offer by any Person (other than an Exempt Person) is first published or sent or given within the meaning of Rule 14d-4(a) of the Exchange Act or any successor rule, if upon consummation thereof such Person could
become an Acquiring Person (such exchange ratio being referred to herein as the “Section 24(a)(ii) Exchange Ratio”). Notwithstanding the foregoing, the Board of Directors of the Company shall not be empowered to effect such exchange
at any time after any Person (other than an Exempt Person), together with all Affiliates and Associates of such Person, becomes the Beneficial Owner of 50% or more of the Common Stock of the Company. 
 (b) Immediately upon the action of the Board of Directors of the Company ordering the exchange of any Rights pursuant to
Section 24(a) hereof and without any further action and without any notice, the right to exercise such Rights shall terminate and the only right thereafter of a holder of such Rights shall be to receive that number of shares of Common Stock of
the Company equal to the number of such Rights held by such holder multiplied by the Section 24(a)(i) Exchange Ratio or the Section 24(a)(ii) Exchange Ratio, as applicable. The Company shall promptly give notice of any such exchange in
accordance with Section 26 hereof and shall promptly mail a notice of any such exchange to all of the holders of such Rights at their respective last addresses as they appear upon the registry books of the Rights Agent; provided that the
failure to give, or any defect in, such notice shall not affect the validity of such exchange. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice. Each such notice of
exchange shall state the method by which the exchange of the shares of Common Stock of the Company for Rights will be effected and, in the event of any partial exchange, the number of Rights which will be exchanged. Any partial exchange shall be
effected pro rata based on the number of Rights (other than Rights which have become null and void pursuant to the provisions of Section 7(e) hereof) held by each holder of Rights. 
 (c) In any exchange pursuant to this Section 24, the Company, at its option, may substitute Preferred Stock (or Preferred Stock
Equivalent) for Common Stock of the Company exchangeable for Rights, at the initial rate of one one-thousandth of a share of Preferred Stock (or Preferred Stock Equivalent) for each share of Common Stock of the Company, as appropriately adjusted to
reflect adjustments in the voting rights of the Preferred Stock pursuant to the terms thereof, so that the fraction of a share of Preferred Stock delivered in lieu of each share of Common Stock of the Company shall have the same voting rights as one
share of Common Stock of the Company. 
 (d) In the event that there shall not be sufficient shares of Common Stock of the
Company or Preferred Stock (or Preferred Stock Equivalents) issued but not outstanding or authorized but unissued to permit any exchange of Rights as contemplated 

  

 32 

 
in accordance with this Section 24, the Company shall take all such action as may be necessary to authorize additional shares of Common Stock of the
Company or Preferred Stock (or Preferred Stock Equivalent) for issuance upon exchange of the Rights. 
 (e) The Company shall
not be required to issue fractions of Common Stock of the Company or to distribute certificates which evidence fractional shares of Common Stock of the Company. If the Company elects not to issue such fractional shares of Common Stock of the
Company, the Company shall pay, in lieu of such fractional shares of Common Stock of the Company, to the registered holders of the Right Certificates with regard to which such fractional shares of Common Stock of the Company would otherwise be
issuable, an amount in cash equal to the same fraction of the Fair Market Value of a whole share of Common Stock of the Company. For the purposes of this paragraph (e), the Fair Market Value of a whole share of Common Stock of the Company shall be
the closing price of a share of Common Stock of the Company (as determined pursuant to the second sentence of Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of exchange pursuant to this Section 24. 

Section 25. Notice of Certain Events. 
 (a) In case the Company shall propose, at any time after the Distribution Date, (i) to pay any dividend payable in stock of any class to the holders of Preferred Stock or to make any other distribution to the
holders of Preferred Stock (other than a regular periodic cash dividend out of earnings or retained earnings of the Company), or (ii) to offer to the holders of Preferred Stock rights or warrants to subscribe for or to purchase any additional
shares of Preferred Stock or shares of stock of any class or any other securities, rights or options, or (iii) to effect any reclassification of its Preferred Stock (other than a reclassification involving only the subdivision of outstanding
shares of Preferred Stock), or (iv) to effect any consolidation or merger into or with, or to effect any sale, mortgage or other transfer (or to permit one or more of its Subsidiaries to effect any sale, mortgage or other transfer), in one
transaction or a series of related transactions, of 50% or more of the assets or earning power of the Company and its Subsidiaries (taken as a whole) to, any other Person (other than a Subsidiary of the Company in one or more transactions each of
which is not prohibited by the proviso at the end of the first sentence of Section 11(n) hereof), or (v) to effect the liquidation, dissolution or winding up of the Company, or (vi) to declare or pay any dividend on the Common Stock
of the Company payable in Common Stock of the Company or to effect a subdivision, combination or consolidation of the Common Stock of the Company (by reclassification or otherwise than by payment of dividends in Common Stock of the Company) then in
each such case, the Company shall give to each holder of a Right Certificate and to the Rights Agent, in accordance with Section 26 hereof, a notice of such proposed action, which shall specify the record date for the purposes of such stock
dividend, distribution of rights or warrants, or the date on which such reclassification, consolidation, merger, sale, transfer, liquidation, dissolution, or winding up is to take place and the date of participation therein by the holders of the
shares of Common Stock of the Company and/or Preferred Stock, if any such date is to be fixed, and such notice shall be so given in the case of any action covered by clause (i) or (ii) above at least twenty (20) days prior to the
record date for determining holders of the shares of Preferred Stock for purposes of such action, and in the case of any such other action, at least twenty (20) days prior to the date of the taking of such proposed action or the date of
participation therein by the holders of the shares of Common Stock of the Company and/or Preferred Stock, whichever shall be the earlier; provided no such notice shall be required pursuant to this Section 25 as a result of any Subsidiary of the
Company effecting a consolidation or merger with or into, or effecting a sale or other transfer of assets or earnings power to, any other Subsidiary of the Company in a manner not inconsistent with the provisions of this Agreement. 
  

 33 

 (b) In case any Section 11(a)(ii) Event shall occur, then, in any such case,
(i) the Company shall as soon as practicable thereafter give to each registered holder of a Right Certificate and to the Rights Agent, in accordance with Section 26 hereof, a notice of the occurrence of such event, which shall specify the
event and the consequences of the event to holders of Rights under Section 11(a)(ii) hereof and (ii) all references in the preceding subsection (a) of this Section 25 shall be deemed thereafter to refer to Common Stock of the
Company and/or other appropriate securities. 
 Section 26. Notices. Notices or demands authorized by this Agreement to be given
or made by the Rights Agent or by the holder of any Right Certificate to or on the Company shall be sufficiently given or made if sent by first-class mail, postage prepaid, by facsimile transmission or by nationally-recognized overnight courier
addressed (until another address is filed in writing with the Rights Agent) as follows: 
 Myriad Pharmaceuticals, Inc. 
 320 Wakara Way 
 Salt Lake City, UT 84108

 Fax: (        )
            -             
 Attention: Chief Executive Officer 
 Subject to the provisions of Section 21, any notice or demand authorized by this
Agreement to be given or made by the Company or by the holder of any Right Certificate to or on the Rights Agent shall be sufficiently given or made if sent by first-class mail, postage prepaid, by facsimile transmission or by nationally-recognized
overnight courier addressed (until another address is filed in writing with the Company) as follows: 
 American Stock Transfer &
Trust Company, LLC 
 59 Maiden Lane 
 Plaza Level 
 New York, NY 10038 
 Fax: (718) 331-1852 
 Attention: Corporate Trust 
 Notices or demands authorized by this Agreement to be given or made by the Company or the Rights Agent to the holder of any Right Certificate (or, prior to the Distribution Date, to the holder of any certificate
representing shares of Common Stock of the Company) shall be sufficiently given or made if sent by first-class mail, postage prepaid, addressed to such holder at the address of such holder as shown on the registry books of the Company. 

Section 27. Supplements and Amendments. Prior to the Stock Acquisition Date, the Company and the Rights Agent shall, if the Company so
directs, supplement or amend any provision of this Agreement without the approval of any holders of certificates representing shares of Common Stock of the Company. From and after the Stock Acquisition Date, the Company and the Rights Agent shall,
if the Company so directs, supplement or amend this Agreement without the approval of the holders of Right Certificates in order to (i) cure any ambiguity, (ii) correct or supplement any provision contained herein which may be defective or
inconsistent with any other provisions herein, or (iii) change or supplement the provisions hereof in any manner which the Board of Directors of the Company may deem necessary or desirable and which shall not adversely affect the interests of
the holders of Right Certificates 

  

 34 

 
(other than an Acquiring Person or any Affiliate or Associate of an Acquiring Person); provided that, from and after the Stock Acquisition Date this
Agreement may not be supplemented or amended to lengthen, pursuant to clause (iii) of this sentence, (A) a time period relating to when the Rights may be redeemed at such time as the Rights are not then redeemable or (B) any other
time period unless such lengthening is for the purpose of protecting, enhancing or clarifying the rights of, and the benefits to, the holders of Rights (other than an Acquiring Person or any Affiliate or Associate of an Acquiring Person). Without
limiting the foregoing, the Company may at any time prior to the Stock Acquisition Date amend this Agreement to lower the threshold set forth in Section 1(a) to not less than the greater of (i) the sum of .001% and the largest percentage
of the outstanding Common Stock of the Company then known by the Company to be Beneficially Owned by any Person (other than the Company, any Subsidiary of the Company, any employee benefit plan of the Company or any Subsidiary of the Company, or any
entity holding Common Stock of the Company for or pursuant to the terms of any such plan) and (ii) 10%. Upon the delivery of such certificate from an appropriate officer of the Company which states that the proposed supplement or amendment is
in compliance with the terms of this Section 27, the Rights Agent shall execute such supplement or amendment, and any failure by the Rights Agent to so execute such supplement or amendment shall not affect the validity of the action taken by
the Board of Directors of the Company pursuant to this Section 27. Prior to the occurrence of a Section 11(a)(ii) Event, the interests of the holders of Rights shall be deemed coincident with the interests of the holders of Common Stock of
the Company. Notwithstanding any other provision hereof, the Rights Agent’s consent must be obtained regarding any amendment or supplement pursuant to this Section 27 which alters the Rights Agent’s rights or duties. 
 Section 28. Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall
bind and inure to the benefit of their respective successors and assigns hereunder. 
 Section 29. Determinations and Actions by the
Board of Directors. The Board of Directors of the Company shall have the exclusive power and authority to administer this Agreement and to exercise all rights and powers specifically granted to the Board of Directors or to the Company, or as may
be necessary or advisable in the administration of this Agreement, including without limitation, the right and power to (i) interpret the provisions of this Agreement and (ii) make all determinations and computations deemed necessary or
advisable for the administration of this Agreement (including a determination to redeem or not redeem the Rights or to amend the Agreement). All such actions, calculations, interpretations and determinations (including, for purposes of clause
(y) below, all omissions with respect to the foregoing) which are done or made by the Board of Directors in good faith shall (x) be final, conclusive and binding on the Company, the Rights Agent, the holders of the Rights and all other
parties, and (y) not subject any member of the Board of Directors to any liability to the holders of the Rights or to any other person. 
 Section 30. Benefits of this Agreement. Nothing in this Agreement shall be construed to give to any Person other than the Company, the Rights Agent and the registered holders of the Right Certificates (and, prior to the
Distribution Date, the Common Stock of the Company) any legal or equitable right, remedy or claim under this Agreement but this Agreement shall be for the sole and exclusive benefit of the Company, the Rights Agent and the registered holders of the
Right Certificates (and, prior to the Distribution Date, registered holders of the Common Stock of the Company). 
 Section 31.
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated; provided that notwithstanding anything in this Agreement to the contrary, if any such term, provision, covenant or
restriction is held by such 

  

 35 

 
court or authority to be invalid, void or unenforceable and the Board of Directors of the Company determines in its good faith judgment that severing the
invalid language from the Agreement would adversely affect the purpose or effect of the Agreement, the right of redemption set forth in Section 23 hereof shall be reinstated and shall not expire until the Close of Business on the tenth
(10th) day following the date of such determination by the Board of Directors of the company. 
 Section 32. Governing Law. This Agreement, each Right and each Right Certificate issued hereunder shall be deemed to be a contract made under
the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such State applicable to contracts to be made and to be performed entirely within such State. The courts of the State of
Delaware and of the United States of America located in the State of Delaware (the “Delaware Courts”) shall have exclusive jurisdiction over any litigation arising out of or relating to this Agreement and the transactions
contemplated hereby, and any Person commencing or otherwise involved in any such litigation shall waive any objection to the laying of venue of such litigation in the Delaware Courts and shall not plead or claim in any Delaware Court that such
litigation brought therein has been brought in an inconvenient forum. 
 Section 33. Counterparts. This Agreement may be executed
in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 
 Section 34. Descriptive Headings. Descriptive headings of the several Sections of this Agreement are inserted for convenience only and shall
not control or affect the meaning or construction of any of the provisions hereof. 
 Section 35. Force Majeure. Notwithstanding
anything to the contrary contained herein, neither the Company nor the Rights Agent shall be liable for any delay or failure in performance resulting directly from any act or event beyond its reasonable control and without the fault or gross
negligence of the delayed or non-performing party that causes a sudden, substantial or widespread disruption in business activities, including, without limitation, fire, flood, natural disaster or act of God, strike or other industrial disturbance,
war (declared or undeclared), embargo, blockade, legal restriction, riot, insurrection, act of terrorism, disruption in transportation, communications, electric power or other utilities, or other vital infrastructure or any means of disrupting or
damaging internet or other computer networks or facilities (each, a “Force Majeure Condition”); provided that such delayed or non-performing party shall use reasonable commercial efforts to resume performance as soon as practicable.
If any Force Majeure Condition occurs, the party delayed or unable to perform shall give prompt written notice to the other party, stating the nature of the Force Majeure Condition and any action being taken to avoid or minimize its effect.

 [Remainder of Page Intentionally Left Blank] 
  

 36 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as an instrument
under seal and attested, all as of the day and year first above written. 
  

							
	ATTEST:	    	MYRIAD PHARMACEUTICALS, INC.
				
	By:	 	  
	    	By:	 	  

		 		    	Name:	 	Adrian N. Hobden, Ph.D.
		 		    	Title:	 	President and Chief Executive Officer
		
	ATTEST:	    	AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC,
		 		    	as Rights Agent
				
	 By:
	 	  
	    	By:	 	  

		 		    	Name:	 	
		 		    	Title:	 	

  

 37 

 EXHIBIT A 
 CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS 
 OF 
 SERIES A JUNIOR PARTICIPATING PREFERRED STOCK 
 OF 
 MYRIAD PHARMACEUTICALS, INC. 
 MYRIAD PHARMACEUTICALS, INC., a Delaware corporation (the “Corporation”), does hereby certify that, pursuant to authority conferred on the Board of Directors of the Corporation by the Restated Certificate of
Incorporation of the Corporation, and pursuant to the provisions of Section 151 of Title 8 of the Delaware Code, the Board of Directors, at a meeting of its members held on June 1, 2009, adopted a resolution providing for the designation,
preferences and relative, participating, optional or other rights, and qualifications, limitations or restrictions thereof, of one million (1,000,000) shares of the Corporation’s Series A Junior Participating Preferred Stock, $0.01 par
value per share, which resolution is as follows: 
  

			
	 RESOLVED:
	 	That pursuant to the authority expressly vested in the Board of Directors of the Corporation by Article Fourth of the Corporation’s Restated Certificate of Incorporation, the Board of
Directors does hereby adopt a resolution, providing for the issuance of a new series of Preferred Stock, $0.01 par value per share, of the Corporation, to be designated “Series A Junior Participating Preferred Stock” (the “Series A
Junior Participating Preferred Stock”) consisting of one million (1,000,000) shares, which number of shares may be decreased (but not below the number of shares then outstanding) from time to time by the Board of Directors of the
Corporation; and herein states and expresses that the designation, preferences and other special or relative rights of the shares of Series A Junior Participating Preferred Stock shall be as set forth in the Certificate of Designation, Preferences,
and Rights of Series A Convertible Preferred Stock (the “Certificate of Designation”), a copy of which has been presented to, reviewed and adopted by this Board of Directors.

 D. Description and Designation of Series A Junior Participating Preferred Stock 

Section 1. Designation and Amount. The shares of such series shall be designated as “Series A Junior Participating Preferred
Stock,” and the number of shares constituting such series shall be 1,000,000. Such number of shares may be increased or decreased by resolution of the Board of Directors; provided, however, that no decrease shall reduce the
number of shares of Series A Junior Participating Preferred Stock to a number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of outstanding options, rights or warrants or upon the
conversion of any outstanding securities issued by the Corporation convertible into Series A Junior Participating Preferred Stock. 
  

 A-1 

 Section 2. Dividends and Distributions. 
 (A) Subject to the rights of the holders of any shares of any series of Preferred Stock ranking prior and superior to the shares of Series A Junior
Participating Preferred Stock with respect to dividends, the holders of shares of Series A Junior Participating Preferred Stock, in preference to the holders of Common Stock, $0.01 par value per share (the “Common Stock”), of the
Corporation, and of any other junior stock, shall be entitled to receive, when, as and if declared by the Board of Directors, out of funds of the Corporation legally available for the payment of dividends, quarterly dividends payable in cash on
March 31, June 30, September 30 and December 31 in each year (each such date being referred to herein as a “Quarterly Dividend Payment Date”), commencing on the first Quarterly Dividend Payment Date
after the first issuance of a share or fraction of a share of Series A Junior Participating Preferred Stock, in an amount per share (rounded to the nearest cent) equal to the greater of (a) $1.00 or (b) subject to the provision for
adjustment hereinafter set forth, 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the aggregate per share amount (payable in kind) of all non-cash dividends or other distributions, other than a dividend payable in
shares of Common Stock or a subdivision of the outstanding shares of Common Stock (by reclassification or otherwise), declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date, or, with respect to the first
Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share of Series A Junior Participating Preferred Stock. The multiple of cash and non-cash dividends declared on the Common Stock to which holders of the Series A
Junior Participating Preferred Stock are entitled, which shall be 1,000 initially, but which shall be adjusted from time to time as hereinafter provided, is hereinafter referred to as the “Dividend Multiple.” In the event the
Corporation shall at any time after [                    ], 2009] (the “Rights Declaration Date”) (i) declare or
pay any dividend on Common Stock payable in shares of Common Stock or (ii) effect a subdivision, combination or consolidation of the outstanding Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common
Stock) into a greater or lesser number of shares of Common Stock, then in each such case the Dividend Multiple thereafter applicable to the determination of the amount of dividends which holders of shares of Series A Junior Participating Preferred
Stock shall be entitled to receive shall be the Dividend Multiple applicable immediately prior to such event multiplied by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the
denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event. 
 (B) The Corporation
shall declare a dividend or distribution on the Series A Junior Participating Preferred Stock as provided in paragraph (A) above immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in
shares of Common Stock) and the Corporation shall pay such dividend or distribution on the Series A Junior Participating Preferred Stock before the dividend or distribution declared on the Common Stock is paid or set apart; provided,
however, that, in the event no dividend or distribution shall have been declared on the Common Stock during the period between any Quarterly Dividend Payment Date and the next subsequent Quarterly Dividend Payment Date, a dividend of $1.00
per share on the Series A Junior Participating Preferred Stock shall nevertheless be payable on such subsequent Quarterly Dividend Payment Date. 
 (C) Dividends shall begin to accrue and be cumulative on outstanding shares of Series A Junior Participating Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares of Series A Junior
Participating Preferred Stock, unless the date of issue of such shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin to accrue from the date of issue of such shares, or
unless the date of issue is a Quarterly Dividend Payment Date or is a date after the record date for the determination of holders of shares of Series A Junior 

  

 A-2 

 
Participating Preferred Stock entitled to receive a quarterly dividend and before such Quarterly Dividend Payment Date, in either of which events such
dividends shall begin to accrue and be cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the shares of Series A Junior Participating Preferred Stock in an amount less than
the total amount of such dividends at the time accrued and payable on such shares shall be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors may fix a record date for the determination
of holders of shares of Series A Junior Participating Preferred Stock entitled to receive payment of a dividend or distribution declared thereon, which record date shall be no more than 60 days prior to the date fixed for the payment thereof.

 Section 3. Voting Rights. In addition to any other voting rights required by law, the holders of shares of Series A Junior
Participating Preferred Stock shall have the following voting rights: 
 (A) Subject to the provision for adjustment hereinafter set forth,
each share of Series A Junior Participating Preferred Stock shall entitle the holder thereof to 1,000 votes on all matters submitted to a vote of the stockholders of the Corporation. The number of votes which a holder of a share of Series A Junior
Participating Preferred Stock is entitled to cast, which shall initially be 1,000 but which may be adjusted from time to time as hereinafter provided, is hereinafter referred to as the “Vote Multiple.” In the event the Corporation
shall at any time after the Rights Declaration Date (i) declare or pay any dividend on Common Stock payable in shares of Common Stock or (ii) effect a subdivision, combination or consolidation of the outstanding Common Stock (by
reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case Vote Multiple thereafter applicable to the determination of the number of votes
per share to which holders of shares of Series A Junior Participating Preferred Stock shall be entitled shall be the Vote Multiple immediately prior to such event multiplied by a fraction, the numerator of which is the number of shares of Common
Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event. 
 (B) Except as otherwise provided herein, by law, or in any other Restated Certificate of Incorporation or Certificate of Designation to the Restated Certificate of Incorporation creating a series of Preferred Stock or
any similar stock, the holders of shares of Series A Junior Participating Preferred Stock, the holders of shares of Common Stock and any other capital stock of the Corporation having general voting rights shall vote together as one class on all
matters submitted to a vote of stockholders of the Corporation. 
 (C) (i) If at any time dividends on any Series A Junior Participating
Preferred Stock shall be in arrears in an amount equal to six (6) quarterly dividends thereon, the occurrence of such contingency shall mark the beginning of a period (herein called a “default period”) which shall extend until
such time when all accrued and unpaid dividends for all previous quarterly dividend periods and for the current quarterly dividend period on all shares of Series A Junior Participating Preferred Stock then outstanding shall have been declared and
paid or set apart for payment. During each default period, all holders of Preferred Stock (including holders of the Series A Junior Participating Preferred Stock) with dividends in arrears in an amount equal to six (6) quarterly dividends
thereon, voting as a class, irrespective of series, shall have the right to elect two (2) Directors. 
 (ii) During any default period,
such voting right of the holders of Series A Junior Participating Preferred Stock may be exercised initially at a special meeting called pursuant to subparagraph (iii) of this Section 3(C) or at any annual meeting of stockholders, and
thereafter at annual meetings of stockholders, provided that neither such voting right nor the right of the holders of any other series of Preferred Stock, if any, to increase, in certain cases, the authorized number of Directors shall be exercised
unless 

  

 A-3 

 
the holders of ten percent (10%) in number of shares of Preferred Stock outstanding shall be present in person or by proxy. The absence of a quorum of
the holders of Common Stock shall not affect the exercise by the holders of Preferred Stock of such voting right. At any meeting at which the holders of Preferred Stock shall exercise such voting right initially during an existing default period,
they shall have the right, voting as a class, to elect Directors to fill such vacancies, if any, in the Board of Directors as may then exist up to two (2) Directors or, if such right is exercised at an annual meeting, to elect two
(2) Directors. If the number which may be so elected at any special meeting does not amount to the required number, the holders of the Preferred Stock shall have the right to make such increase in the number of Directors as shall be necessary
to permit the election by them of the required number. After the holders of the Preferred Stock shall have exercised their right to elect Directors in any default period and during the continuance of such period, the number of Directors shall not be
increased or decreased except by vote of the holders of Preferred Stock as herein provided or pursuant to the rights of any equity securities ranking senior to or pari passu with the Series A Junior Participating Preferred Stock. 
 (iii) Unless the holders of Preferred Stock shall, during an existing default period, have previously exercised their right to elect Directors, the
Board of Directors may order the calling of a special meeting of the holders of Preferred Stock, which meeting shall thereupon be called by the Chairman of the Board or the President of the Corporation. Notice of such meeting and of any annual
meeting at which holders of Preferred Stock are entitled to vote pursuant to this paragraph (C)(iii) shall be given to each holder of record of Preferred Stock by mailing a copy of such notice to him at his last address as the same appears on the
books of the Corporation. Such meeting shall be called for a time not earlier than 10 days and not later than 60 days after such order or request. Notwithstanding the provisions of this paragraph (C)(iii), no such special meeting shall be called
during the period within 60 days immediately preceding the date fixed for the next annual meeting of the stockholders. 
 (iv) In any
default period, the holders of Common Stock, and other classes of stock of the Corporation if applicable, shall continue to be entitled to elect the whole number of Directors until the holders of Preferred Stock shall have exercised their right to
elect two (2) Directors voting as a class, after the exercise of which right (x) the Directors so elected by the holders of Preferred Stock shall continue in office until their successors shall have been elected by such holders or until
the expiration of the default period, and (y) any vacancy in the Board of Directors may (except as provided in paragraph (C)(ii) of this Section 3) be filled by vote of a majority of the remaining Directors theretofore elected by the
holders of the class of stock which elected the Director whose office shall have become vacant. References in this paragraph (C) to Directors elected by the holders of a particular class of stock shall include Directors elected by such
Directors to fill vacancies as provided in clause (y) of the foregoing sentence. 
 (v) Immediately upon the expiration of a default
period, (x) the right of the holders of Preferred Stock as a class to elect Directors shall cease, (y) the term of any Directors elected by the holders of Preferred Stock as a class shall terminate, and (z) the number of Directors
shall be such number as may be provided for in the Restated Certificate of Incorporation or By-laws irrespective of any increase made pursuant to the provisions of paragraph (C)(ii) of this Section 3 (such number being subject, however, to
change thereafter in any manner provided by law or in the Restated Certificate of Incorporation or By-laws). Any vacancies in the Board of Directors effected by the provisions of clauses (y) and (z) in the preceding sentence may be filled
by a majority of the remaining Directors. 
 (D) Except as otherwise required by applicable law or as set forth herein, or as otherwise
provided by law, holders of Series A Junior Participating Preferred Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein)
for taking any corporate action. 
  

 A-4 

 Section 4. Certain Restrictions. 
 (A) Whenever quarterly dividends or other dividends on distributions payable on the Series A Junior Participating Preferred Stock as provided in
Section 2 are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series A Junior Participating Preferred Stock outstanding shall have been paid in full, the Corporation
shall not: 
 (i) declare or pay dividends on or make any other distributions on any shares of stock ranking junior (either as to dividends
or upon liquidation, dissolution or winding up) to the Series A Junior Participating Preferred Stock; 
 (ii) declare or pay dividends on or
make any other distributions on, or redeem or purchase or otherwise acquire for consideration any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series A Junior Participating
Preferred Stock, except dividends paid ratably on the Series A Junior Participating Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to which the holders of all such shares are
then entitled; 
 (iii) redeem or purchase or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends
or upon liquidation/dissolution or winding up) to the Series A Junior Participating Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise acquire shares of any such junior stock in exchange for shares of any
stock of the Corporation ranking junior (either as to dividends or upon dissolution, liquidation or winding up) to the Series A Junior Participating Preferred Stock; 
 (iv) purchase or otherwise acquire for consideration any shares of Series A Junior Participating Preferred Stock, or any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or
winding up) with the Series A Junior Participating Preferred Stock, except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders of such shares upon such terms as the Board of
Directors, after consideration of the respective annual dividend rates and other relative rights and preferences of the respective Series Fund classes, shall determine in good faith will result in fair and equitable treatment among the respective
series or classes. 
 (B) The Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for
consideration any shares of stock of the Corporation unless the Corporation could, under paragraph (A) of this Section 4, purchase or otherwise acquire such shares at such time and in such manner. 
 Section 5. Reacquired Shares. Any shares of Series A Junior Participating Preferred Stock purchased or otherwise acquired by the Corporation
in any manner whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of
Preferred Stock to be created by resolution or resolutions of the Board of Directors, subject to the conditions and restrictions on issuance set forth herein. 
 Section 6. Liquidation, Dissolution or Winding Up. (A) Upon any liquidation (voluntary or otherwise), dissolution or winding up of the Corporation, no distribution shall be made to the holders of
shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series A Junior Participating Preferred Stock unless, prior thereto, the holders of shares of Series A Junior Participating Preferred Stock
shall have received $1,000 per share, plus an amount equal to accrued and unpaid 

  

 A-5 

 
dividends and distributions thereon, whether or not declared, to the date of such payment (the “Series A Liquidation Preference”). Following
the payment of the full amount of the Series A Liquidation Preference, no additional distributions shall be made to the holders of shares of Series A Junior Participating Preferred Stock unless, prior thereto, the holders of shares of Common Stock
shall have received an amount per share (the “Common Adjustment”) equal to the quotient obtained by dividing (i) the Series A Liquidation Preference by (ii) 1,000 (as appropriately adjusted as set forth in subparagraph C
below to reflect such events as stock splits, stock dividends and recapitalizations with respect to the Common Stock) (such number in clause (ii), the “Adjustment Number”). Following the payment of the full amount of the Series A
Liquidation Preference and the Common Adjustment in respect of all outstanding shares of Series A Junior Participating Preferred Stock and Common Stock, respectively, holders of Series A Junior Participating Preferred Stock and holders of shares of
Common Stock shall receive their ratable and proportionate share of the remaining assets to be distributed in the ratio of the Adjustment Number to 1 with respect to such Preferred Stock and Common Stock, on a per share basis, respectively.

 (B) In the event, however, that there are not sufficient assets available to permit payment in full of the Series A Liquidation Preference
and the liquidation preferences of all other series of Preferred Stock, if any, which rank on a parity with the Series A Junior Participating Preferred Stock, then such remaining assets shall be distributed ratably to the holders of such parity
shares in proportion to their respective liquidation preferences. In the event, however, that there are not sufficient assets available to permit payment in full of the Common Adjustment, then such remaining assets shall be distributed ratably to
the holders of Common Stock. 
 (C) In the event the Corporation shall at any time declare or pay any dividend on Common Stock payable in
shares of Common Stock, or effect a subdivision, combination or consolidation of the outstanding Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of
Common Stock, then in each such case the Adjustment Number in effect immediately prior to such event shall be adjusted by multiplying such Adjustment Number by a fraction the numerator of which is the number of shares of Common Stock outstanding
immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event. 
 (D) Neither the consolidation, merger or other business combination of the Corporation with or into any other corporation the sale, lease, exchange or conveyance of all or any part of the property, assets or business
of the Corporation shall be deemed to be a liquidation, dissolution or winding up of the Corporation for purposes of this Section 6. 
 Section 7. Consolidation, Merger, etc. In case the Corporation shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or
securities, cash and/or any other property, then in any such case the shares of Series A Junior Participating Preferred Stock shall at the same time be similarly exchanged or changed in an amount per share (subject to the provision for adjustment
hereinafter set forth) equal to 1,000 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. In the event the
Corporation shall at any time declare or pay any dividend on Common Stock payable in shares of Common Stock, or effect a subdivision, combination or consolidation of the outstanding Common Stock (by reclassification or otherwise than by payment of a
dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the amount set forth in the preceding sentence with respect to the exchange or change of shares of Series A Junior Participating
Preferred Stock shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock
that were outstanding immediately prior to such event. 
  

 A-6 

 Section 8. No Redemption. The shares of Series A Junior Participating Preferred Stock shall
not be redeemable; provided, however, that the foregoing shall not limit the ability of the Corporation to purchase or otherwise deal in such shares to the extent otherwise permitted hereby or by law. 
 Section 9. Ranking. Unless otherwise expressly provided in the Certificate of Incorporation or Certificate of Designation to the Restated
Certificate of Incorporation relating to any other series of Preferred Stock, the Series A Junior Participating Preferred Stock shall rank junior to every other series of the Corporation’s Preferred Stock previously or hereafter authorized, as
to the payment of dividends and the distribution of assets on liquidation, dissolution or winding up, unless the terms of any such series shall provide otherwise, and shall rank senior to the Common Stock. 
 Section 10. Amendment. The Restated Certificate of Incorporation of the Corporation shall not be further amended in any manner which would
materially alter or change the powers, preferences or special rights of the Series A Junior Participating Preferred Stock so as to affect them adversely without the affirmative vote of the holders of two-thirds (2/3) or more of the outstanding
shares of Series A Junior Participating Preferred Stock, voting together as a single class. 
 Section 11. Fractional Shares.
Series A Junior Participating Preferred Stock may be issued in whole shares or in any fraction of a share that is one one-thousandth (1/1,000th) of a share or any integral multiple of such fraction, which shall entitle the holder, in proportion
to such holder’s fractional shares, to exercise voting rights, receive dividends, participate in distributions and to have the benefit of all other rights of holders of Series A Junior Participating Preferred Stock. In lieu of fractional
shares, the Corporation may elect to make a cash payment as provided in the Rights Agreement for fractions of a share other than one one-thousandth (1/1,000th) of a share or any integral multiple thereof. 
  

 A-7 

 EXHIBIT B 
 FORM OF RIGHT CERTIFICATE 
 Certificate No.
R-            Rights 
 NOT EXERCISABLE AFTER
[            ] , 2019 OR EARLIER IF NOTICE OF REDEMPTION IS GIVEN. THE RIGHTS ARE SUBJECT TO REDEMPTION, AT THE OPTION OF MYRIAD PHARMACEUTICALS, INC., AT $0.01 PER RIGHT, ON THE
TERMS SET FORTH IN THE SHAREHOLDER RIGHTS AGREEMENT BETWEEN MYRIAD PHARMACEUTICALS, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, AS RIGHTS AGENT, DATED AS OF
[            ], 2009 (THE “RIGHTS AGREEMENT”). UNDER CERTAIN CIRCUMSTANCES SPECIFIED IN SECTION 7(e) OF THE RIGHTS AGREEMENT, RIGHTS BENEFICIALLY OWNED BY AN
ACQUIRING PERSON OR AN ASSOCIATE OR AFFILIATE OF AN ACQUIRING PERSON (AS SUCH TERMS ARE DEFINED IN THE RIGHTS AGREEMENT) AND ANY SUBSEQUENT HOLDER OF SUCH RIGHTS MAY BECOME NULL AND VOID. 
 Right Certificate 
 MYRIAD PHARMACEUTICALS, INC. 
 This certifies
that                                        
, or registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles the owner thereof, subject to the terms, provisions and conditions of the Shareholder Rights Agreement dated as of
[            ], 2009 (the “Rights Agreement”) between Myriad Pharmaceuticals, Inc. (the “Company”) and the American Stock Transfer & Trust
Company, LLC, as Rights Agent (the “Rights Agent”), to purchase from the Company at any time after the Distribution Date (as such term is defined in the Rights Agreement) and prior to the close of business on
[            ], 2009 at the office or offices of the Rights Agent designated for such purpose, or its successors as Rights Agent, one one-thousandth of a fully paid, non-assessable
share of the Series A Junior Participating Preferred Stock (the “Preferred Stock”) of the Company, at a purchase price of $72.00 per one one-thousandth of a share (the “Exercise Price”), upon presentation and
surrender of this Right Certificate with the Form of Election to Purchase and the related Certificate duly executed. The number of Rights evidenced by this Right Certificate (and the number of shares which may be purchased upon exercise thereof) set
forth above, and the Exercise Price per share set forth above, are the number and Exercise Price as of [            ], based on the Preferred Stock as constituted at such date.

 Upon the occurrence of a Section 11(a)(ii) Event (as such term is defined in the Rights Agreement), if the Rights evidenced by this
Right Certificate are beneficially owned by (i) an Acquiring Person or an Affiliate or Associate of any such Person (as such terms are defined in the Rights Agreement), (ii) a transferee of any such Acquiring Person or Associate or
Affiliate thereof, or (iii) under certain circumstances specified in the Rights Agreement, a transferee of a Person who, after such transfer, became an Acquiring Person or an Affiliate or Associate of an Acquiring Person, such Rights shall
become null and void and no holder hereof shall have any right with respect to such Rights from and after the occurrence of such Section 11(a)(ii) Event. 
 As provided in the Rights Agreement, the Exercise Price and the number of shares of Preferred Stock or other securities which may be purchased upon the exercise of the Rights evidenced by this Right Certificate are
subject to modification and adjustment upon the happening of certain events. 
 This Right Certificate is subject to all of the terms,
provisions and conditions of the Rights Agreement, which terms, provisions and conditions are hereby incorporated herein by reference and made a part hereof and to which Rights Agreement reference is 

  

 B-1 

 
hereby made for a full description of the rights, limitations of rights, obligations, duties and immunities hereunder of the Rights Agent, the Company and
the holders of the Right Certificates, which limitations of rights include the temporary suspension of the exercisability of such Rights under the specific circumstances set forth in the Rights Agreement. Copies of the Rights Agreement are on file
at the principal office of the Company and the designated office of the Rights Agent and are also available upon written request to the Company or the Rights Agent. 
 This Right Certificate, with or without other Right Certificates, upon surrender at the office or offices of the Rights Agent designated for such purpose, may be exchanged for another Right Certificate or Certificates
of like tenor and date evidencing Rights entitling the holder to purchase a like aggregate number of shares of Preferred Stock as the Rights evidenced by the Right Certificate or Certificates surrendered shall have entitled such holder to purchase.
If this Right Certificate shall be exercised in part, the holder shall be entitled to receive upon surrender hereof another Right Certificate or Certificates for the number of whole Rights not exercised. If this Right Certificate shall be exercised
in whole or in part pursuant to Section 11(a)(ii) of the Rights Agreement, the holder shall be entitled to receive this Right Certificate duly marked to indicate that such exercise has occurred as set forth in the Rights Agreement. 

Under certain circumstances, subject to the provisions of the Rights Agreement, the Board of Directors of the Company at its option may exchange all
or any part of the Rights evidenced by this Certificate for shares of the Company’s Common Stock or Preferred Stock at an exchange ratio (subject to adjustment) specified in the Rights Agreement. 
 Subject to the provisions of the Rights Agreement, the Rights evidenced by this Certificate may be redeemed by the Board of Directors of the Company at
its option at a redemption price of $0.01 per Right (payable in cash, Common Stock or other consideration deemed appropriate by the Board of Directors). 
 The Company is not obligated to issue fractional shares of stock upon the exercise of any Right or Rights evidenced hereby (other than fractions which are integral multiples of one one- thousandth of a share of
Preferred Stock, which may, at the election of the Company, be evidenced by depositary receipts). If the Company elects not to issue such fractional shares, in lieu thereof a cash payment shall be made, as provided in the Rights Agreement.

 No holder of this Right Certificate, as such, shall be entitled to vote or receive dividends or be deemed for any purpose the holder of
shares of Preferred Stock, Common Stock or any other securities of the Company which may at any time be issuable on the exercise hereof, nor shall anything contained in the Rights Agreement or herein be construed to confer upon the holder hereof, as
such, any of the rights of a shareholder of the Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive
notice of meetings or other actions affecting shareholders (except as provided in the Rights Agreement), or to receive dividends or subscription rights, or otherwise, until the Right or Rights evidenced by this Right Certificate shall have been
exercised as provided in the Rights Agreement. 
 This Right Certificate shall not be valid or obligatory for any purpose until it shall have
been countersigned by an authorized signatory of the Rights Agent. 
 WITNESS the facsimile signature of the authorized officers of the
Company as a document under corporate seal. 
  

 B-2 

											
	Attested:	 		  		 	MYRIAD PHARMACEUTICALS, INC.	 	
						
	By:	 	  
	 		  	By:	 	  
	 	
		 	[                    ], Secretary	 		  		 	 Adrian N. Hobden, Ph.D., President and Chief
 Executive Officer
	 	

 Countersigned: 
 AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC 
  

			
	By:	 	  

		 	Name:
		 	Title:

  

 B-3 

 [Form of Reverse Side of Right Certificate] 
 FORM OF ASSIGNMENT 
 (To be executed by the registered holder if such 

 holder desires to transfer the Right Certificate.) 
 FOR VALUE RECEIVED,
                                         
                    hereby sells, assigns and transfers unto
                                         
                                         
                           (Please print name and address of transferee)
                                         
                                         
   this Right Certificate, together with all right, title and interest therein, and does hereby irrevocably constitute and appoint
                                         
                                         
                                         
      Attorney, to transfer the within Right Certificate on the books of the within-named Company, with full power of substitution. 
  

							
	 Dated:             ,
                                
	  		  	  
	  	
		  		  	  
  
	  	
		  		  	 Signature
	  	

 Signature
Guaranteed:                                       
                                  
 CERTIFICATE 
 The undersigned hereby
certifies by checking the appropriate boxes that: 
 (1) the Rights evidenced by this Right Certificate
                     are
                     are not being transferred by or on behalf of a Person who is or was an Acquiring Person or an Affiliate or Associate of
any such Person (as such terms are defined in the Rights Agreement); and 
 (2) after due inquiry and to the best knowledge of the undersigned, the
undersigned
                                         
    did
                                         
    did not directly or indirectly acquire the Rights evidenced by this Right Certificate from any Person who is, was or became an Acquiring Person or an Affiliate or Associate of any such Person. 
  

							
	 Dated:             ,
                                
	  		  	  
	  	
		  		  	  
  
	  	
		  		  	 Signature
	  	

  

 B-4 

 NOTICE 
 The signature to the foregoing Assignment and Certificate must correspond to the name as written upon the face of this Right Certificate in every particular, without alteration or enlargement or any change whatsoever.

  

 B-5 

 FORM OF ELECTION TO PURCHASE 
 (To be executed if holder desires to 
 exercise the Right Certificate.) 

 To         MYRIAD PHARMACEUTICALS, INC.: 
 The undersigned hereby irrevocably elects to exercise
                                        
Rights represented by this Right Certificate to purchase the shares of Preferred Stock issuable upon the exercise of the Rights (or such other securities of the Company or of any other person which may be issuable upon the exercise of the Rights)
and requests that certificates for such shares be issued in the name of: 
  

	
	Please insert social security or other identifying taxpayer
number:                                        
                                         
                                         
         
	                                       
                                         
                                         
                                         
                                         
                                         
             

			
	                                       
                                         
                                         
                                         
              	 	
	 (Please print name and address)
	 	

 If such number of Rights shall not be all the Rights evidenced by this Right Certificate or if the
Rights are being exercised pursuant to Section 11(a)(ii) of the Rights Agreement, a new Right Certificate for the balance of such Rights shall be registered in the name of and delivered to: 
  

	
	Please insert social security or other identifying taxpayer
number:                                        
                                       
                                         
           
	                                       
                                         
                                         
                                         
                                         
                                         
             

			
	                                       
                                         
                                         
                                         
              	 	
	 (Please print name and address)
	 	

  

							
	 Dated:                                     
,                 
	  		  	                                       
                                  	  	
		  		  	  
                                        
                                  
	  	

  
 Signature Guaranteed:
                                         
                                
  

 B-6 

 CERTIFICATE 
 The undersigned hereby certifies, by checking the appropriate boxes, that: 
 (1) the Rights evidenced by this Right Certificate
                     are
                     are not being exercised by or on behalf of a Person who is or was an Acquiring Person or an Affiliate or Associate of any
such Person (as such terms are defined in the Rights Agreement); and 
 (2) after due inquiry and to the best knowledge of the undersigned, the undersigned
                     did
                     did not directly or indirectly acquire the Rights evidenced by this Right Certificate from any Person who is, was or
became an Acquiring Person or an Affiliate or Associate of any such Person. 
  

									
	 Dated:                             ,        
     
	 		 		 	                                       
                                    	  	
					
		 		 		 	                                       
                                    	  	
		 		 		 	        Signature	  	

  

 B-7 

 NOTICE 
 The signature to the foregoing Election to Purchase and Certificate must correspond to the name as written upon the face of this Right Certificate in every particular, without alteration or enlargement or any change
whatsoever. 
  

 B-8Form of Sublease Agreement

 Exhibit 10.1 
  
  
  
  
  
  
 SUBLEASE
AGREEMENT 
  

			
		
	LANDLORD:	 	Myriad Genetics, Inc.
		
	TENANT:	 	Myriad Pharmaceuticals, Inc.

 TABLE OF CONTENTS 
  

			
	DESCRIPTION	  	PAGE
	 I.    PREMISES
	  	1
	 1.1    Description of Premises
	  	1
	 1.2    Work of Improvement
	  	1
	 1.3    Construction of Shell Building
	  	2
	 1.4    Construction of Tenant Finish
	  	2
		
	 II.    TERM
	  	2
	 2.1    Length of Term
	  	2
	 2.2    Commencement Date; Obligation to Pay Rent
	  	2
	 2.3    Option to Extend
	  	3
	 2.4    Acknowledgment of Commencement Date
	  	3
		
	 III.    BASIC RENTAL PAYMENTS
	  	3
	 3.1    Basic Annual Rent
	  	3
	 3.2    Laboratory Facility Basic Annual Rent
	  	4
	 3.3    Additional Monetary Obligations
	  	4
		
	 IV.    ADDITIONAL RENT
	  	4
	 4.1    Basic Annual Rent.
	  	4
	 4.2    Report of Basic Costs and Statement of Estimated Costs
	  	6
	 4.3    Payment of Additional Rent
	  	6
	 4.4    Resolution of Disagreement
	  	7
	 4.5    Limitations
	  	7
		
	 V.    SECURITY DEPOSIT
	  	7
		
	 VI.    USE
	  	7
	 6.1    Use of Leased Premises
	  	7
	 6.2    Prohibition of Certain Activities or Uses
	  	7
	 6.3    Affirmative Obligations with Respect to Use
	  	8
	 6.4    Suitability
	  	8
	 6.5    Taxes
	  	8
		
	 VII.    UTILITIES AND SERVICE
	  	9
	 7.1    Obligation of Landlord
	  	9
	 7.2    Tenant’s Obligations
	  	9
	 7.3    Additional Limitations
	  	9
	 7.4    Limitation on Landlord’s Liability
	  	10
		
	 VIII.    MAINTENANCE AND REPAIRS; ALTERATIONS; ACCESS
	  	10
	 8.1    Maintenance and Repairs by Landlord
	  	10
	 8.2    Maintenance and Repairs by Tenant
	  	10
	 8.3    Tenant Approval of Management and Maintenance Services
	  	10

			
	DESCRIPTION	  	PAGE
	 8.4    Alterations
	  	11
	 8.5    Landlord’s Access to Leased Premises
	  	11
		
	 IX.    ASSIGNMENT
	  	12
	 9.1    Assignment Prohibited
	  	12
	 9.2    Consent Required
	  	12
	 9.3    Landlord’s Right in Event of Assignment
	  	12
		
	 X.    INDEMNITY
	  	14
	 10.1    Indemnification
	  	14
	 10.2    Release of Landlord
	  	14
	 10.3    Notice
	  	14
	 10.4    Litigation
	  	14
		
	 XI.    INSURANCE
	  	14
	 11.1    Fire and “All Risk” Insurance on Tenant’s Personal Property and Fixtures
	  	14
	 11.2    Liability Insurance
	  	14
	 11.3    Property Coverage
	  	15
	 11.4    Subrogation
	  	15
	 11.5    Lender
	  	15
		
	 XII.    DESTRUCTION
	  	15
		
	 XIII.    CONDEMNATION
	  	16
	 13.1    Total Condemnation
	  	16
	 13.2    Partial Condemnation
	  	16
	 13.3    Landlord’s Option to Terminate
	  	16
	 13.4    Award
	  	16
	 13.5    Definition
	  	16
		
	 XIV.    LANDLORD’S RIGHTS TO CURE
	  	.17
	 14.1    General Right
	  	17
	 14.2    Mechanic’s Lien
	  	17
		
	 XV.    FINANCING; SUBORDINATION
	  	17
	 15.1    Subordination
	  	17
	 15.2    Attornment
	  	18
	 15.3    Financial Information
	  	18
		
	 XVI.    EVENTS OF DEFAULT; REMEDIES OF LANDLORD
	  	18
	 16.1    Default by Tenant
	  	18
	 16.2    Remedies
	  	19
	 16.3    Past Due Sums; Penalty
	  	19

			
	DESCRIPTION	  	PAGE
	 XVII.    PROVISIONS APPLICABLE AT TERMINATION OF LEASE
	  	19
	 17.1    Surrender of Premises
	  	19
	 17.2    Holding Over
	  	20
		
	 XVIII.    ATTORNEYS’ FEES
	  	20
		
	 XIX.    ESTOPPEL CERTIFICATE
	  	20
	 19.1    Landlord’s Right to Estoppel Certificate
	  	20
	 19.2    Effect of Failure to Provide Estoppel Certificate
	  	20
		
	 XX.    PARKING
	  	21
		
	 XXI. SIGNS, AWNINGS, AND CANOPIES
	  	21
		
	 XXII. MISCELLANEOUS PROVISIONS
	  	21
	 22.1    No Partnership
	  	21
	 22.2    Force Majeure
	  	21
	 22.3    No Waiver
	  	21
	 22.4    Notice
	  	21
	 22.5    Captions; Attachments; Defined Terms
	  	22
	 22.6    Recording
	  	22
	 22.7    Partial Invalidity
	  	22
	 22.8    Broker’s Commissions
	  	23
	 22.9    Tenant Defined: Use of Pronouns
	  	23
	 22.10    Provisions Binding, Etc.
	  	23
	 22.11    Entire Agreement, Etc.
	  	24
	 22.12    Governing Law
	  	25
	 22.13    Base Rent Reconciliation
	  	25
		
	 XXIII. INTERIM LEASE PROVISIONS
	  	
	 23.1    Interim Lease Definitions
	  	25
	 23.2    Interim Lease
	  	25
	 23.3    Interim Lease Rent
	  	25
	 23.4    No Additional Rents
	  	26
	 23.5    Responsibility for Damages
	  	26
	 23.6    Applicable Articles
	  	26
	 23.7    No Assignment
	  	26
	 23.8    Security Deposit
	  	26

			
	DESCRIPTION	  	PAGE
	 EXHIBIT “A”    LEGAL DESCRIPTION OF PROPERTY
	  	
	 EXHIBIT “B”    PLANS AND SPECIFICATIONS OF BUILDING
	  	
	 EXHIBIT “C”    WORK LETTER-CONSTRUCTION AND/OR FINISH OF IMPROVEMENTS TO LEASED PREMISES
	  	
	 EXHIBIT “D”    ACKNOWLEDGMENT OF COMMENCEMENT DATE & TENANT ESTOPPEL CERTIFICATE
	  	
	 EXHIBIT “E”    COST TO CONSTRUCT LEASED PREMISES
	  	
	 EXHIBIT “F”    IMPROVEMENT REMOVAL AGREEMENT
	  	

 SUBLEASE AGREEMENT 
 RESEARCH PARK BUILDING—PHASE V 
 THIS SUBLEASE AGREEMENT (the “Lease”) is made and entered
into effective as of July 1, 2009 by and between Myriad Genetics, Inc. (the “Landlord”), and Myriad Pharmaceuticals, Inc. (the “Tenant”). 
 For and in consideration of the rental to be paid by Tenant and of the covenants and agreements herein set forth to be kept and performed by Tenant, Landlord hereby subleases to Tenant and Tenant hereby subleases from
Landlord, the Leased Premises (as hereafter defined), at the rental and subject to and upon all of the terms, covenants and agreements hereinafter set forth. 
 I. PREMISES 
 1.1 Description of Premises. Landlord does hereby demise, sublease and let unto Tenant, and Tenant
does hereby take and receive from Landlord the following: 
 (a) That certain floor area containing approximately 87,000 gross
rentable square feet (the “Leased Premises”), more particularly, 30,675 gross rentable square feet on Floor One, 26,886 gross rentable square feet on Floor Two, 22,261 gross rentable square feet on level three, 7,178 gross rentable square
feet of Mechanical, Electrical and of storage space in the three story office building (the “Building”) located at approximately 300 South Chipeta Way in Salt Lake City, Utah, on the real property (the “Property”) described on
Exhibit “A” attached hereto and by this reference incorporated herein. The Building to be constructed is described on the Plans and Specifications attached as Exhibit “B.” In addition to the foregoing, the Leased Premises shall
also include approximately 1960 gross rentable square feet being presently utilized as laboratory facilities located on the P1 level of Building No. 3, located at 320 Wakara Way in Salt Lake City, Utah (the “Laboratory Facility”).

 (b) Such non-exclusive rights-of-way, easements and similar rights with respect to the Building and Property and the
Laboratory Facility, as may be reasonably necessary for access to and egress from, the Leased Premises. 
 (c) The exclusive
right to use Two Hundred Eight (208) designated stalls in the parking structure under the building for which Tenant shall pay Landlord the sum of $36,250.00 per month and shall be subject to annual adjustments as specified in Section 3.1
of the Lease. 
 1.2 Work of Improvement. The obligation of Landlord and Tenant to perform the work and supply the necessary
materials and labor to prepare the Leased Premises for occupancy is described in detail on Exhibit “C”. Landlord and Tenant shall expend all funds and do all acts required of them as described on Exhibit “C” and shall perform or

  

 1 

 have the work performed promptly and diligently in a first class and workmanlike manner.

 1.3 Construction of Shell Building. Landlord shall, through its landlord Boyer Research Park Associates IX
(“Boyer”), at Boyer’s own cost and expense, cause to be constructed and completed a three story 87,000 gross rentable square foot building and cause all of the construction which is to be performed in completing the Building and
performing the work (including the Tenant Finish work) as set forth on Exhibit “C”, to be substantially completed as evidenced by a Certificate of Occupancy, and the Leased Premises ready for Tenant’s occupancy as soon as reasonably
possible, but in no event later than Eighteen months from Landlord’s or Boyer’s receipt of a building permit (“Target Date”). In the event that Landlord’s construction obligation has not been fulfilled upon the expiration of
the “Target Date”, Tenant shall have the right to charge Landlord and cause Landlord to pay any increased costs associated with Tenant’s current leases due to holding over in such space or moving to temporary space; provided that
under no circumstances shall Landlord be liable to Tenant resulting from delay in construction covered by circumstances beyond Landlord’s or Boyer’s direct control. 
 1.4 Construction of Tenant Finish. Upon completion of Tenant Finish plans as contemplated by Exhibit “C,” Landlord shall provide
a budget for Tenant’s approval (see Exhibit “E”). Landlord shall itemize each part of the construction and its associated estimated cost. Tenant shall be obligated for all Tenant Finish costs shown on Exhibit “E”. Upon
acceptance by Tenant of the budget, Landlord shall cause to be constructed in accordance with Exhibit “C” all items pertaining to the Tenant Finish, including the obligation to pay for all cost changes not initiated by Tenant. 

II. TERM 
 2.1 Length of Term. The term of
this Lease shall be for a period of three (3) years plus the partial calendar month, if any, occurring after the Commencement Date (as hereinafter defined) if the Commencement Date occurs other than on the first day of a calendar month.

 2.2 Commencement Date; Obligation to Pay Rent. The term of this Lease and Tenant’s obligation to pay rent hereunder
shall commence on the first to occur of the following dates (“Commencement Date”): 
 (a) The date Tenant occupies
the Leased Premises and conducts business. 
 (b) The date fifteen (15) days after the Landlord, or Landlord’s
supervising contractor, notified Tenant in writing that Landlord’s construction obligations respecting the Leased Premises have been fulfilled and that the Leased Premises are ready for 
  

 2 

 occupancy. Such notice shall be accompanied by an occupancy permit and a certificate from
the Building Architect stating that remaining punch list items can be completed within fifteen (15) days and will not materially interfere with Tenant’s business. 
 2.3 Option to Extend. Landlord grants Tenant the right to extend this Lease for four additional periods of three years each by giving
Landlord six (6) months prior written notice. All terms and conditions of the Lease during the extension terms shall remain the same, with the exception the new Basic Annual Rent and new Laboratory Facility Basic Annual Rent for each renewal
period shall be adjusted as provided for in section 3.1 below. 
 2.4 Acknowledgment of Commencement Date. Landlord and Tenant
shall execute a written acknowledgment of the commencement Date in the form attached hereto as Exhibit “D”. 
 III. BASIC RENTAL PAYMENTS

 3.1 Basic Annual Rent. Tenant agrees to pay to Landlord as basic annual rent (the “Basic Annual Rent”) at such
place as Landlord may designate, without prior demand therefore and without any deduction or set off whatsoever, the sum of Two Million Ninety Nine Thousand Six Hundred Seventy Four dollars and no/100 (2,099,674.00). Said Basic Annual Rent shall be
due and payable in twelve (12) equal monthly installments to be paid in advance on or before the first day of each calendar month during the term of the Lease. If the Lease is extended as provided for in section 2.3, then the Basic Annual Rent
shall escalate at the beginning of the fourth year and every three (3) years thereafter using either a 3% annually compounded rate or the change in the All Urban Index, whichever is less (each such anniversary being referred to as an
“adjustment date”). For purposes of this Lease the term “All Urban Index” shall mean the Consumer Price Index for All Urban Consumers-U.S. City Average-all Items (1982-1984 equals 100 base) as published by the United States
Bureau of Labor Statistics or any successor agency or any other index hereinafter employed by the Bureau of Labor Statistics in lieu of said index. The price index for the third month proceeding the month in which the Lease commences shall be
considered the Basic Price Index. Therefore, the beginning of the fourth year and every three years thereafter, the Basic Annual Rent set forth in this Section 3.1 shall be adjusted by multiplying such rental by a fraction, the numerator of
which is the Price Index for the third month preceding the beginning of the anniversary (or each such adjustment date) and the denominator of which is the Basic Price Index. Additionally, the Laboratory Facility Basic Annual Rent will be adjusted in
the same manner. 
 In no event shall Basic Annual Rent or the Laboratory Facility Basic Annual Rent be reduced. In the event
the Commencement Date occurs on a day other than the first day of a calendar month, then rent shall be paid on the Commencement Date for the initial fractional calendar month prorated on a per-diem basis (based upon a thirty (30) day month).

  

 3 

 3.2 Laboratory Facility Basic Annual Rent. In addition to the Basic Annual Rent provided
for in section 3.1, Tenant agrees to pay Landlord as basic annual rent (the “Laboratory Facility Basic Annual Rent”) for the Laboratory Facility, at such place as Landlord may designate, without prior demand therefore and without any
deduction or set off whatsoever, the sum of $60,000; such rent amount shall be due and payable in twelve (12) equal monthly installments to be paid in advance on or before the first day of each calendar month during the term of the Lease. The
Laboratory Facility Basic Annual Rent shall be inclusive of all costs for reasonable and customary utilities and janitorial costs. The Laboratory Facility Basic Annual Rent shall be adjusted as provided for in section 3.1 if the Lease term is
extended as provided for in section 2.3. 
 3.3 Additional Monetary Obligations. Tenant shall also pay as rental (in addition
to the Basic Annual Rent and the Laboratory Facility Basic Annual Rent) all other sums of money as shall become due and payable by Tenant to Landlord under this Lease. Landlord shall have the same remedies in the case of a default in the payment of
said other sums of money as are available to Landlord in the case of a default in the payment of one or more installments of Basic Annual Rent and the Laboratory Facility Basic Annual Rent. 
 IV. ADDITIONAL RENT 
 4.1 Basic Annual Rent.
It is the intent of both parties that the Basic Annual Rent herein specified shall be absolutely net to the Landlord throughout the term of this Lease, and that all costs, expenses and obligations relating to Tenant’s pro-rata share of the
Building, Property and/or Building, Property and/or Leased Premises which may arise or become due during the term shall be paid by Tenant in the manner hereafter provided. 
 For purposes of this Part IV and the Lease in general, the following words and phrases shall have the meanings set forth below:

 (a) “Basic Costs” shall mean all actual costs and expenses incurred by Landlord in connection with the ownership,
operation, management and maintenance of the Building and Property and related improvements located thereon (the “Improvements”), including, but not limited to, all expenses incurred by Landlord as a result of Landlord’s compliance
with any and all of its obligations under this Lease other than the performance by Landlord of its work under Sections 1.2, 1.3 and 1.4 of this Lease or similar provisions of leases with other tenants. In explanation of the foregoing, and not in
limitation thereof, Basic Costs shall include: all real and personal property taxes and assessments (whether general or special, known or unknown, foreseen or unforeseen) and any tax or assessment levied or charged in lieu thereof, whether assessed
against Landlord and/or Tenant and whether collected from Landlord and/or Tenant; snow removal, trash removal, supplies, insurance, license, permit and inspection fees, cost of services of independent contractors, cost of compensation (including
employment taxes and fringe benefits) of all persons who perform regular and recurring duties connected with day-to-day operation, maintenance, repair, and replacement of the Building, its equipment and the adjacent walk, and landscaped area 

  

 4 

 
(including, but not limited to janitorial, scavenger, gardening, security, parking, elevator, painting, plumbing, electrical, mechanical, carpentry, window
washing, structural and roof repairs, land lease payments to the University Research Park and reserves (Landlord may collect up to one percent (1%) of total Basic Costs as a contribution toward reserves), signing and advertising, and rental
expense or a reasonable allowance for depreciation of personal property used in the maintenance, operation and repair of the Building. Basic Costs shall not include expenses incurred in connection with leasing, renovating, or improving space for
tenant, expenses incurred for repairs resulting from damage by fire, windstorm or other casualty, to the extent such repairs are paid for by insurance proceeds, expenses paid by any tenant directly to third parties, or as to which Landlord is
otherwise reimbursed by any third party or Tenant; expenses which, by generally accepted accounting principles, are treated as capital items except that if, as a result of governmental requirements, laws or regulations, Landlord shall expend monies
directly or indirectly for improvements, additions or alterations to the Building which, by generally accepted accounting principles, are treated as a capital expenditures, the amortization of such capital expenditures based on a life acceptable to
the appropriate taxing authority together with interest at the rate of 9% per annum shall be considered Basic Costs. The foregoing notwithstanding, Basic Costs shall not include depreciation on the Building and Tenant Finish; amounts paid
toward principal or interest of loans of Landlord; nor shall Basic Costs include “Direct Costs” as defined in Section 4.1(b) below. 
 (b) “Direct Costs” shall mean all actual costs and expense incurred by Landlord in connection with the operation, management, maintenance, replacement, and repair of tenants’ premises, including but not
limited to janitorial services (if Landlord is responsible to provide this service), maintenance, repairs, supplies, utilities, heating, ventilation, air conditioning, and property management fees, which property management fees shall be equal to a
percentage of Tenant’s Basic Annual Rent and Estimated Costs including electricity, which percentage shall not exceed one percent (1%) of the sum of Basic Annual Rent, Estimated Costs and cost of electricity for the Leased Premises.

 (c) “Estimated Costs” shall mean the projected amount of Tenant’s Direct Costs and Basic Costs, excluding
the costs of electricity provided to Tenant’s Leased Premises. The Estimated Costs for the calendar year in which the Lease commences are $343,998.00, and are not included in the Basic Annual Rent. If the Estimated Costs as of the date Tenant
takes occupancy are greater than Tenant’s Estimated Costs at the time this Lease is executed, the Estimated Costs shall be increased to equal the Estimated Costs as of the date of Tenant’s occupancy. 
 (d) “Tenant’s Proportionate Share of Basic Costs” shall mean the percentage derived from the fraction, the numerator of
which is the gross rentable square footage of the Lease Premises (87,000), the denominator of which is the gross rentable square footage of the building (87,000). In this Lease, Tenant’s Proportionate Share of Basic Costs shall be 100% of the
Basic Costs for the Leased Premises. 
 4.2 Report of Basic Costs and Statement of Estimated Costs. 
  

 5 

 (a) After the expiration of each calendar year occurring during the term of this Lease,
Landlord shall furnish Tenant a written statement of Tenant’s Proportionate Share of Basic Costs (Section 4.1(d)) and the Tenant’s Direct Costs occurring during the previous calendar year. The written statement shall specify the amount by
which Tenant’s Direct Costs and Basic Costs exceed or are less than the amounts paid by Tenant during the previous calendar year pursuant to Section 4.3(b) below. 
 (b) At the same time specified in Section 4.2(a) above, Landlord shall furnish Tenant a written statement of the Estimated Costs for
the then current calendar year. 
 4.3 Payment of Additional Rent. Tenant shall pay as additional rent (“Additional Rent”)
Tenant’s Direct Costs and Tenant’s Proportionate Share of Basic Costs. The Additional Rent shall be paid as follows: 
 (a) With each monthly payment of Basic Annual Rent due pursuant to Section 3.1 above, Tenant shall pay to Landlord, without offset or deduction, one-twelfth (1/12th) of the Estimated Costs as defined in Section 4.1(c).

 (b) Within thirty (30) days after delivery of the written statement referred to in section 4.2(a) above, Tenant shall
pay to Landlord the amount by which Tenant’s Direct Costs and Basic Costs, as specified in such written statements, exceed and aggregate of Estimated Costs actually paid by Tenant for the year at issue. Tenant shall have the right to audit
Landlord’s books upon reasonable notice. Tenant shall pay costs associated with the audit unless Tenant finds that Landlord has inflated expenses by more than ten percent (10%), in which case, Landlord will pay audit charges. Payments by Tenant
shall be made pursuant to this Section 4.3(b) notwithstanding that a statement pursuant to Section 4.2(a) is furnished to Tenant after the expiration of the term of this Lease. 
 (c) If the annual statement of costs indicates that the Estimated Costs paid by Tenant pursuant to subsection (b) above for any year
exceeded Tenant’s actual Direct Costs and Basic Costs for the same year, Landlord, at its election, shall either (i) promptly pay the amount of such excess to Tenant, or (ii) apply such excess against the next installment of Basic
Annual Rental or Additional Rent due hereunder. 
  

 6 

 4.4 Resolution of Disagreement. Every statement given by Landlord pursuant to
Section 4.2 shall be conclusive and binding upon Tenant unless within sixty (60) days after the receipt of such statement Tenant shall notify Landlord that it disputes the correctness thereof, specifying the particular respects in which
the statement is claimed to be incorrect. If such dispute shall not have been settled by agreement, the parties hereto shall submit the dispute to arbitration within ninety (90) days after Tenant’s receipt of statement. Pending the
determination of such dispute by agreement or arbitration as aforesaid, Tenant shall, within thirty (30) days after receipt of such statement, pay Additional Rent in accordance with Landlord’s statement, and such payment shall be without
prejudice to Tenant’s position. If the dispute shall be determined in Tenant’s favor, Landlord shall forthwith pay Tenant the amount of Tenant’s overpayment of rents resulting from compliance with Landlord’s statement, including
interest on disputed amounts at prime plus two percent (2%). Landlord agrees to grant Tenant reasonable access to Landlord’s books and records for the purpose of verifying Basic Costs and Direct Costs for operating expenses incurred by
Landlord. 
 4.5 Limitations. Nothing contained in this Part IV shall be construed at any time so as to reduce the monthly
installments of Basic Annual Rent and Laboratory Facility Basic Annual Rent payable hereunder below the amount set forth in Section 3.1 and 3.2, respectively, of this Lease. 
 V. SECURITY DEPOSIT 
 On the Commencement Date, Tenant shall pay Landlord the sum of one
month’s Basic Annual Rent as a Security Deposit to secure the performance of Tenant’s obligations hereunder. The Security Deposit shall be returned to Tenant thirty (30) days following the termination of the Lease, less any amounts
that Landlord may reasonably retain as an off set to cover (i) any amounts due and owing Landlord under the Lease; and (ii) any repairs or damages to the Leased Premises occasioned by Tenant’s use of, or exiting from, the Leased
Premises. 
 VI. USE 
 6.1 Use of
Leased Premises. The Leased Premises shall be used and occupied by Tenant for commercial laboratory, pharmaceutical research and development, and general office purposes only and for no other purpose whatsoever without the prior written consent of
Landlord. 
 6.2 Prohibition of Certain Activities or Uses. The Tenant shall not do or permit anything to be done in or about,
or bring or keep anything in the Leased Premises which is prohibited by this Lease or will, in any way or to any extent: 
 (a) Adversely affect any fire, liability or other insurance policy carried with respect to the Building, the Leased Premises or any of the contents of the Building or Leased Premises (except with Landlord’s express written permission,
which will not be unreasonably withheld, but which may be contingent upon Tenant’s agreement to bear any additional costs, expenses or liability for risk that may be involved). 
  

 7 

 (b) Conflict with or violate any law, statute, ordinance, rule, regulation or requirement
of any governmental unit, agency or authority (whether existing or enacted as promulgated in the future, known or unknown, foreseen or unforeseen). 
 (c) Adversely overload the floors or otherwise damage the structural soundness of the Leased Premises or Building, or any part thereof (except with Landlord’s express written permission, which will not be
unreasonably withheld, but which may be contingent upon Tenant’s agreement to bear any additional costs, expenses or liability for risk that may be involved). 
 6.3 Affirmative Obligations with Respect to Use. 
 (a) Tenant will comply with all governmental laws, ordinances, regulations, and requirements, now in force or which hereafter may be in
force, of any lawful governmental body or authorities having jurisdiction over the Leased Premises, will keep the Leased Premises and every part thereof in a clean, neat, and orderly condition, free of objectionable noise, odors, or nuisances, will
in all respects and at all times fully comply with all applicable health and policy regulations, and will not suffer, permit, or commit any waste. 
 (b) At all times during the term hereof, Tenant shall, at Tenant’s sole cost and expense, comply with all statutes, ordinances, laws, orders, rules, regulations and requirements of all applicable federal, state,
county, municipal and other agencies or authorities, now in effect or which may hereafter become effective, which shall impose any duty upon Landlord or Tenant with respect to the use, occupation or alterations of the Leased Premises (including,
without limitation, all applicable requirements of the Americans with Disabilities Act of 1990 and all other applicable laws relating to people with disabilities, and all rules and regulations which may be promulgated hereunder from time to time and
whether relating to barrier removal, providing auxiliary aids and services or otherwise) and upon request of Landlord shall deliver evidence thereof to Landlord. 
 6.4 Suitability. The Leased Premises, Building and Improvements (and each and every part thereof) shall be deemed to be in satisfactory
condition unless, within ninety (90) days after the Commencement Date, Tenant shall give Landlord written notice specifying, in reasonable detail, the respects in which the Leased Premises, Building or Improvements are not in satisfactory
condition. Landlord, through Boyer, shall pass through those warranties as provided in Exhibit C, Section II, paragraphs C and E. 
 6.5 Taxes. Tenant shall pay all taxes, assessments, charges, and fees which during the term hereof may be imposed, assessed or levied by any governmental or public authority against or upon Tenant’s use of the Leased Premises or any
personal property or fixture kept or installed therein by Tenant and on the value of leasehold improvements to the extent that the same exceed Building allowances; excluding therefrom any taxes, assessments, charges and fees attributable to the
Laboratory Facilities. 
  

 8 

 VII. UTILITIES AND SERVICES 
 7.1 Obligation of Landlord. During the term of this Lease the Landlord and Tenant agree that following Landlord’s construction and installation of the base Mechanical, Electrical and Elevator systems in the
Building per the plans and specifications, Tenant shall manage the periodic maintenance and pay for all expenses related thereto for the term of the Lease. Tenant further agrees to manage the janitorial service, security system, snow removal
service, landscaping and grounds keeping services and elevator service within the Building and pay for the expense thereof through the term of the Lease. 
 7.2 Tenant’s Obligations. Tenant shall arrange for and shall pay the entire cost and expense of all telephone stations, equipment and use charges, electric light bulbs (but not fluorescent bulbs used in fixtures
originally installed in the Leased Premises) and all other materials and services not expressly required to be provided and paid for pursuant to the provisions of Section 7.1 above. 
 7.3 Additional Limitations. If and where heat generating machines devices are used in the Leased Premises which affect the temperature
otherwise maintained by the air conditioning system, Landlord reserves the right with Tenant’s concurrence to install additional or supplementary air conditioning units for the Leased premises, and the entire cost of installing, operating,
maintaining and repairing the same shall be paid by Tenant to Landlord promptly after demand by Landlord. 
 7.4 Limitation on
Landlord’s Liability. Landlord shall not be liable for and Tenant shall not be entitled to terminate this Lease or to effectuate any abatement or reduction of rent by reason of Landlord’s failure to provide or furnish any of the foregoing
utilities or services if such failure was reasonably beyond the control of Landlord. In no event shall Landlord be liable for loss or injury to persons or property, however, arising or occurring in connection with or attributable to any failure to
furnish such utilities or services even if within the control of Landlord, except in the event of Landlord’s negligence or intentional conduct. 
 VIII.
MAINTENANCE AND REPAIRS; ALTERATIONS; ACCESS 
 8.1 Maintenance and Repairs by Landlord. Landlord shall maintain in good
order, condition and repair the structural components of the Leased Premises, including without limitation roof, exterior walls and foundations, as well as all repairs covered under construction warranties provided if Landlord is required to make
structural repairs by reason of Tenant’s negligent acts or omissions, Tenant shall pay Landlord’s costs for 

  

 9 

 
making such repairs. 
 8.2
Maintenance and Repairs by Tenant. Tenant, at Tenant’s sole cost and expense and without prior demand being made, shall maintain the Leased Premises in good order, condition and repair, and will be responsible for the painting, carpeting or
other interior design work of the Leased Premises beyond the initial construction phase as specified in Section 1.4 and Exhibit “C” and “E” of the Lease and shall maintain all equipment and fixtures installed by Tenant. If
repainting or recarpeting is required and authorized by Tenant, the cost for such are the sole obligation of Tenant and shall be paid for by Tenant immediately following the performance of said work and a presentation of an invoice for payment.

 8.3 Tenant Approval of Management and Maintenance Services. Tenant shall have the right to approve of persons who have or
will contract with Landlord for Building and Property management and maintenance services. In addition, in the event that Tenant reasonably believes that another person could (i) provide better property management or maintenance service at the
same or less cost than the person currently providing such property management or maintenance service, or (ii) provide equal property management or maintenance service for less cost, then Tenant shall, at its option, provide to Landlord the
name and address of such person. Landlord agrees to take reasonable steps to verify that such person referred by Tenant could better or more economically provide the contracted for management and/or maintenance services for the Building and/or
Property, then upon such verification, Landlord agrees to contract with and substitute such person to provide such service. The foregoing applies to services rendered pursuant to Articles 4, 7 and 8. 
 8.4 Alterations. Tenant shall not make or cause to be made any alterations, additions or improvements or install or cause to be installed
any fixtures, signs, floor coverings, interior or exterior lighting, plumbing fixtures, or shades or awnings, or make any other changes to the Leased Premises without first obtaining Landlord’s written approval, which approval shall not be
unreasonably withheld. Tenant shall present to the Landlord plans and specifications for such work at the time approval is sought. In the event Landlord consents to the making of any alterations, additions, or improvements to the Leased Premises by
Tenant, the same shall be made by Tenant at Tenant’s sole cost and expense. All such work with respect to any alterations, additions, and changes shall be done in a good and workmanlike manner and diligently prosecuted to completion such that,
except as absolutely necessary during the course of such work, the Leased Premises shall at all times be a complete operating unit. Any such alterations, additions, or changes shall be performed and done strictly in accordance with all laws and
ordinances relating thereto. In performing the work or any such alterations, additions, or changes, Tenant shall have the same performed in such a manner as not to obstruct access to any portion of the Building. Any alterations, additions, or
improvements to or of the Leased Premises, including, but not limited to, wall covering, fume hoods, darkroom, paneling, and built-in cabinet work, 

  

 10 

 
but excepting movable furniture and equipment, shall at once become a part of the realty and shall be surrendered with the Premises, unless Landlord and
Tenant agree at any time that the specific improvement may be removed by Tenant at the end of the Term provided Tenant restores the premises to its original condition, wear and tear excepted. If there is an agreement to allow removal, such items
which are the subject of agreement shall be listed on Exhibit F which agreement, as may be revised by the parties from time to time, shall be made a part of this Lease. 
 8.5 Landlord’s Access to Leased Premises. Landlord (including Boyer as landlord to Landlord) shall have the right to place, maintain,
and repair all utility equipment of any kind in, upon, and under the Leased Premises as may be necessary for the servicing of the Leased Premises and other portion of the Building. Landlord shall upon providing adequate notice to Tenant, also have
the right to enter the Leased Premises at all times to inspect or to exhibit the same to prospective purchasers, mortgagees, tenants, and lessees, and to make such repairs, additions, alterations, or improvements as Landlord may deem desirable.
Landlord shall be allowed to take all material upon said Leased Premises that may be required therefore without the same constituting an actual or constructive eviction of Tenant in whole or in part and the rents reserved herein shall in no wise
abate while said work is in progress by reason of loss or interruption of Tenant’s business or otherwise, and Tenant shall have no claim for damages unless due to Landlord negligence. During the three (3) months prior to expiration of this
Lease or of any renewal term, Landlord may place upon the Leased Premises “For Lease” or “For Sale” signs which Tenant shall permit to remain thereon. 
 IX. ASSIGNMENT 
 9.1 Assignment Prohibited. Tenant shall not transfer, assign, mortgage, or
hypothecate this Lease, in whole or in part, or permit the use of the Leased Premises by any person or persons other than Tenant, or sublet the Leased Premises, or any part thereof, without the prior written consent of Landlord in each instance,
which consent shall not be unreasonably withheld, provided sufficient information is provided to Landlord to accurately represent the financial condition of those to whom this Lease will be transferred, assigned, mortgaged, or hypothecated. Such
prohibition against assigning or subletting shall include any assignment or subletting by operation of law. Any transfer of this Lease from the Tenant by merger, consolidation, transfer of assets, or liquidation shall constitute an assignment for
purposes of this Lease. In the event that Tenant hereunder is a corporation, an unincorporated association, or a partnership, the transfer, assignment, or hypothecation of any stock or interest in such corporation, association, or partnership in the
aggregate in excess of forty-nine percent (49%) shall be deemed an assignment within the meaning of this Section. The above prohibition of assignment will not apply in the case of a registered offering of shares by Tenant or the public trading
of registered shares subsequent to an initial offering. 
  

 11 

 9.2 Consent Required. 
 (a) Any assignment or subletting without Landlord’s consent shall be void, and shall constitute a default hereunder which, at the
option of Landlord, shall result in the termination of this Lease or exercise of Landlord’s other remedies hereunder. Consent to any assignment or subletting shall not operate as a waiver of the necessity for consent to any subsequent
assignment or subletting, and the terms of such consent shall be binding upon any person holding by, under, or through Tenant. 
 (b) Landlord shall have no obligation to consent to the proposed sublease or assignment if the proposed sublessee or assignee or its business is or may be subject to compliance with additional requirements of the law, including any related
rules or regulations, commonly known as the “Americans with Disabilities Act of 1990” or similar state or local laws relating to persons with disabilities beyond those requirements which are applicable to the tenant desiring to so sublease
or assign”. 
 9.3 Landlord’s Right in Event of Assignment. If this Lease is assigned or if the Leased Premises or
any portion thereof are sublet or occupied by any person other than the Tenant, Landlord may collect rent and other charges from such assignee or other party, and apply the amount collected to the rent and other charges reserved hereunder, but such
collection shall not constitute consent or waiver of the necessity of consent to such assignment, subleasing, or other transfer, nor shall such collection constitute the recognition of such assignee, sublessee, or other party as the Tenant hereunder
or a release of Tenant from the further performance of all of the covenants and obligations, including obligation to pay rent, of Tenant herein contained. In the event that Landlord shall consent to a sublease or assignment hereunder, Tenant shall
pay to Landlord reasonable fees, not to exceed $100.00, incurred in connection with processing of documents necessary to the giving of such consent. In the event Landlord consents to the assignment as provided by paragraph 9.1, then Tenant shall be
released from further performance of any covenant and obligation under this Lease. 
 X. INDEMNITY 
 10.1 Indemnification. Tenant and Landlord shall indemnify each other and save each other harmless from and against any and all suits,
actions, damage and claims, liability and expense in connection with loss of life, bodily or personal injury, or property damage arising from or out of any occurrence in, upon, at or from the Leased Premises, or occasioned wholly or in part by any
act or omission of Tenant or Landlord, their agents, contractors, employees, servants, invitees, licensees or concessionaires. All insurance policies carried by Tenant and Landlord shall include a waiver of subrogation endorsement which specifies
that the insurance carrier(s) will waive any right of subrogation against 

  

 12 

 
Tenant and/or Landlord arising out of any insurance claim. 
 10.2 Release of Landlord. Landlord shall not be responsible or liable at any time for any loss or damage to Tenant’s personal property or to Tenant’s business. Tenant shall store its property in and shall
use and enjoy the Leased Premises and all other portions of the Building and Improvements at its own risk, and hereby releases Landlord, to the full extent permitted by law, from all claims of every kind resulting in loss of life, personal or bodily
injury, or property damage. 
 10.3 Notice. Tenant shall give prompt notice to Landlord in case of fire or accidents in the
Leased Premises or in the Building of which the Leased Premises are a part or of defects therein or in any fixtures or equipment. 
 10.4 Litigation. In case Landlord, without fault on its part, shall be made a party to any litigation commenced against Tenant, then Tenant shall protect and hold Landlord harmless and shall pay all costs, expenses, and reasonable
attorneys’ fees. 
 XI. INSURANCE 
 11.1 Fire and “All Risk” Insurance on Tenant’s Personal Property and Fixtures. At all times during the term of this Lease, Tenant shall keep in force at its sole cost and expense, fire insurance and “All Risk”
insurance (including vandalism and malicious mischief) equal to the replacement cost of Tenant Finish, Tenant’s fixtures, furnishings, equipment, and contents upon the Leased Premises and all improvements or additions made by Tenant to the
Leased Premises. The Landlord and Boyer shall be named as an additional insured on all such policies. 
 11.2 Liability
Insurance. Tenant shall, during the entire term hereof, keep in full force and affect a policy of public liability and property damage insurance to include contractual coverage with respect to the Leased Premises and the business operated by Tenant
in the Leased Premises, with a combined single limit for personal or bodily injury and property damage of not less than $1,000,000.00. The policy shall name Boyer, Landlord and any person, firms, or corporations designated by Landlord, and Tenant as
insured, and shall contain a clause that the insurer will not cancel or materially change the insurance pertaining to the Leased Premises without first giving Landlord ten (10) days written notice. Tenant shall at all times during the term
hereof provide Landlord with evidence of current insurance coverage. All public liability, property damage, and other liability policies shall be written as primary policies, not contributing with coverage which Landlord may carry. 
 11.3 Property Coverage. Landlord, through Boyer, shall obtain and maintain in force an “all-risk type” or equivalent policy
form, and shall include fire, theft, extended coverages, vandalism and malicious mischief on the Building during the Lease period and 

  

 13 

 
any extension thereof. At the Landlord’s discretion coverage for flood and earthquake may be obtained if commercially available at reasonable rates.
Such insurance shall also include coverage against loss of rental income. Tenant shall pay Landlord as an expense covered in Basic Costs the cost to purchase the insurance called for in this paragraph. 
 11.4 Subrogation. Tenant and Landlord each waive its right of subrogation against each other for any reason whatsoever. 
 11.5 Lender. Any mortgage lender interest in any part of the Building or Improvements may, at Landlord’s option, be afforded coverage
under any policy required to be secured by Tenant hereunder, by use of a mortgagee’s endorsement to the policy concerned. 
 XII. DESTRUCTION

 If the Leased Premises shall be partially damaged by any casualty insured against under any insurance policy maintained
through Landlord, Landlord shall, upon receipt of the insurance proceeds, repair the Leased Premises and until repair is complete the Basic Annual Rent, Laboratory Facility Basic Annual Rent and Additional Rent shall be abated proportionately as to
that portion of the Leased Premises rendered untenantable. Notwithstanding the foregoing, if: (a) the Leased Premises by reason of such occurrence are rendered wholly untenantable, or (b) the Leased Premises should be damaged as a result
of a risk which is not covered by insurance, or (c) the Leased Premises should be damaged in whole or in part during the last six (6) months of the term or of any renewal hereof, or (d) the Leased Premises or the Building (whether the
Leased Premises are damaged or not) should be damaged to the extent of fifty percent (50%) or more of the then-monetary value thereof, then and in any such events, Landlord may either elect to repair the damage or may cancel this Lease by
notice of cancellation within Ninety (90) days after such event and thereupon this Lease shall expire, and Tenant shall vacate and surrender the Leased Premises to Landlord. Tenant’s liability for rent upon the termination of this Lease
shall cease as of the day following Landlord’s giving notice of cancellation. In the event Landlord elects to repair any damage, any abatement of rent shall end five (5) days after notice by Landlord to Tenant that the Leased Premises have
been repaired. If the damage is caused by the negligence of Tenant or its employees, agents, invitees, or concessionaires, there shall be no abatement of rent. Unless this Lease is terminated by Landlord, Tenant shall repair and refixture the
interior of the Leased Premises to the extent of the Tenant Finish in a manner and in at least a condition equal to that existing prior to the destruction or casualty. 
 XIII. CONDEMNATION 
 13.1 Total Condemnation. If the whole of the Leased Premises shall be
acquired 

  

 14 

 
or taken by condemnation proceeding, then this Lease shall cease and terminate as of the date of title vesting in such proceeding. 
 13.2 Partial Condemnation. If any part of the Leased Premises shall be taken as aforesaid, and such partial taking shall render that
portion not so taken unsuitable for the business of Tenant, then this Lease shall cease and terminate as aforesaid. If such partial taking is not extensive enough to render the Leased Premises unsuitable for the business of Tenant, then this Lease
shall continue in effect except that the Basic Annual Rent, Laboratory Facility Basic Annual Rent and Additional Rent shall be reduced in the same proportion that the portion of the Leased Premises (including basement, if any) taken bears to the
total area initially demised and Landlord shall, upon receipt of the award in condemnation, make all necessary repairs or alterations to the Building in which the Leased Premises are located, provided that Landlord shall not be required to expend
for such work an amount in excess of the amount received by Landlord as damages for the part of the Leased Premises to taken. “Amount received by Landlord” shall mean that part of the award in condemnation which is free and clear to
Landlord of any collection by mortgage lenders for the value of the diminished fee. 
 13.3 Landlord’s Option to
Terminate. If more than twenty percent (20%) of the Building shall be taken as aforesaid, Landlord may, by written notice to Tenant, terminate this Lease. If this Lease is terminated as provided in this Section, rent shall be paid up to the day
that possession is so taken by public authority and Landlord shall make an equitable refund of any rent paid by Tenant in advance. 
 13.4 Award. Tenant shall not be entitled to and expressly waives all claim to any condemnation award for any taking, whether whole or partial and whether for diminution in value of the leasehold or to the fee, although Tenant shall have the
right, to the extent that the same shall not reduce Landlord’s award, to claim from the condemnor, but not from the Landlord, such compensation as may be recoverable by Tenant in its own right for damages to Tenant Finish, Tenant’s
business and fixtures or equipment. 
 13.5 Definition. As used in this Part XIII the term “condemnation proceeding”
means any action or proceeding in which any interest in the Leased Premises is taken for any public or quasi-public purpose by any lawful authority through exercise of eminent domain or right of condemnation or by purchase or otherwise in lieu
thereof. 
 XIV. LANDLORD’S RIGHTS TO CURE 
 14.1 General Right. In the event of breach, default, or noncompliance hereunder by Landlord, Tenant shall, before exercising any right or remedy available to it, give Landlord written notice of the claimed breach,
default, or noncompliance. If prior to its giving such notice Tenant has been notified in writing (by way of Notice of Assignment of Rents and Leases, or otherwise) of the address of a lender which has furnished any of the financing 

  

 15 

 
referred to in Part XV hereof, concurrently with giving the aforesaid notice to Landlord, Tenant shall, by registered mail, transmit a copy thereof to such
lender. For the thirty (30) days following the giving of the notice(s) required by the foregoing portion of this section (or such longer period of time as may be reasonably required to cure a matter which, due to its nature, cannot reasonably
be rectified within thirty (30) days), Landlord shall have the right to cure the breach, default, or noncompliance involved. If Landlord has failed to cure a default within said period, any such lender shall have an additional thirty
(30) days within which to cure the same or, if such default cannot be cured within that period, such additional time as may be necessary if within such thirty (30) day period said lender has commenced and is diligently pursuing the actions
or remedies necessary to cure the breach default, or noncompliance involved (including, but not limited to, commencement and prosecution of proceedings to foreclose or otherwise exercise its rights under its mortgage or other security instrument, if
necessary to effect such cure), in which event this Lease shall not be terminated by Tenant so long as such actions or remedies are being diligently pursued by said lender. 
 14.2 Mechanic’s Lien. Should any mechanic’s or other lien be filed against the Leased Premises or any part thereof by reason of
Tenant’s acts or omissions or because of a claim against Tenant, Tenant shall cause the effect of the same to be cancelled and discharged or bonded over or otherwise within ten (10) days after written notice by Landlord. 
 XV. FINANCING; SUBORDINATION 
 15.1
Subordination. Tenant acknowledges that it might be necessary for Landlord or its successors or assigns, or those who hold superior realty claims, to secure mortgage loan financing or refinancing affecting the Leased Premises. Tenant also
acknowledges that the lender interested in any given loan may desire that Tenant’s interest under this Lease be either superior or subordinate to the mortgage then held or to be taken by said Lender. Accordingly, Tenant agrees that at the
request of Landlord at any time and from time to time Tenant shall execute and deliver to Landlord an instrument, in form reasonably acceptable to Landlord and Tenant, whereby Tenant subordinates its interest under this Lease and in the Leased
Premises to such of the following encumbrances as may be specified by Landlord: Any mortgage or trust deed and customary related instruments are herein collectively referred to merely as a “Mortgage” and securing a loan obtained by
Landlord or its successors or assigns, or those who hold superior realty claims, for the purpose of enabling acquisition of the Building and/or construction of additional improvements to provide permanent financing for the Building, or for the
purpose of refinancing any such construction, acquisition, standing or permanent loan. Provided, however, that any such instrument or subordination executed by Tenant shall provide that so long as Tenant continues to perform all of its obligations
under this Lease its tenancy shall remain in full force and effect notwithstanding Landlord’s default in connection with the Mortgage concerned or any resulting foreclosure or sale or transfer in lieu of such 

  

 16 

 
proceedings. Tenant shall not subordinate its interests hereunder or in the Leased Premises to any lien or encumbrance other than the Mortgages described in
and specified pursuant to this Section 15.1 without the prior written consent of Landlord and of the lender interested under each mortgage then affecting the Leased Premises. Any such unauthorized subordination by Tenant shall be void and of no
force or effect whatsoever. 
 15.2 Attornment. Any sale, assignment, or transfer of Landlord’s interest, or those who
hold superior realty claims, under this Lease or in the Leased Premises including any such disposition resulting from Landlord’s default under a mortgage, shall be subject to this Lease and also Tenant shall attorn to Landlord’s successor
and assigns and shall recognize such successor or assigns as Landlord under this Lease, regardless of any rule of law to the contrary or absence of privities of contract. 
 15.3 Financial Information. As a condition to Landlord’s acceptance of this Lease, Tenant shall provide financial information
sufficient to verify to Landlord the financial condition of Tenant. Tenant hereby represents and warrants that none of such information contains or will contain any untrue statement of material fact, nor will such information omit any material fact
necessary to make the statements contained therein misleading or unreliable. Any financial information provided by Tenant shall beheld in confidence and distributed only to Landlord’s investors or lenders for the Leased Premises. 
 XVI. EVENTS OF DEFAULT; REMEDIES OF LANDLORD 
 16.1 Default by Tenant. Upon the occurrence of any of the following events, Landlord shall have the remedies set forth in Section 16.2: 
 (a) Tenant fails to pay any installment of Basic Annual Rent, Laboratory Facility Basic Annual Rent or Estimated Costs or any other sum due hereunder within ten (10) days after Tenant receives written notice of
rent due. 
 (b) Tenant fails to perform any other term, condition, or covenant to be performed by it pursuant to this Lease
within thirty (30) days after written notice of such default shall have been given to Tenant by Landlord or, if cure would reasonably require more than thirty (30) days to complete, if Tenant fails to commence performance within the thirty
(30) day period or fails diligently to pursue such cure to completion. 
 (c) Tenant shall become bankrupt or insolvent
or file any debtor proceedings or have taken against such party in any court pursuant to state or federal statute, a petition in bankruptcy or insolvency, reorganization, or 

  

 17 

 
appointment of a receiver or trustee; or Tenant petitions for or enters into an arrangement; or suffers this Lease to be taken under a writ of execution.

 16.2 Remedies. In the event of any default by Tenant hereunder, Landlord may at any time, without waiving or limiting any
other right or remedy available to it, terminate Tenant’s rights under this Lease by written notice, reenter and take possession of the Premises by any lawful means (with or without terminating this Lease), or pursue any other remedy allowed by
law. Tenant agrees to pay to Landlord the cost of recovering possession of the Premises, all costs of reletting, and arising out of Tenant’s default, including attorneys’ fees. Notwithstanding any reentry, the liability of Tenant for the
rent reserved herein shall not be extinguished for the balance of the Term, and Tenant agrees to compensate Landlord upon demand for any deficiency arising from reletting the Premises at a lesser rent than applies under this Lease. 
 16.3 Past Due Sums; Penalty. If Tenant fails to pay, when the same is due and payable, any Basic Annual Rent, Laboratory Facility Basic
Annual Rent, Estimated Costs and electrical charges within ten (10) days after the same is due and payable, or other sum required to be paid by it hereunder, such unpaid amounts shall bear interest from the due date thereof to the date of
payment at a fluctuating rate equal to two percent (2%) per annum above the prime rate of interest charged by Zions Bank, Salt Lake City, Utah. Notwithstanding the foregoing, however, Landlord’s right concerning such interest shall be
limited by the maximum amount which may properly be charged by Landlord for such purposes under applicable law. 
 XVII. PROVISIONS APPLICABLE AT TERMINATION
OF LEASE 
 17.1 Surrender of Premises. At the expiration of this Lease, except for changes made by Tenant that were approved
by Landlord, Tenant shall surrender the Leased Premises in the same condition, less reasonable wear and tear, as they were in upon delivery of possession thereto under this Lease and shall deliver all keys to Landlord. Before surrendering the Leased
Premises, Tenant shall remove all of its personal property including, but not limited to, those items, if any, showing on Exhibit “F” and trade fixtures and such property or the removal thereof shall in no way damage the Leased Premises,
and Tenant shall be responsible for all costs, expenses and damages incurred in the removal thereof. If Tenant fails to remove its personal property and fixtures upon the expiration of this Lease, the same shall be deemed abandoned and shall become
the property of Landlord. 
 17.2 Holding Over. Any holding over after the expiration of the term hereof or of any renewal
term shall be construed to be a tenancy from month to month at such rates as Landlord may designate and on the terms herein specified so far as possible. Landlord may not in any event raise the rent above 110% of the last month’s rent.

  

 18 

 XVIII. ATTORNEYS’ FEES 
 In the event that at any time during the term of this Lease either Landlord or the Tenant institutes any action or proceeding against the other relating to the provisions of this Lease or any default hereunder, then
the unsuccessful party in such action or proceeding agrees to reimburse the successful party for the reasonable expenses of such action including reasonable attorneys’ fees, incurred therein by the successful party. 
 XIX. ESTOPPEL CERTIFICATE 
 19.1
Landlord’s Right to Estoppel Certificate. Tenant shall, within fifteen (15) days after Landlord’s request, execute and deliver to Landlord a written declaration, in form and substance similar to Exhibit “D”, in recordable
form: (1) ratifying this Lease; (2) expressing the Commencement Date and termination date hereof; (3) certifying that this Lease is in full force and effect and has not been assigned, modified, supplemented or amended (except by such
writing as shall be stated); (4) that, to the knowledge of Tenant, if true, all conditions under this Lease to be performed by Landlord have been satisfied; (5) that, to the knowledge of Tenant, there are no defenses or offsets against the
enforcement of this Lease by the Landlord, or stating those claimed by Tenant; (6) the amount of advance rental, if any, (or none if such is the case) paid by Tenant; (7) the date to which rental has been paid; (8) the amount of
security deposited with Landlord; and (9) such other information as Landlord may reasonably request. Landlord’s landlord and its mortgage lenders and/or purchasers shall be entitled to rely upon such declaration. 
 19.2 Effect of Failure to Provide Estoppel Certificate. Tenant’s failure to furnish any Estoppel Certificate within fifteen
(15) days after request therefore shall be deemed a default hereunder and moreover, it shall be conclusively presumed that: (a) this Lease is in full force and effect without modification in accordance with the terms set forth in the
request; (b) that there are no unusual breaches or defaults on the part of the Landlord; and (c) no more than one (1) month’s rent has been paid in advance. 
 XX. PARKING 
 Automobiles of Tenant and all visitors associated with Tenant shall be parked
only within parking areas designated by Landlord for parking. Landlord or its agents shall, without any liability to Tenant or its occupants, have the right to cause to be removed any automobile that may be wrongfully parked in a prohibited or
reserved parking area, and Tenant agrees to indemnify, defend and hold Landlord harmless from and against any and all claims, losses, demands, damages and liabilities asserted or arising with respect to or in connection with any such removal of an
automobile except due to Landlord’s negligence. 
  

 19 

 XXI. SIGNS, AWNINGS, AND CANOPIES 
 Tenant shall not place or suffer to be placed or maintained on any exterior door, wall, or window of the Leased Premises, or elsewhere in
the Building, any sign, awning, marquee, decoration, lettering, attachment, or canopy, or advertising matter or other thing of any kind, and will not place or maintain any decoration, lettering, or advertising matter on the glass of any window or
door of the Leased Premises without obtaining the proper authorization from Salt Lake County prior to installing. Tenant will otherwise be free to install signage of its choice. 
 XXII. MISCELLANEOUS PROVISIONS 
 22.1 No Partnership. Landlord does not by this Lease, in any
way or for any purpose, become a partner or joint venture of Tenant in the conduct of its business or otherwise. 
 22.2 Force
Majeure. Landlord shall be excused for the period of any delay in the performance of any obligations hereunder when prevented from so doing by cause or causes beyond Landlord’s control, including labor disputes, civil commotion, war,
governmental regulations or controls, fire or other casualty, inability to obtain any material or service, or acts of God. 
 22.3 No Waiver. Failure of Landlord or Tenant to insist upon the strict performance of any provision or to exercise any option hereunder shall not be deemed a waiver of such breach by Landlord or Tenant. No provision of this Lease shall be
deemed to have been waived unless such waiver is in writing signed by Landlord or Tenant, as the case may be. 
 22.4 Notice.
Any notice, demand, request, or other instrument which may be or is required to be given under this Lease shall be (i) given by facsimile, (ii) delivered in person or (iii) sent by United States certified or registered mail, postage
prepaid and shall be addressed (a) if to Landlord, at the place specified for payment of rent, and (b) if to Tenant, either at the Leased Premises or at any other current address for Tenant which is known to Landlord. Either party may
designate such other address as shall be given by written notice or by facsimile transmission. 
  

	 	Landlord:	MYRIAD GENETICS, INC. 

	 	    	320 WAKARA WAY 

	 	    	SALT LAKE CITY, UTAH 84108 

	 	    	(801) 582-3400/FAX (801) 584-3640 

	 	    	ATTENTION: CFO 

  

 20 

	 	    	with copy to: 

	 	    	MYRIAD GENETICS, INC. 

	 	    	320 WAKARA WAY 

	 	    	SALT LAKE CITY, UTAH 84108 

	 	    	(801) 582-3400/FAX (801) 584-3640 

	 	    	ATTENTION: General Counsel 

  

	 	Tenant:	MYRIAD PHARMACEUTICALS, INC. 

	 	    	305 CHIPETA WAY 

	 	    	SALT LAKE CITY, UTAH 84108 

	 	    	(801) 214-7810/FAX (801) 214-7992 

	 	    	ATTENTION: PRESIDENT 

  

	 	    	with copy to: 

	 	    	MYRIAD PHARMACEUTICALS, INC. 

	 	    	305 CHIPETA WAY 

	 	    	SALT LAKE CITY, UTAH 84108 

	 	    	(801) 214-7934/FAX (801) 214-7992 

	 	    	ATTENTION: Legal Counsel 

 22.5 Captions;
Attachments; Defined Terms. 
 (a) The captions to the section of this Lease are for convenience of reference only and shall
not be deemed relevant in resolving questions of construction or interpretation under this Lease. 
 (b) Exhibits referred to
in this Lease, and any addendums and schedules attached to this Lease shall be deemed to be incorporated in this Lease as though part thereof. 
 22.6 Recording. Tenant may record this Lease or a memorandum thereof with the written consent of Landlord, which consent shall not be unreasonably withheld. Landlord, at its option and at any time, may file this Lease
for record with the Recorder of the County in which the Building is located. 
 22.7 Partial Invalidity. If any provision of
this Lease or the application thereof to any person or circumstance shall to any extent be invalid, the remainder of this Lease or the application of such provision to persons or circumstances other than those as to which it is held invalid shall
not be affected thereby and each provision of this Lease shall be valid and enforced to the fullest extent permitted by law. 
  

 21 

 22.8 Broker’s Commissions. Tenant and Landlord represent and warrant to each other
that there are no claims for brokerage commissions or finder’s fees in connection with this Lease and agree to indemnify each other against and hold them harmless from all liabilities arising from such claim, including any attorneys’ fees
connected therewith. 
 22.9 Tenant Defined: Use of Pronouns. The word “Tenant” shall be deemed and taken to mean
each and every person or party executing this document as a Tenant herein. If there is more than one person or organization set forth on the signature line as the Tenant, their liability hereunder shall be joint and several. If there is more than
one Tenant, any notice required or permitted by the terms of this Lease may be given by or to any one thereof, and shall have the same force and effect as if given by or to all thereof. The use of the neuter singular pronoun to refer to Landlord or
Tenant shall be deemed a proper reference even though Landlord or Tenant may be an individual, a partnership, a corporation, or a group of two or more individuals or corporation. The necessary grammatical changes required to make the provisions of
this Lease apply in the plural sense where there is more than one Landlord or Tenant and to corporations, associations, partnerships, or individuals, males or females, shall in all instances be assumed as though in each case fully expressed.

 22.10 Provisions Binding, Etc. Except as otherwise provided, all provisions herein shall be binding upon and shall inure to
the benefit of the parties, their legal representatives, heirs, successors, and assigns. Each provision to be performed by Tenant shall be construed to be both a covenant and a condition. In the event of a sale or assignment (except for purposes of
security or collateral) by Landlord of all of (i) the Building, (ii) the Leased Premises, or (iii) this Lease, to an unrelated third party (the “Buyer”) reasonably acceptable to Tenant, Landlord shall, from and after the
date of such sale or assignment, be entirely relieved of all of its obligations under this Lease, provided that (i) such Buyer fully assumes all of the obligations of Landlord under this Lease, and (ii) Tenant’s rights and benefits
under this Lease continue in full force and effect following the date of such sale or assignment. 
 22.11 Entire Agreement,
Etc. This Lease and the Exhibits, Riders, and/or Addenda, if any, attached hereto, constitute the entire agreement between the parties. All Exhibits, riders, or addenda mentioned in this Lease are incorporated herein by reference. Any prior
conversations or writings are merged herein and extinguished. No subsequent amendment to this Lease shall be binding upon Landlord or Tenant unless reduced to writing and signed. Submission of this Lease for examination does not constitute an option
for the Leased Premises and becomes effective as a lease only upon execution and delivery thereof by Landlord to Tenant. If any provision contained in the rider or addenda is inconsistent with a provision in the body of this Lease, the provision
contained in said rider or addenda shall control. The captions and Section numbers appearing herein are inserted only as a matter of convenience and are not intended to define, limit, construe, or describe the scope or intent of any section or
paragraph. 
  

 22 

 22.12 Governing Law. The interpretation of this Lease shall be governed by the laws of
the State of Utah. The parties hereto expressly and irrevocably agree that either party may bring any action or claim to enforce the provisions of this Lease in the State of Utah, County of Salt Lake, and each party irrevocably consents to personal
jurisdiction in the State of Utah for the purposes of any such action or claim. Each party further irrevocably consents to service of process in accordance with the provisions of the laws of the State of Utah. Nothing herein shall be deemed to
preclude or prevent the parties hereto from bringing any action or claim to enforce the provisions of this Lease in any other appropriate place or forum. 
 22.13 Base Rent Reconciliation. Tenant and Landlord agree that there will be a final base rent reconciliation after the final construction costs have been determined. Therefore, effective on the Commencement Date, or
as soon as possible thereafter, Tenant agrees to pay to Landlord as Basic Annual Rent, including Parking, an amount equal to eleven and one-half (11.5) percent of the total project cost, which shall mean any and all “hard” and
“soft” costs and expenditures incurred by Landlord in connection with the acquisition, design, or construction of the Phase V building and parking. Tenant shall have the opportunity, upon request, to review Landlord’s records
regarding the total project costs related to Landlord’s work. Tenant and Landlord agree that the Basic Annual Rent and Parking rent contained herein are estimated and are based upon a budget attached to this lease as Exhibit E. Landlord and
Tenant shall execute an amendment to the Lease to reflect the calculation of Basic Annual Rent as outlined herein once the final total project costs have been determined. 
 XXIII. INTERIM LEASE 
 23.01 Interim Lease Definitions. The following capitalized terms will
have the following meanings for purposes of this Article XXIII. 
  

	 	a.	Interim Lease shall mean the temporary lease of space by Landlord to Tenant on the terms and conditions set forth in this Article XXIII. 

	 	b.	Interim Leased Premises shall mean approximately 72,000 sq. ft. of office and laboratory space at Landlord’s current premises, in buildings 1-4, located at 320 Wakara Way, Salt
Lake City, Utah as is currently being utilized by Tenant as of June 30, 2009. 

	 	c.	Interim Lease Term shall mean that period of time commencing on July 1, 2009, and ending on the Commencement Date as defined in section 2.2 above. 

 23.02 Interim Lease. Landlord shall lease the Interim Leased Premises to Tenant for the Interim Lease Term. 
 23.03 Interim Lease Rent. In consideration for the Interim Lease, Tenant agrees to pay to Landlord as basic monthly rent (the
“Monthly Rent”) at such place as Landlord may designate, without prior demand therefore and without any deduction or set off whatsoever, the sum of 

  

 23 

 
$275,000. The Monthly Rent shall be due and payable in advance on or before the first day of each calendar month during the Interim Lease Term, and shall be
prorated for any partial month at the conclusion of the Interim Lease Term. 
 23.04 No Additional Rents. The Interim Lease
Rent shall be inclusive of all utilities, property taxes, janitorial expenses and other common expenses with respect to Tenant’s occupancy of the Interim Leased Premises. 
 23.05 Responsibility for Damage. Tenant shall be responsible for any damage to the Interim Leased Premises occasioned by Tenant’s use
of, or exit from, the Interim Leased Premises. 
 23.06 Applicable Articles. For purposes of the Interim Lease, the provisions
of Articles VI, VIII, IX, X, XII, XIII, XIV, XV, XVI, XVII, XVIII, XIX, XX, XXI and XXII shall apply to Tenant and Landlord, and Tenant and Landlord shall comply with the terms and conditions of such Articles as applicable to Tenant and Landlord,
respectively, with respect to the Interim Leased Premises. 
 23.07 No Assignment. Tenant shall not transfer, assign,
mortgage, or hypothecate this Interim Lease, in whole or in part, or permit the use of the Interim Leased Premises by any person or persons other than Tenant, or sublet the Leased Premises, or any part thereof, without the prior written consent of
Landlord in each instance, which consent shall be at the sole discretion of Landlord. 
 23.08 Security Deposit. On
July 1, 2009, Tenant shall pay Landlord the sum of $275,000 (one month’s interim rent) as a Security Deposit to secure the performance of Tenant’s obligations under the Interim Lease. The Security Deposit shall be returned to Tenant
thirty (30) days following the date that Tenant has vacated the Interim Lease Premises, less any amounts that Landlord may reasonably retain as an off set to cover (i) any amounts due and owing Landlord under the Interim Lease; and
(ii) any repairs or damages to the Interim Leased Premises occasioned by Tenant’s use of, or exiting from, the Interim Leased Premises. 
 IN WITNESS WHEREOF, the Landlord and Tenant have executed this Lease on the day first set forth above. 
  

			
	LANDLORD: MYRIAD GENETICS, INC.
		
	By:	 	 
		 	 Peter D. Meldrum
 President and
CEO

  

 24 

			
	TENANT: MYRIAD PHARMACEUTICALS, INC.
		
	By:	 	 
		 	 Adrian Hobden
 President and CEO

  

 25 

 NOTARY 
 STATE OF UTAH 
 COUNTY OF SALT LAKE 
 On this ____ day of ______________, 2009, personally appeared before me Peter D. Meldrum
who duly acknowledged to me that he executed the foregoing Lease as the President and CEO of Myriad Genetics, Inc., a Delaware Corporation, and that said instrument was signed in behalf of said corporation by authority of its by-laws or a resolution
of its Board of Directors, and said Peter D. Meldrum acknowledged to me that said corporation executed the same. 
 On this ____ day ______,
2009, personally appeared before me Adrian Hobden, who being duly sworn, did say that he is the President and CEO of Myriad Pharmaceuticals, Inc., a DELAWARE Corporation, and that said instrument was signed in behalf of said corporation by authority
of its by-laws or a resolution of its Board of Directors, and said Adrian Hobden acknowledged to me that said corporation executed the same. 
  

									
		 		 	
				
	My Commission Expires:	 		 		 	 
		 		 		 		 	Notary Public

  

 26 

 EXHIBIT “A”  
 LEGAL DESCRIPTION OF PROPERTY  
 TO BE PROVIDED. 
  

 27 

 EXHIBIT “B”  
 PLANS AND SPECIFICATIONS OF BUILDING 
 EXHIBIT “B” TO BE PROVIDED.

  

 B-1 

 EXHIBIT “C” 
 WORK LETTER 
 CONSTRUCTION AND/OR FINISHING OF 
 IMPROVEMENTS TO LEASED PREMISES 
 In
accordance with the provisions of the body of the Lease to which this Exhibit “C” is attached, the improvements to the Leased Premises shall be constructed and/or finished (as the case may be) in the manner described, and upon all of the
terms and conditions contained in the following portion of this Exhibit “C”. 
  

	I.	CONSTRUCTION OF PHASE V BUILDING (“THE BUILDING”): 

 A. Landlord, through the BOYER RESEARCH PARK ASSOCIATES IX (“Boyer”), agrees to erect at Boyers’ sole cost and expense, the Building described on the Property described in Exhibit
“A.” Landlord shall build-out and finish the Leased Premises according to Tenant’s plans and specifications at Tenant’s cost and expense. The Building and the Leased Premises shall be constructed in a good and workmanlike manner,
with any change orders thereto approved by Landlord and Tenant with respect to the Leased Premises pursuant to Article B below, and in compliance with all applicable laws and ordinances. Preliminary Plans shall provide for a completely finished
building, of a type and quality that is consistent with newly constructed first-class office buildings in the Salt Lake City, Utah area, and shall include site plans showing all driveways, sidewalks, parking areas that provide parking in an amount
equal to two and 50/100 (2.50) cars for every 1,000 Usable Square Feet in the Building, landscaping and other site improvements. Without limiting the generality of the foregoing, Preliminary Plans shall provide for a three (3) story
building containing 87,000 rentable square feet of space and shall be generally consistent with the conceptual plans and drawings attached hereto as Exhibit “B” and incorporated herein (the “Conceptual Drawings”). The build-out
and interior finish work within the Leased Premises shall be in accordance with plans and specifications that shall be prepared by Boyer’s architect, Architectural Nexus Architects, and engineers (“Tenant Finish Plans”). Tenant Finish
Plans shall be prepared in accordance with the time periods set forth to meet a December 31, 2009 Target Date. The Target Date shall be extended by any period of Tenant’s delay in providing decisions that need to be made in connection with
the preparation of Tenant Finish Plans. 
 B. Tenant may make changes to Final Plans only if Tenant signs a change order requesting the
change and then only if Landlord and Boyer approves the change by signing the change order, which approval shall not be unreasonably withheld, conditioned, or delayed. Landlord shall notify Tenant in writing, within ten (10) business days of
Tenant’s change order request, of its approval or detailed reason of its disapproval of such change order and a good faith estimate of the actual cost of such change order and any delay to the Target Date or in achieving substantial completion
that would result there from. Tenant may, within five (5) business days of its receipt of such estimate, elect to rescind its request for such change order upon written notice to Landlord. Landlord may require changes in Final Plans only if
Landlord and Tenant sign a 
  

 C-1 

 change order. The cost of any change orders that are necessary to comply with applicable building codes and other laws
shall be borne by Landlord, unless such change orders are necessitated only because of (1) other change orders requested by Tenant; (2) Tenant Finish Plans; (3) changes to Tenant Finish Plans; or (4) Tenant’s early occupancy
to the Building prior to substantial completion of Landlord’s Work. Any change order shall be effective only when set forth on a written change order executed by Landlord, Tenant, and the Base Building General Contractor. By approving a change
order, Tenant and Landlord shall agree to a delay in Substantial Completion and to the Target Date, as specified therein, if any. 
 Tenant
shall furnish Landlord with a written list of Tenant’s authorized construction representatives for Landlord’s Work. Only such construction representatives are authorized to sign any change order, receipt, or other document on behalf of
Tenant related to Landlord’s Work, and without the signature of any one of such authorized construction representatives, no such document shall be binding upon Tenant. Tenant may, from time to time, change or add to the list of authorized
construction representatives by giving Landlord written notice of the addition or change. Landlord’s authorized representative shall be James Evans, and until changed by written notice from Landlord to Tenant, only James Evans shall be
authorized to sign change orders, receipts, or other documents on behalf of Landlord related to Landlord’s Work. 
 C. The Building Work
shall be performed by a general contractor selected by Boyer (the “Base Building General Contractor”). 
 D. Boyer will cause
Contractor to provide, at Contractor’s expense, an Owner’s Protective Liability (OPL) Policy acceptable to Landlord. The Owner’s Protective Liability Policy shall name Myriad Genetics, Inc. as the Named Insured. The policy will be
provided by an insurance company rated A, Class XV or better by Best’s Key Rating Guide system. The policy will maintain a limit of liability of not less than five million dollars ($5,000,000.00). Such insurance policy must be in force prior to
the commencement of construction operation of any kind. The Contractor will also insure the Building at Contractor’s expense during the course of construction in an amount equal to or greater than the value of the construction. Insurance
coverage shall be provided by an insurance company rated A, Class XV or better by Best’s Key Rating Guide system. Insurance coverage shall be provided on a coverage form equal to or more comprehensive than Insurance Services Office (U.S.A.)
Special form. Such insurance policy must be in force prior to construction operations of any kind. 
  

	II.	TENANT FINISH PLANS: 

 A. Landlord, through
Boyer, shall cause Architectural Nexus Architects (the “Architect”) to prepare plans and specifications for the interior improvement of the Building and the Leased Premises as necessary to render the Leased Premises in first-class
condition and suitable for the conduct of Tenant’s business (such improvement being referred to herein as the “Tenant Finish”). Landlord, through Boyer, shall require the Architect to meet periodically with Tenant in connection with
the preparation of the plans and, upon Landlord’s approval thereof (which approval shall not be unreasonably withheld), to incorporate Tenant’s requested features and specifications into the plans. Landlord shall submit a complete draft of
the plans to Tenant by an agreed to date (the “Base Line Date”). Tenant shall within seven (7) days after the plans are submitted to them, either approve the 

  

 C-2 

 
plans in writing or submit to Landlord a written itemization of all objections which Tenant may have to the plans. If Tenant approves the plans, the plans
shall be deemed final. If Tenant submits to Landlord a written itemization of objections to the plans, Landlord and Tenant shall negotiate in good faith to resolve Tenant’s objections to their mutual satisfaction. If Landlord and Tenant are
able to resolve all of Tenant’s objections to their mutual satisfaction, then Landlord and Tenant shall each approve the plans as modified to incorporate the resolution of Tenant’s objections and the plans as so modified shall be deemed
final. 
 B. Changes to Plans. After the plans are deemed final, the plans shall not be subject to further change except as provided
under this Paragraph. If either Landlord or Tenant desires any change to the plans after they are deemed final, it shall submit to the other for approval (which approval shall not be unreasonably withheld) a proposed change order, in writing,
setting forth the change. Thereupon the other party shall either approve the proposed change order or notify the party submitting the proposed change order of its reason for withholding such approval, within two (2) business days after receipt
of the proposed change order for approval. Without limiting the reasons for which approval of any proposed change order may be reasonably withheld, approval shall be deemed to have been reasonably withheld if the proposed change (1) would
result in additional construction maintenance repair or replacement costs which could not be fully borne by the party proposing the change, (2) would result in a violation of any applicable law, regulation, ordinance or code, or (3) in the
case of a change proposed by Landlord would materially reduce the usable area of the Building or would materially adversely affect the aesthetics of the Leased Premises or the usability thereof for the conduct of Tenant’s business. Upon
approval of any proposed change order pursuant to this Paragraph, Landlord shall cause the plans and construction contracts to be modified or amended as necessary to reflect such change order. 
 Landlord’s Construction Responsibilities. Landlord, through Boyer, shall be fully responsible for the installation and construction of Tenant Finish,
including, without limitation, the following: (1) the obtaining of all building and sign permits, licenses and other approvals required to construct the Tenant Finish; (2) the management and supervision of all architects, contractors,
subcontractors and material providers participating in the construction of the Tenant Finish; (3) all necessary coordination with governmental entities having jurisdiction over the Lease Premises and utility companies; (4) enforcement of
construction contracts; (5) security with respect to the Leased Premises during the construction period; (6) quality control and inspection of work; (7) construction clean up and refuse disposal; (8) construction timetables and
deadlines as necessary to comply with the Lease; (9) compliance with applicable laws, regulations, ordinances and codes; and (10) all other matters relating to the construction of the Tenant Finish, except as otherwise expressly provided
in the Lease. Landlord, through Boyer, represents and covenants that upon the completion of the Tenant Finish, the Leased Premises shall conform to the Tenant Finish Plans and shall be in compliance with all applicable laws, regulations, ordinances,
and codes, including, without limitation, applicable building codes and environmental laws. Tenant shall be entitled at any time during the construction period to inspect the construction of the Tenant Finish, provided that such inspection does not
unreasonably interfere with the construction of the Tenant Finish. No failure of Tenant to conduct such inspections or to discover or assert any defect in connection therewith shall 
  

 C-3 

 constitute a waiver by Tenant of, or preclude Tenant from thereafter asserting, any rights it may have with respect to
any representation, warranty or covenant made by Landlord, through Boyer, with respect to the Leased Premises or the Tenant Finish. 
 D.
Construction Contracts. Boyer shall act as general contractor with respect to, or install and construct using its own personnel, all or portions of the Tenant Finish, provided, however, Boyer shall contract with and use licensed, qualified
and reputable companies or persons for the performance of all such work to the extent Boyer is not licensed and fully qualified to perform the same. Boyer shall be entitled to select all contractors and material providers to perform work with
respect to the Tenant Improvements which Boyer does not elect to perform directly and to negotiate the terms and conditions of the contracts with such contractors and material providers. Notwithstanding Paragraphs C and D, Tenant may choose its own
contractor to perform Landlord’s work pursuant to Paragraphs C and D. 
 E. Warranty. Unless Tenant substitutes the contractor
pursuant to Paragraph D above, Landlord, through Boyer, warrants to Tenant for one (1) year after the Commencement Date of the Lease, that Tenant Finish shall be completed in a good and workmanlike manner, free from faulty materials, in
accordance with all applicable legal requirements, and sound engineering standards, and in accordance with the Final Plans and Tenant Finish Plans. Such warranty includes, without limitation, the repair or replacement (including labor), for one
(1) year at Boyer’s sole cost, of all materials, fixtures and equipment which are defective or which are defectively installed by Boyer or its agents in connection with Landlord’s Work. In addition, Boyer shall obtain
manufacturer’s warranties, including, without limitation, for air conditioner, compressors, and the roof of the Building. 
 F.
Commencement Date Agreement. When the Commencement Date has been determined, Landlord and Tenant shall execute Exhibit D (attached) expressly confirming the Commencement Date and the expiration date of the Initial Term of this Lease and
confirming, to the best knowledge of Tenant and Landlord, that Substantial Completion has occurred. 
 G. Tenant’s Construction
Obligations. Except as provided in paragraph C and D above, Tenant shall be fully responsible for the installation of all of Tenant’s trade fixtures, equipment, furnishings or decorations, except to the extent such installation is
contemplated or provided for in the Plans. Landlord shall provide Tenant reasonable access to the Leased Premises for such purposes. 
  

 C-4 

 EXHIBIT “D “ 
 ACKNOWLEDGMENT OF COMMENCEMENT DATE AND TENANT ESTOPPEL CERTIFICATE 
 TO: Myriad Genetics,
Inc. 
 RE: Lease Commencement Date 
  
  
 Gentlemen: 
  
  
  
  
  
 The undersigned hereby confirms the following: 
  

	1.	That it has accepted possession and is in full occupancy of the Leased Premises, that the Lease is in full force and effect, that Tenant has received no notice of any default of any
of its obligations under the Lease, and that the Lease Commencement Date is: ________________. 

  

	2.	That, to Tenant’s knowledge, the improvements and space required to be furnished according to the Lease have been completed and paid for in all respects, and that Landlord has
fulfilled all of its duties under the terms, covenants and obligations of the Lease and is not currently in default thereunder. 

  

	3.	That the Lease has not been modified, altered, or amended, and represents the entire agreement of the parties, except as follows: 

  
  

	4.	That, to Tenant’s knowledge, there are no offsets, counterclaims or credits against rentals, nor have rentals been prepaid or forgiven, except as provided by the terms of the
Lease. 

  

	5.	That said rental payments commenced or will commence to accrue on
                                        , and the
Lease term expires
                                         
   . 

  

 D-1 

	6.	That Tenant has no actual notice of a prior assignment, hypothecation or pledge of rents of the Lease,
except:                                        
                             

  

	7.	That this letter shall inure to your benefit and to the benefit of your successors and assigns, and shall be binding upon Tenant and Tenant’s heirs, personal representatives,
successors and assigns. This letter shall not be deemed to alter or modify any of the terms, covenants or obligations of the Lease. 

 The above statements are made with the understanding that you will rely on them in connection with the purchase of the above-referenced property. 
  

	
	Very truly yours,
	
	 
	

  

							
		 		 	
				
	Date of Signature:
                                         
   	 		 	By:	 	 
		 		 		 	
		 		 		 	

  

 D-2 

 EXHIBIT “E” 
 1-10-08 
 Myriad V 
 Cost Summary – Building 
 Square Feet 87,000 
  

							
	 Hard Costs
	  			  	 	S.F.
	 Shell/Site/Parking/Lab
	  	$	17,369,815	  	$	199.65
	 (Shoring, Storm Detention, Connector, Retaining Walls)
	  	$	1,699,053	  	$	19.53
		  			  	$	219.18
	 Additional Costs
	  			  		
	 A & E Fees
	  	$	800,000	  		
	 Permits/Fees/Testing
	  	$	200,000	  		
	 Contingency
	  	$	400,000	  	$	16.09
	 Total
	  	$	20,468,868	  	$	235.27
			
	 Soft Costs
	  			  		
	 Interest, Points, Legal, Title, Set up Fee, Construction Management Fee
	  	$	1,571,775	  	$	18.07
	 Net Project Cost
	  	$	22,040,643	  	$	253.34
		  	 	 	  	 	 
			
	 Lease Rate (11.5%)
	  			  		
	 Shell
	  	$	2,099,674	  	$	24.13
	 Parking
	  	$	435,000	  	$	5.00

  

 E-1 

 Cost Summary – Tenant Finish 
 [To Be Provided] 
  

 E-2 

 EXHIBIT “F” 
 IMPROVEMENT REMOVAL AGREEMENT 
 Landlord and Tenant agree that the following may be removed by
Tenant at end of the term, or at Landlord’s election, Tenant will sell to Landlord at a mutually agreeable price the following: 
 [To
Be Provided] 
  
  
  
  
  
  
  
 Notwithstanding the above, if Tenant removes the fixtures and any walls, ceilings,
or flooring are damaged by such removal, then Tenant at Tenant’s expense shall repair the damage. 
  

 F-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]